false Q3 --12-31 0001722731 0001722731 2026-01-01 2026-09-30 0001722731 2026-11-13 0001722731 2026-09-30 0001722731 2025-12-31 0001722731 us-gaap:SeriesAPreferredStockMember 2026-09-30 0001722731 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001722731 us-gaap:SeriesBPreferredStockMember 2026-09-30 0001722731 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001722731 2026-07-01 2026-09-30 0001722731 2025-07-01 2025-09-30 0001722731 2025-01-01 2025-09-30 0001722731 us-gaap:TechnologyServiceMember 2026-07-01 2026-09-30 0001722731 us-gaap:TechnologyServiceMember 2025-07-01 2025-09-30 0001722731 us-gaap:TechnologyServiceMember 2026-01-01 2026-09-30 0001722731 us-gaap:TechnologyServiceMember 2025-01-01 2025-09-30 0001722731 FDCT:WealthManagementMember 2026-07-01 2026-09-30 0001722731 FDCT:WealthManagementMember 2025-07-01 2025-09-30 0001722731 FDCT:WealthManagementMember 2026-01-01 2026-09-30 0001722731 FDCT:WealthManagementMember 2025-01-01 2025-09-30 0001722731 FDCT:BrokerageTradingMember 2026-07-01 2026-09-30 0001722731 FDCT:BrokerageTradingMember 2025-07-01 2025-09-30 0001722731 FDCT:BrokerageTradingMember 2026-01-01 2026-09-30 0001722731 FDCT:BrokerageTradingMember 2025-01-01 2025-09-30 0001722731 us-gaap:PreferredStockMember 2025-06-30 0001722731 us-gaap:CommonStockMember 2025-06-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001722731 FDCT:SubscriptionReceivableMember 2025-06-30 0001722731 us-gaap:NoncontrollingInterestMember 2025-06-30 0001722731 us-gaap:RetainedEarningsMember 2025-06-30 0001722731 2025-06-30 0001722731 us-gaap:PreferredStockMember 2026-06-30 0001722731 us-gaap:CommonStockMember 2026-06-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001722731 FDCT:SubscriptionReceivableMember 2026-06-30 0001722731 us-gaap:NoncontrollingInterestMember 2026-06-30 0001722731 us-gaap:RetainedEarningsMember 2026-06-30 0001722731 2026-06-30 0001722731 us-gaap:PreferredStockMember 2024-12-31 0001722731 us-gaap:CommonStockMember 2024-12-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001722731 FDCT:SubscriptionReceivableMember 2024-12-31 0001722731 us-gaap:NoncontrollingInterestMember 2024-12-31 0001722731 us-gaap:RetainedEarningsMember 2024-12-31 0001722731 2024-12-31 0001722731 us-gaap:PreferredStockMember 2025-12-31 0001722731 us-gaap:CommonStockMember 2025-12-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001722731 FDCT:SubscriptionReceivableMember 2025-12-31 0001722731 us-gaap:NoncontrollingInterestMember 2025-12-31 0001722731 us-gaap:RetainedEarningsMember 2025-12-31 0001722731 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001722731 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001722731 FDCT:SubscriptionReceivableMember 2025-07-01 2025-09-30 0001722731 us-gaap:NoncontrollingInterestMember 2025-07-01 2025-09-30 0001722731 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001722731 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001722731 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001722731 FDCT:SubscriptionReceivableMember 2026-07-01 2026-09-30 0001722731 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0001722731 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001722731 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001722731 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-09-30 0001722731 FDCT:SubscriptionReceivableMember 2025-01-01 2025-09-30 0001722731 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-09-30 0001722731 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001722731 us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-09-30 0001722731 FDCT:SubscriptionReceivableMember 2026-01-01 2026-09-30 0001722731 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-09-30 0001722731 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001722731 us-gaap:PreferredStockMember 2025-09-30 0001722731 us-gaap:CommonStockMember 2025-09-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001722731 FDCT:SubscriptionReceivableMember 2025-09-30 0001722731 us-gaap:NoncontrollingInterestMember 2025-09-30 0001722731 us-gaap:RetainedEarningsMember 2025-09-30 0001722731 2025-09-30 0001722731 us-gaap:PreferredStockMember 2026-09-30 0001722731 us-gaap:CommonStockMember 2026-09-30 0001722731 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001722731 FDCT:SubscriptionReceivableMember 2026-09-30 0001722731 us-gaap:NoncontrollingInterestMember 2026-09-30 0001722731 us-gaap:RetainedEarningsMember 2026-09-30 0001722731 us-gaap:SeriesBPreferredStockMember 2025-09-30 0001722731 FDCT:ADAdvisoryServicesLtdMember 2026-09-30 0001722731 FDCT:ADAdvisoryServicesLtdMember 2026-01-01 2026-09-30 0001722731 FDCT:CrestmarkTradingLtdMember 2026-09-30 0001722731 FDCT:CrestmarkTradingLtdMember 2026-01-01 2026-09-30 0001722731 FDCT:AlchemyPrimeLtdMember 2026-09-30 0001722731 FDCT:AlchemyPrimeLtdMember 2026-01-01 2026-09-30 0001722731 FDCT:TICGIntegratedSolutionsLtdMember 2026-09-30 0001722731 FDCT:TICGIntegratedSolutionsLtdMember 2026-01-01 2026-09-30 0001722731 FDCT:AlchemyInternationalLtdMember 2026-09-30 0001722731 FDCT:AlchemyInternationalLtdMember 2026-01-01 2026-09-30 0001722731 FDCT:XoalaAsiaMember 2026-09-30 0001722731 FDCT:XoalaAsiaMember 2026-01-01 2026-09-30 0001722731 FDCT:PrimeIntermarketGroupEurasiaMember 2026-09-30 0001722731 FDCT:PrimeIntermarketGroupEurasiaMember 2026-01-01 2026-09-30 0001722731 FDCT:AlchemyMarketsCaymanLtdMember 2026-09-30 0001722731 FDCT:AlchemyMarketsCaymanLtdMember 2026-01-01 2026-09-30 0001722731 FDCT:XoalaAPCyprusLtdMember 2026-09-30 0001722731 FDCT:XoalaAPCyprusLtdMember 2026-01-01 2026-09-30 0001722731 2026-06-29 0001722731 srt:MinimumMember 2026-09-30 0001722731 srt:MaximumMember 2026-09-30 0001722731 FDCT:XoalaAPCyprusLtdMember 2026-09-30 0001722731 FDCT:AlchemyMarketsCaymanLtdMember FDCT:SharePurchaseAgreementMember 2026-05-01 2026-05-01 0001722731 FDCT:AlchemyMarketsCaymanLtdMember 2026-06-19 2026-06-19 0001722731 FDCT:AlchemyPrimeHoldingsLimitedMember 2026-05-01 2026-05-01 0001722731 FDCT:MrKundnaniMember 2026-01-01 2026-09-30 0001722731 FDCT:AlchemyMarketsLtdMember 2026-09-30 0001722731 FDCT:AlchemyMarketsLtdMember 2026-01-01 2026-09-30 0001722731 2025-09-03 0001722731 2025-09-04 0001722731 us-gaap:SeriesBPreferredStockMember 2023-12-04 0001722731 us-gaap:SeriesBPreferredStockMember 2023-12-04 2023-12-04 0001722731 us-gaap:CommonClassAMember 2026-06-16 2026-06-16 0001722731 us-gaap:SeriesBPreferredStockMember 2026-07-13 0001722731 FDCT:SeriesBConvertiblePreferredStockMember 2026-07-13 0001722731 2026-08-16 0001722731 2026-08-17 0001722731 us-gaap:SeriesAPreferredStockMember 2026-08-16 0001722731 us-gaap:SeriesAPreferredStockMember 2026-08-17 0001722731 2026-08-17 2026-08-17 0001722731 2026-08-27 2026-08-27 0001722731 2026-08-28 2026-08-28 0001722731 2026-09-30 2026-09-30 0001722731 2026-08-20 0001722731 2026-09-15 0001722731 2026-09-15 2026-09-15 0001722731 FDCT:SharePurchaseAgreementMember 2026-08-07 0001722731 FDCT:SharePurchaseAgreementMember 2026-09-30 0001722731 2026-08-03 2026-08-03 0001722731 2026-09-18 2026-09-18 0001722731 2021-09-03 0001722731 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-09-30 0001722731 srt:ScenarioPreviouslyReportedMember 2026-01-01 2026-03-31 0001722731 2026-01-01 2026-03-31 0001722731 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2026-01-01 2026-03-31 0001722731 FDCT:ADAdvisoryServicesLtdMember 2026-03-31 0001722731 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2026-03-31 0001722731 2026-03-31 0001722731 FDCT:RestrictedCashMember 2026-09-30 0001722731 FDCT:RestrictedCashMember FDCT:ClientDesignatedBankMember 2026-09-30 0001722731 FDCT:RestrictedCashMember FDCT:ThirdPartyMember 2026-09-30 0001722731 us-gaap:SalesRevenueNetMember FDCT:SalesAndMarketingOneMember FDCT:CustomerMember 2026-07-01 2026-09-30 0001722731 us-gaap:SalesRevenueNetMember FDCT:SalesAndMarketingOneMember FDCT:CustomerMember 2025-07-01 2025-09-30 0001722731 us-gaap:SalesRevenueNetMember FDCT:SalesAndMarketingOneMember FDCT:CustomerMember 2026-01-01 2026-09-30 0001722731 us-gaap:SalesRevenueNetMember FDCT:SalesAndMarketingOneMember FDCT:CustomerMember 2025-01-01 2025-09-30 0001722731 2025-01-01 2025-12-31 0001722731 us-gaap:SoftwareInDevelopmentMember 2026-09-30 0001722731 us-gaap:SeriesBPreferredStockMember 2026-08-01 2026-08-31 0001722731 srt:ScenarioPreviouslyReportedMember 2026-03-31 0001722731 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2026-03-31 0001722731 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesAPreferredStockMember 2026-03-31 0001722731 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:SeriesAPreferredStockMember 2026-03-31 0001722731 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001722731 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesBPreferredStockMember 2026-03-31 0001722731 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:SeriesBPreferredStockMember 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001722731 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2026-01-01 2026-03-31 0001722731 2026-01-01 2026-06-30 0001722731 FDCT:PeriodEndUSDToAUDMember 2026-09-30 0001722731 FDCT:PeriodEndUSDToAUDMember 2025-12-31 0001722731 FDCT:PeriodEndUSDToEURMember 2026-09-30 0001722731 FDCT:PeriodEndUSDToEURMember 2025-12-31 0001722731 FDCT:PeriodEndUSDToGBPMember 2026-09-30 0001722731 FDCT:PeriodEndUSDToGBPMember 2025-12-31 0001722731 FDCT:AverageEndUSDToAUDMember 2026-09-30 0001722731 FDCT:AverageEndUSDToAUDMember 2025-09-30 0001722731 FDCT:AverageEndUSDToEURMember 2026-09-30 0001722731 FDCT:AverageEndUSDToEURMember 2025-09-30 0001722731 FDCT:AverageEndUSDToGBPMember 2026-09-30 0001722731 FDCT:AverageEndUSDToGBPMember 2025-09-30 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:CommonStockMember 2026-06-30 0001722731 FDCT:SeriesBConvertiblePreferredStockMember 2026-07-13 2026-07-13 0001722731 us-gaap:SeriesBPreferredStockMember 2026-07-13 2026-07-13 0001722731 us-gaap:SeriesAPreferredStockMember 2026-07-13 2026-07-13 0001722731 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001722731 FDCT:AlchemyInternationalLtdMember 2025-12-31 0001722731 FDCT:AlchemyDMCCMember 2026-09-30 0001722731 FDCT:AlchemyCaptialMarketMember 2026-09-30 0001722731 FDCT:SyncCaptialMember 2026-09-30 0001722731 2026-01-01 2026-12-31 0001722731 FDCT:ImranFirozMember 2026-01-01 2026-09-30 0001722731 FDCT:SyncCapitalLimitedMember 2026-09-30 0001722731 FDCT:MrKundnaniMember 2025-09-30 0001722731 FDCT:MrKundnaniMember 2025-12-31 0001722731 FDCT:IntellectualPropertyAgreementMember 2026-09-30 0001722731 us-gaap:IntellectualPropertyMember 2026-01-01 2026-09-30 0001722731 us-gaap:IntellectualPropertyMember 2026-09-30 0001722731 FDCT:IntellectualPropertyAgreementMember 2026-01-01 2026-09-30 0001722731 FDCT:BankOfAmericaMember 2016-06-30 0001722731 FDCT:BankOfAmericaMember srt:MinimumMember 2016-06-30 0001722731 FDCT:BankOfAmericaMember srt:MaximumMember 2016-06-30 0001722731 FDCT:BankOfAmericaMember 2016-06-01 2016-06-30 0001722731 FDCT:BankOfAmericaMember 2026-09-30 0001722731 FDCT:BankOfAmericaMember 2025-12-31 0001722731 FDCT:PaycheckProtectionProgramMember 2020-05-01 2020-05-01 0001722731 FDCT:PaycheckProtectionProgramMember 2020-05-01 0001722731 FDCT:PaycheckProtectionProgramMember 2026-09-30 0001722731 FDCT:PaycheckProtectionProgramMember 2025-12-31 0001722731 FDCT:SmallBusinessAdministrationMember 2020-05-22 2020-05-22 0001722731 FDCT:SmallBusinessAdministrationMember 2020-05-22 0001722731 FDCT:SmallBusinessAdministrationMember 2026-09-30 0001722731 FDCT:SmallBusinessAdministrationMember 2025-12-31 0001722731 FDCT:AlchemyMarketsLtdMember 2026-09-30 0001722731 FDCT:SyncCapitalLimitedMember 2026-09-30 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member 2026-08-20 0001722731 FDCT:VanquishFundingGroupPromissoryNotesMember 2026-08-20 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member 2026-08-20 2026-08-20 0001722731 FDCT:VanquishFundingGroupPromissoryNotes2Member 2026-08-20 0001722731 FDCT:VanquishFundingGroupPromissoryNotes2Member 2026-08-20 2026-08-20 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1And2Member 2026-08-20 2026-08-20 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member us-gaap:SubsequentEventMember 2027-02-28 2027-02-28 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member us-gaap:SubsequentEventMember 2027-03-30 2027-03-30 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member us-gaap:SubsequentEventMember 2027-04-30 2027-04-30 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member us-gaap:SubsequentEventMember 2027-05-30 2027-05-30 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1Member us-gaap:SubsequentEventMember 2027-06-30 2027-06-30 0001722731 2026-08-22 2026-08-22 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1And2Member 2026-01-01 2026-09-30 0001722731 FDCT:VanquishFundingGroupPromissoryNotes1And2Member 2026-09-30 0001722731 FDCT:LimassolCyprusPrincipalExecutiveOfficeMember 2026-09-09 2026-09-09 0001722731 FDCT:ADSOfficeMember 2026-01-01 2026-09-30 0001722731 FDCT:GeneralAndAdministrativeExpensesMember 2023-07-01 2026-06-30 0001722731 2023-07-31 2026-06-30 0001722731 FDCT:ATECHOfficeMember 2024-08-26 2024-08-26 0001722731 FDCT:ATECHOfficeMember 2024-08-26 0001722731 2026-07-26 2026-07-26 0001722731 2026-07-30 2026-07-30 0001722731 FDCT:AMLOfficeMember 2024-07-11 2024-07-11 0001722731 FDCT:AMLOfficeMember 2024-07-11 0001722731 FDCT:APLOfficeMember 2024-12-20 0001722731 FDCT:APLOfficeMember 2024-12-20 2024-12-20 0001722731 FDCT:APLSubsidiaryOfficeMember 2026-07-01 2026-09-30 0001722731 FDCT:APLSubsidiaryOfficeMember 2026-01-01 2026-09-30 0001722731 FDCT:EcasticaMember 2023-10-01 2024-08-31 0001722731 FDCT:EcasticaMember 2024-08-31 0001722731 FDCT:ChelyabinskMember 2019-04-01 2022-08-31 0001722731 FDCT:AMLSalesOfficeMember 2023-07-01 2026-06-30 0001722731 FDCT:ChiefExecutiveOfficerAndChiefFinancialOfficerMember 2018-09-01 2020-09-30 0001722731 FDCT:ChiefExecutiveOfficerAndChiefFinancialOfficerMember 2020-10-01 2020-10-01 0001722731 FDCT:ChiefExecutiveOfficerAndChiefFinancialOfficerMember 2023-01-01 2023-01-01 0001722731 FDCT:ShareSaleAgreementMember 2026-01-01 2026-09-30 0001722731 2023-09-23 0001722731 2021-02-12 0001722731 2022-02-16 0001722731 2022-02-17 0001722731 2022-02-17 2022-02-17 0001722731 2025-09-04 2025-09-04 0001722731 2026-06-28 0001722731 FDCT:SeriesBConvertiblePreferredStockMember 2026-09-30 0001722731 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-06-30 0001722731 2026-07-13 0001722731 us-gaap:SubsequentEventMember us-gaap:RestrictedStockMember 2026-11-03 2026-11-03 0001722731 us-gaap:SubsequentEventMember 2026-11-03 0001722731 us-gaap:SeriesAPreferredStockMember 2026-12-31 0001722731 us-gaap:SeriesBPreferredStockMember 2026-07-01 2026-09-30 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesAPreferredStockMember 2023-11-30 2023-11-30 0001722731 FDCT:AlchemyPrimeHoldingsLtdMember us-gaap:SeriesAPreferredStockMember 2023-11-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:MitchellMEaglsteinMember 2024-01-30 2024-01-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:FelixRHongMember 2024-01-30 2024-01-30 0001722731 2026-07-10 2026-07-10 0001722731 2026-08-31 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2023-11-30 2023-11-30 0001722731 FDCT:AlchemyMarketsLtdMember us-gaap:SeriesBPreferredStockMember 2023-11-30 0001722731 FDCT:AlchemyPrimeLtdMember us-gaap:SeriesBPreferredStockMember 2023-11-30 0001722731 FDCT:MitchellMEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:MitchellMEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:ImranFirozMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:ImranFirozMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:FRHGroupCorpMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:FRHGroupCorpMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:WilliamBBarnettMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:WilliamBBarnettMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:SusanEEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:SusanEEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-30 2024-01-30 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-30 0001722731 FDCT:NickyGKundnaniMember us-gaap:SeriesBPreferredStockMember 2025-02-07 2025-02-07 0001722731 FDCT:NickyGKundnaniMember us-gaap:SeriesBPreferredStockMember 2025-02-07 0001722731 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0001722731 FDCT:MitchEaglsteinMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:MitchEaglsteinMember 2024-12-31 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:GopeSKundnaniMember 2024-12-31 0001722731 FDCT:OfficersAndDirectorsMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:OfficersAndDirectorsMember 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-06-30 0001722731 FDCT:MitchellEaglsteinMember us-gaap:SeriesAPreferredStockMember 2016-12-12 2016-12-12 0001722731 FDCT:ImranFirozMember us-gaap:SeriesAPreferredStockMember 2016-12-12 2016-12-12 0001722731 FDCT:FelixRHongMember us-gaap:SeriesAPreferredStockMember 2016-12-12 2016-12-12 0001722731 FDCT:MitchellEaglsteinMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-01-31 0001722731 FDCT:ImranFirozMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-01-31 0001722731 us-gaap:SeriesAPreferredStockMember 2026-06-30 0001722731 FDCT:MitchEaglsteinMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:MitchEaglsteinMember 2026-09-30 0001722731 FDCT:ImranFirozMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:ImranFirozMember 2026-09-30 0001722731 FDCT:BrianPlattMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:BrianPlattMember 2026-09-30 0001722731 FDCT:JonathanBaumgartMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:JonathanBaumgartMember 2026-09-30 0001722731 FDCT:GopeSKundnaniMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:GopeSKundnaniMember 2026-09-30 0001722731 FDCT:OfficersAndDirectorsMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:OfficersAndDirectorsMember 2026-09-30 0001722731 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2026-11-03 2026-11-03 0001722731 us-gaap:CommonStockMember FDCT:SeriesBConvertiblePreferredStockMember 2026-09-30 0001722731 FDCT:CommonStockOneMember FDCT:SeriesBConvertiblePreferredStockMember 2026-09-30 0001722731 FDCT:CommonStockTwoMember FDCT:SeriesBConvertiblePreferredStockMember 2026-09-30 0001722731 FDCT:SeriesBConvertiblePreferredStockOneMember 2026-09-30 0001722731 FDCT:SeriesBConvertiblePreferredStockTwoMember 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:MrPlattMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:MrBaumgartMember 2026-01-01 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:MrKundnaniMember 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:AlchemyPrimeHoldingsLimitedMember 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:AlchemyPrimeHoldingsLimitedMember FDCT:DirectorsMember 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:AlchemyPrimeHoldingsLimitedMember FDCT:ExecutiveMember 2026-09-30 0001722731 us-gaap:CommonStockMember FDCT:AlchemyPrimeHoldingsLimitedMember FDCT:OfficersMember 2026-09-30 0001722731 FDCT:APSIMember 2026-01-01 2026-09-30 0001722731 FDCT:APSIMember 2026-07-13 2026-07-13 0001722731 FDCT:GopeSKundnaniMember 2026-01-01 2026-09-30 0001722731 FDCT:GopeSKundnaniMember 2026-07-13 2026-07-13 0001722731 FDCT:MitchellEaglsteinMember 2026-01-01 2026-09-30 0001722731 FDCT:MitchellEaglsteinMember 2026-07-13 2026-07-13 0001722731 FDCT:ImranFirozMember 2026-01-01 2026-09-30 0001722731 FDCT:ImranFirozMember 2026-07-13 2026-07-13 0001722731 FDCT:FRHGroupMember 2026-01-01 2026-09-30 0001722731 FDCT:FRHGroupMember 2026-07-13 2026-07-13 0001722731 FDCT:WilliamBBarnettMember 2026-01-01 2026-09-30 0001722731 FDCT:WilliamBBarnettMember 2026-07-13 2026-07-13 0001722731 FDCT:SusanEaglsteinMember 2026-01-01 2026-09-30 0001722731 FDCT:SusanEaglsteinMember 2026-07-13 2026-07-13 0001722731 FDCT:NickyKundnaniMember 2026-01-01 2026-09-30 0001722731 FDCT:NickyKundnaniMember 2026-07-13 2026-07-13 0001722731 us-gaap:CommonStockMember 2026-07-13 2026-07-13 0001722731 FDCT:ADSMember 2025-01-01 2025-09-30 0001722731 FDCT:AMLMember 2025-01-01 2025-09-30 0001722731 FDCT:APLMember 2025-01-01 2025-09-30 0001722731 FDCT:ATECHMember 2025-01-01 2025-09-30 0001722731 FDCT:ADSMember 2026-01-01 2026-09-30 0001722731 FDCT:AMLMember 2026-01-01 2026-09-30 0001722731 FDCT:APLMember 2026-01-01 2026-09-30 0001722731 FDCT:ATECHMember 2026-01-01 2026-09-30 0001722731 FDCT:AILMember 2026-01-01 2026-09-30 0001722731 FDCT:ADSMember 2026-07-01 2026-09-30 0001722731 FDCT:ADSMember 2025-07-01 2025-09-30 0001722731 FDCT:AMLMember 2026-07-01 2026-09-30 0001722731 FDCT:AMLMember 2025-07-01 2025-09-30 0001722731 FDCT:APLMember 2026-07-01 2026-09-30 0001722731 FDCT:APLMember 2025-07-01 2025-09-30 0001722731 FDCT:ATECHMember 2026-07-01 2026-09-30 0001722731 FDCT:ATECHMember 2025-07-01 2025-09-30 0001722731 FDCT:ADSMember 2025-10-29 0001722731 FDCT:AILMember 2025-10-29 0001722731 FDCT:SeriesBConvertiblePreferredStockMember 2026-01-01 2026-09-30 0001722731 FDCT:SeriesBConvertiblePreferredStockMember 2026-07-01 2026-07-12 0001722731 2026-08-27 0001722731 2026-08-28 0001722731 srt:MinimumMember 2026-01-01 2026-09-30 0001722731 srt:MaximumMember 2026-01-01 2026-09-30 0001722731 us-gaap:SubsequentEventMember 2026-10-06 2026-10-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:EUR utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended September 30, 2026

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File No. 000-56338

 

FDCTECH, INC.

(Exact name of the small business issuer as specified in its charter)

 

Delaware   81-1265459

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

Ground Floor, 10A Eleftheriou Venizelou Street

3035 Limassol, Cyprus

(Address of principal executive offices)

 

(877) 445-6047

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☒
Emerging growth company ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

The number of shares of Common Stock, $0.0001 par value, of the registrant outstanding on November 13, 2026, was 125,348,068.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
PART I.
     
  Item 1. Financial Statements. F-1
     
  Consolidated Balance Sheets as of September 30, 2026 (Unaudited), and December 31, 2025 (Audited; Restated) F-2
     
  Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited; Restated) F-3
     
  Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited; Restated) F-4
     
  Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited; Restated) F-6
     
  Notes to Unaudited Consolidated Financial Statements F-7
     
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
     
  Item 3. Quantitative and Qualitative Disclosures About Market Risks. 15
     
  Item 4. Controls and Procedures 15
     
PART II.
     
  Item 1. Legal Proceedings. 17
     
  Item 1A. Risk Factors. 17
     
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 17
     
  Item 3. Defaults Upon Senior Securities. 17
     
  Item 4. Mine Safety Disclosures. 17
     
  Item 5. Other Information. 18
     
  Item 6. Exhibits. 18
     
SIGNATURES 19
     
EXHIBIT INDEX 20

 

2

 

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (“Form 10-Q”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue, or other financial items; any statements of the plans, strategies, and objectives of management for future operations; any statements concerning proposed new products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties.

 

Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” “desire,” “goal,” “should,” “objective,” “seek,” “plan,” “strive” or “anticipate,” as well as variations of such words or similar expressions, or the negatives of these words. These forward-looking statements present our estimates and assumptions only as of the date of this Form 10-Q. Except for our ongoing obligation to disclose material information as required by the federal securities laws, we do not intend to and undertake no obligation to update any forward-looking statement. We caution readers not to place undue reliance on any such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes will likely vary materially from those indicated.

 

3

 

 

PART I.

 

Item 1. Financial Statements.

 

FDCTECH, INC.

 

Index to Consolidated Financial Statements

 

  Pages
   
Consolidated Balance Sheets as of September 30, 2026 (Unaudited), and December 31, 2025 (Audited; Restated) F-2
   
Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited; Restated) F-3
   
Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited; Restated) F-4
   
Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited; Restated) F-6
   
Notes to the Consolidated Financial Statements F-7

 

F-1

 

 

FDCTECH, INC.

 

CONSOLIDATED BALANCE SHEETS

 

   September 30, 2026   December 31, 2025 
   (Unaudited)   (Audited; Restated) 
         
Assets          
Current assets:          
Cash and cash equivalents  $21,415,387   $11,855,861 
Restricted cash (client funds, segregated)   11,729,042    5,813,888 
Accounts receivable, net of allowance for doubtful accounts of $209,357 and $22,382, respectively   264,372    188,415 
Prepaid – current   334,245    353,089 
Related party receivable   6,492,563    40,090,051 
Total Current assets   40,235,609    58,301,304 
Fixed assets, net   175,755    199,058 
Other Non-Current Assets          
Prepaid – non-current   200,958    244,008 
Capitalized software, net   1,760,022    1,480,246 
Investment through subsidiary   35,885    36,062 
Accrued income   5,010,848    279,889 
Acquired intangible assets   4,457,595    1,326,062 
Tax receivable   492,087    190,346 
Trade receivable   88,986    - 
Fair value of trading positions for the firm, profit   89,168    1,183,873 
Right of use (lease)   673,254    811,038 
Total assets  $53,220,167   $64,051,886 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $537,528   $166,212 
Line of credit   245,617    111,352 
Promissory notes, net of unamortized discount (Note 7)   425,545    - 
Accrued expenses, related party   1,040,112    532,287 
Business acquisition loan   350,000    2,350,000 
Related party advances   1,939,946    29,197,470 
Client funds payable   11,729,042    5,813,888 
Operating lease liability, current   106,969    165,692 
Other current liabilities   1,697,778    2,132,993 
Financial liability at fair value through profit and loss   85,856    - 
Income tax payable   128,031    - 
Total Current liabilities   18,286,424    40,469,894 
Deferred tax liabilities   156,525    377,975 
SBA loan – non-current   99,299    105,678 
Operating lease liability – non-current   283,437    364,655 
Accrued interest – non-current   109,502    42,396 
Total liabilities   18,935,187    41,360,598 
Commitments and Contingencies (Note 8)   -    - 
           
Stockholders’ Equity:          
Series A Preferred stock, par value $0.0001, 10,000,000 shares authorized, 4,500,000 and 4,500,000 issued and outstanding, as of September 30, 2026 and December 31, 2025   450    450 
Series B Preferred stock, par value $0.0001, 3,000,000 shares authorized, 0 and 2,371,844 issued and outstanding, as of September 30, 2026 and December 31, 2025, respectively (all Series B Preferred stock converted to common stock on July 13, 2026)   -    237 
Common stock, par value $0.0001, 750,000,000 and 500,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively; 125,323,068 and 4,230,868 shares issued and outstanding, as of September 30, 2026 and December 31, 2025, respectively   12,532    423 
Additional paid-in capital, Common Series A, Series B   22,532,234    26,959,111 
Subscription receivable   -    (8,000,000)
Accumulated other comprehensive income   73,872    296,257 
Accumulated surplus (deficit)   11,658,387    3,401,487 
Total FDCTech, Inc. stockholders’ equity   34,277,475    22,657,965 
Noncontrolling interest   7,505    33,323 
Total Stockholders’ Equity   34,284,980    22,691,288 
Total liabilities and stockholders’ equity  $53,220,167   $64,051,886 

 

See accompanying notes to the financial statements.

 

F-2

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

 

             
   Three Months Ended   Nine Months Ended 
   September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025 
   (Unaudited)   (Restated, Unaudited)   (Unaudited)   (Restated, Unaudited) 
Revenues                
Technology & software  $925,656   $1,361,636   $3,524,259   $3,353,598 
Wealth management   1,759,384    1,788,079    5,139,340    4,976,601 
Brokerage (Trading)   986,735    2,722,657    27,261,143    8,938,912 
Total revenue   3,671,775    5,872,372    35,924,742    17,269,111 
Cost of sales                    
Technology & software   -    -    115,610    - 
Wealth management   1,582,285    1,576,991    4,672,338    4,410,589 
Brokerage (Trading)   4,474,097    60,237    10,016,018    3,458,121 
Total cost of sales   6,056,382    1,637,228    14,803,966    7,868,710 
Gross Profit   (2,384,607)   4,235,144    21,120,776    9,400,401 
Operating expenses:                    
General and administrative   3,955,799    3,234,153    12,507,681    7,505,861 
Sales and marketing   102,376    317,379    720,763    887,520 
Depreciation   19,920    44,992    112,258    127,100 
Total operating expenses   4,078,095    3,596,524    13,340,702    8,520,481 
Operating income (loss)   (6,462,702)   638,620    7,780,074    879,920 
Other income (expense):                    
Other interest income (expense)   64,353    (172,107)   269,649    (156,638)
Other income (expense)   98,674    268,739    200,114    (99,364)
Total other income (expense)   163,027    96,632    469,763    (256,002)
Income (loss) before provision for income taxes   (6,299,675)   735,252    8,249,837    623,918 
Provision (benefit) for income taxes   -    -    -    - 
Net income (loss)   (6,299,675)   735,252    8,249,837    623,918 
Less: Net income (loss) attributable to noncontrolling interest   21,620    79,765    (7,065)   113,542 
Net income attributable to FDCTech’s shareholders   (6,321,295)   655,487    8,256,902    510,376 
Net income (loss) per common share, basic   (0.06)   0.15    0.21    0.12 
Net income (loss) per common share, diluted   (0.06)   0.15    0.07    0.12 
Weighted average number of common shares outstanding, basic   106,978,518    4,230,868    38,856,450    4,230,868 
Weighted average number of common shares outstanding, diluted   106,978,518    4,230,868    122,696,357    4,230,868 
Other comprehensive income (loss):                    
Change in foreign currency translation   (4,449)   (240,851)   (222,385)   96,584 
Total other comprehensive income (loss)   (4,449)   (240,851)   (222,385)   96,584 
Total comprehensive income (loss)   (6,304,124)   494,401    8,027,452    720,502 
Comprehensive income (loss) attributable to noncontrolling interests   10,299    44,289    (25,818)   69,077 
Comprehensive income (loss) attributable to FDCTech stockholders   (6,314,423)   450,112    8,053,270    651,425 

 

See accompanying notes to the financial statements

 

F-3

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

   Shares      Shares                      
   Preferred stock   Common stock  

Additional

Paid-in

  

Accumulated other

comprehensive

income

   Subscription   Noncontrolling  

Accumulated

Surplus

  

Total

Stockholders’

 
   Shares   Amount   Shares   Amount   Capital   (loss)   Receivable   Interest   (Deficit)   Equity 
Three months ended September 30, 2025 (Restated)                                                  
Balance, June 30, 2025 (Restated)   6,871,844   $687    4,230,868   $423   $18,501,488   $264,654   $(8,000,000)  $41,608   $(2,541,213)  $8,267,647 
Three months ended September 30, 2025 (Restated)                                                  
Change in APIC due to common control   -    -    -    -    (250,169)   -    -    -    -    (250,169)
FX gain (loss)   -    -    -    -    -    (240,851)   -         -    (240,851)
Net income (loss) attributable to noncontrolling interest   -    -    -    -    -    -    -    79,765    -    79,765 
Foreign currency translation — noncontrolling interest   -    -    -    -    -    -    -    (35,476)   -    (35,476)
Net income (loss) attributable to FDCTech shareholders   -    -    -    -    -    -    -         655,487    655,487 
Balance, September 30, 2025 (Restated)   6,871,844   $687    4,230,868   $423   $18,251,319   $23,803   $(8,000,000)  $85,897   $(1,885,726)  $8,476,403 
Three months ended September 30, 2026                                                  
Balance, June 30, 2026   6,871,844   $687    4,230,868   $423   $29,254,158   $78,321   $(8,000,000)  $(2,794)  $17,979,684   $39,310,479 
Three months ended September 30, 2026                                                  
Conversion of Series B Preferred stock into common stock   (2,371,844)   (237)   118,592,200    11,859    (11,622)   -    -    -    -    - 
Common stock issued for consulting services   -    -    2,500,000    250    914,750    -    -    -    -    915,000 
Stock subscription receivable settled   -    -    -    -    -    -    8,000,000    -    -    8,000,000 
Change in APIC due to common control   -    -    -    -    (7,625,052)   -    -    -    -    (7,625,052)
FX gain (loss)   -    -    -    -    -    (4,449)   -         -    (4,449)
Net income (loss) attributable to noncontrolling interest   -    -    -    -    -    -    -    21,620    -    21,620 
Foreign currency translation — noncontrolling interest   -    -    -    -    -    -    -    (11,321)   -    (11,321)
Rounding   -    -    -    -    -    -    -    -    (2)   (2)
Net income (loss) attributable to FDCTech shareholders   -    -    -    -    -    -    -    -    (6,321,295)   (6,321,295)
Balance, September 30, 2026   4,500,000   $450    125,323,068   $12,532   $22,532,234   $73,872   $-   $7,505   $11,658,387   $34,284,980 

 

F-4

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

   Preferred stock   Common stock  

Additional

Paid-in

  

Accumulated other

comprehensive

income

   Subscription   Noncontrolling  

Accumulated

Surplus

  

Total

Stockholders’

 
   Shares   Amount   Shares   Amount   Capital   (loss)   Receivable   Interest   (Deficit)   Equity 
Nine months ended September 30, 2025 (Restated)                                        
Balance, December 31, 2024 (Restated)   6,861,844   $686    3,910,868   $391   $16,922,337   $(72,781)  $(8,000,000)  $16,820   $(2,396,102)  $6,471,351 
Nine months ended September 30, 2025                                                  
Common stock issued for services   -    -    320,000    32    35,168    -    -         -    35,200 
Series B issuances at $1.41 per share   10,000    1    -    -    14,099    -    -         -    14,100 
Change in APIC due to common control   -    -    -    -    1,279,715    -    -    -    -    1,279,715 
FX gain (loss)   -    -    -    -    -    96,584    -         -    96,584 
Net income (loss) attributable to noncontrolling interest   -    -    -    -    -    -    -    113,542    -    113,542 
Foreign currency translation — noncontrolling interest   -    -    -    -    -    -    -    (44,465)   -    (44,465)
Net income (loss) attributable to FDCTech shareholders   -    -    -    -    -    -    -    -    510,376    510,376 
Balance, September 30, 2025 (Restated)   6,871,844   $687    4,230,868   $423   $18,251,319   $23,803   $(8,000,000)  $85,897   $(1,885,726)  $8,476,403 
Nine months ended September 30, 2026                                                  
Balance, December 31, 2025 (Restated)   6,871,844   $687    4,230,868   $423   $26,959,111   $296,257   $(8,000,000)  $33,323   $3,401,487   $22,691,288 
Nine months ended September 30, 2026                                                  
Conversion of Series B Preferred stock into common stock   (2,371,844)   (237)   118,592,200    11,859    (11,622)   -    -    -    -    - 
Common stock issued for consulting services   -    -    2,500,000    250    914,750    -    -    -    -    915,000 
Stock subscription receivable settled   -    -    -    -    -    -    8,000,000    -    -    8,000,000 
Change in APIC due to common control   -    -    -    -    (5,330,005)   -    -    -    -    (5,330,005)
FX gain (loss)   -    -    -    -    -    (222,385)   -         -    (222,385)
Net income (loss) attributable to noncontrolling interest   -    -    -    -    -    -    -    (7,065)   -    (7,065)
Foreign currency translation — noncontrolling interest   -    -    -    -    -    -    -    (18,753)   -    (18,753)
Rounding   -    -    -    -    -    -    -    -    (2)   (2)
Net income (loss) attributable to FDCTech shareholders   -    -    -    -    -    -    -    -    8,256,902    8,256,902 
Balance, September 30, 2026   4,500,000   $450    125,323,068   $12,532   $22,532,234   $73,872   $-   $7,505   $11,658,387   $34,284,980 

 

See accompanying notes to the financial statements

 

F-5

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

       
   Nine Months Ended 
   September 30, 2026   September 30, 2025 
   (Unaudited)   (Unaudited; Restated) 
Net income (loss)  $8,249,837   $623,918 
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   112,258    127,100 
Common stock issued for services   915,000    35,200 
Series B Preferred issued for services   -    14,100 
Amortization of debt discount — promissory notes   19,200    - 
Accounts receivable allowance   186,975    22,382 
Acquired intangible assets   33,757    (46,280)
Change in assets and liabilities:          
Accounts receivable, net of allowance for doubtful accounts   (262,932)   (303,254)
Prepaid – current and non-current   61,894    (339,637)
Related party receivable   (23,803,179)   (4,042,260)
Accounts payable   371,316    91,605 
Other current liabilities   (435,215)   (4,348,074)
Accrued interest – non-current   (1,549)   (25,114)
Client funds payable   5,915,154    5,924,533 
Fair value of trading positions, net of financial liability at fair value   1,180,561    (588,221)
Operating lease liabilities, current and non-current   (139,941)   (134,477)
Deferred tax liabilities   (221,450)   44,557 
Trade and Tax receivable and income tax payable   (173,710)   (22,439)
Trade receivables   (88,986)   - 
Accrued income   (4,730,959)   (685,715)
Right of use (lease)   137,784    123,703 
Accrued expenses, related party   507,825    12,500 
Net cash provided by (used in) operating activities  $(12,166,360)  $(3,515,873)
Investing Activities:          
Capitalized software, net   (367,154)   (224,177)
Purchases of fixed assets   (1,577)   (135,791)
Investment in private entities   177    - 
Net cash provided by (used in) investing activities  $(368,554)  $(359,968)
Financing Activities:          
Borrowing from (payments to) line of credit   134,265    64,037 
Proceeds from promissory notes, net of original issue discount and fees   475,000    - 
Net payments on SBA and PPP loans   (6,379)   (12,040)
Related party advances   32,839,241    (5,270,225)
Stock subscription receivable collected in cash and capital contributions / common-control adjustments to paid-in capital, net   66,277    1,279,715 
Net cash provided by (used in) financing activities  $33,508,404   $(3,938,513)
Effect of exchange rates on cash   (222,387)   96,584 
Change in noncontrolling interest share of subsidiary net assets   (18,753)   (44,465)
Non-cash assignment of liquidity-provider balance included within cash and cash equivalents   (5,257,670)   - 
Net increase (decrease) in cash   15,474,680    (7,762,235)
Cash and cash equivalents, and restricted cash at beginning of the period   17,669,749    25,376,957 
Cash and cash equivalents, and restricted cash at end of the period  $33,144,429   $17,614,722 
Cash paid for income taxes  $-   $- 
Cash paid for interest  $-   $- 
Non - cash investing and financing activities:          
Common-control combination — Alchemy Markets (Cayman) Ltd.:          
Consideration paid directly by principal shareholder on behalf of the Company  $581,266   $- 
Less: carryover book value of net assets acquired   (143,981)   - 
Deemed distribution to principal shareholder   437,285    - 
Common-control adjustment to APIC, net of subscription-settlement capital   (2,273,247)   1,279,715 
Excess consideration allocated to acquired intangible assets on consolidation of ADS   1,292,305    - 
Supplemental non-cash disclosures:          
Cash and cash equivalents acquired in the common-control combination   80,086    - 
Noncontrolling interest movements recognized directly in equity   (25,818)   (44,465)
Conversion of 2,371,844 shares of Series B Preferred stock into 118,592,200 shares of common stock   3,344,300    - 
Stock subscription receivable settled on a non-cash basis under the Settlement Agreement (Note 9)   5,660,476    - 
Reclassification of receivable from Iconic Advisors and Consulting Limited to acquired intangible assets under the IP Purchase Agreement (Note 5)   3,165,290    - 

 

See accompanying notes to the financial statements

 

F-6

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS

 

Organization and General

 

FDCTech, Inc. (“FDCTech,” “the Company,” “we,” “us,” or “our”) is a financial technology company incorporated in the State of Delaware, United States of America, specializing in developing and delivering innovative software solutions and business services to the over-the-counter (“OTC”) brokerage and financial services industries. The Company provides a range of proprietary and third-party technology solutions, including its flagship Condor Trading Technology, which supports multi-asset trading, risk management, and pricing for foreign exchange, equities, commodities, and digital assets. The Company is publicly traded on the OTC markets under the ticker symbol OTC: FDCT and is a fully reporting public company subject to the reporting obligations of the Securities Exchange Act of 1934, as amended.

 

The Company was founded in January 2016 as a back-office technology solution provider to the OTC brokerage and financial services industries and has transformed into a comprehensive, end-to-end trading platform offering foreign exchange (“FX”), contracts for difference (“CFDs”), equities, bonds, and wealth management services. The Company follows a strategic growth model centered on acquiring, integrating, and scaling legacy financial services firms, and through its acquisitions has expanded its global footprint in wealth management, brokerage, and financial advisory services. These acquisitions and formations include AD Advisory Services Pty Ltd. (2021), Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (2022–2023), Alchemy Prime Limited (2023), Alchemytech Ltd., now T.I.C.G. Integrated Solutions Ltd. (2024), Alchemy International Ltd. (2025), XOALA (formerly Xoala Asia) (2025), and Alchemy Markets (Cayman) Ltd. (2026), collectively expanding the Company’s operational footprint across Australia, Malta, the United Kingdom, Cyprus, Seychelles, Mauritius, and the Cayman Islands.

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries (collectively, the “Company”) for the three and nine months ended September 30, 2026. All intercompany balances and transactions have been eliminated in consolidation.

 

Corporate Structure and Subsidiaries

 

FDCTech, Inc. serves as the parent holding company. The following table presents the Company’s consolidated subsidiaries as of September 30, 2026:

 

Subsidiary   Ownership   Jurisdiction   Primary Business   Markets Served   Technology
AD Advisory Services Ltd. (ADS)   51.00%   Australia   Wealth Management   Australia   Third-party software
Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (Crestmark or AML)   100.00%   Malta   FX, CFDs, Stocks, Bonds   Europe (excl. UK)   Condor Trading & Third-party
Alchemy Prime Ltd. (APL)   100.00%   United Kingdom   FX, CFDs   United Kingdom   Condor Trading & Third-party
T.I.C.G. Integrated Solutions Ltd. (ATECH)   100.00%   Cyprus   Technology Services   Europe   Condor Trading
Alchemy International Ltd. (AIL)   99.90%   Seychelles   FX, CFDs   Asia   Condor Trading & Third-party
XOALA (formerly Xoala Asia) (XOA)   100.00%   Mauritius   Payment Intermediary Services   Asia   Third-party
Prime Intermarket Group Eurasia (PIG)   100.00%   Mauritius   FX, CFDs   Asia   Condor Trading & Third-party
Alchemy Markets (Cayman) Ltd. (AML Cayman)   100.00%   Cayman Islands   Securities Investment Business (Broker/Dealer)   International   Condor Trading & Third-party
Xoala AP Cyprus Ltd. (XOA, Cyprus)   100.00%   Cyprus   Intra-group Treasury and Payment Processing   Europe   Third-party

 

The Company consolidates all subsidiaries in which it holds a controlling financial interest. AD Advisory Services Ltd. (ADS) is consolidated as a majority-owned subsidiary (51.00% ownership), with the remaining 49.00% recognized as a noncontrolling interest in the consolidated balance sheet and statements of operations. Alchemy International Ltd. (AIL) is consolidated at 99.90% ownership, with the remaining 0.10% recognized as a noncontrolling interest. All other subsidiaries are wholly owned (100%) and fully consolidated. Xoala AP Cyprus Ltd. is held 100% through XOALA.

 

F-7

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS (continued)

 

Nature of Operations

 

The Company operates through four complementary business segments, as follows:

 

(a) Margin Brokerage

 

Through Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (Malta, regulated by the Malta Financial Services Authority (“MFSA”)), Alchemy Prime Limited (United Kingdom, regulated by the Financial Conduct Authority (“FCA”)), and Alchemy International Ltd. (Seychelles, regulated by the Financial Services Authority (“FSA”)), the Company provides multi-asset online trading services—including foreign exchange (“FX”), contracts for difference (“CFDs”), equities, commodities, and digital assets—to retail and institutional clients globally.

 

(b) Wealth Management

 

Through AD Advisory Services Pty Ltd. (Australia, regulated by the Australian Securities and Investments Commission (“ASIC”)), the Company operates a wealth management business with 26 financial advisors collectively managing and advising on approximately $770 million in funds under advice as of September 30, 2026. This segment provides licensing solutions and financial planning services to independent financial advisors operating under the Company’s Australian Financial Services license.

 

(c) Technology and Software Development

 

Through FDCTech, Inc. and T.I.C.G. Integrated Solutions Ltd. (Cyprus), a technology, sales, and marketing service provider supporting the Company’s subsidiaries and affiliated companies, the Company develops, licenses, and supports its proprietary Condor Trading Technology suite, which includes the Condor Pro Multi-Asset Trading Platform and the Condor Risk Management back-office system. This technology supports multi-asset trading, risk management, and pricing across FX, equities, commodities, and digital assets and is utilized both internally across the Company’s brokerage subsidiaries and licensed to third-party brokerage firms.

 

(d) Payment Intermediary Services

 

Through XOALA (formerly Xoala Asia) (Mauritius, licensed by the Financial Services Commission (“FSC”)), the Company is developing a payment gateway, merchant acquiring, and cross-border payment capabilities to complement its brokerage and wealth management operations. As of September 30, 2026, this segment remains in the development stages and has not yet generated material revenue.

 

Regulatory Environment

 

The Company’s brokerage and wealth management subsidiaries operate under licenses and regulatory oversight from multiple international financial regulatory authorities, including the MFSA (Malta), FCA (United Kingdom), FSA (Seychelles), ASIC (Australia), FSC (Mauritius), and, following the acquisition of AML Cayman in June 2026 described below, CIMA (Cayman Islands). The Company’s Cyprus subsidiaries, T.I.C.G. Integrated Solutions Ltd. and Xoala AP Cyprus Ltd., provide intra-group technology, treasury, and payment-processing services; XOA, Cyprus operates under the intra-group exemption in Section 3(3)(n) of the Cyprus Payment Services Law and does not hold a Central Bank of Cyprus payment institution or electronic money institution license. The Company is required to maintain minimum regulatory capital levels and comply with ongoing reporting, conduct-of-business, and anti-money-laundering obligations in each of its operating jurisdictions. Regulatory compliance and capital adequacy are monitored by management on an ongoing basis.

 

Going Concern Consideration

 

These consolidated financial statements have been prepared on a going concern basis, which assumes the Company will continue its operations for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. Management has evaluated the Company’s ability to continue as a going concern in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 205-40, Presentation of Financial Statements—Going Concern. The Company’s assessment of going concern, including any identified conditions or events that may raise substantial doubt, and management’s plans to mitigate such conditions, are further described in Note 3.

 

Fiscal Year

 

The Company’s fiscal year ends on December 31. The consolidated financial statements presented herein are as of and for the three and nine months ended September 30, 2026.

 

Reverse Stock Split

 

On June 29, 2026, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the reverse stock split, with any resulting fractional share rounded up to the nearest whole share for each holder of record. The Financial Industry Regulatory Authority announced the reverse stock split on its Daily List on July 9, 2026, and the reverse stock split became effective, and the Company’s Common Stock began trading on a post-split basis, at the open of business on July 10, 2026. The number of authorized shares of Common Stock was not affected by the reverse stock split.

 

In accordance with ASC 260-10-55-12 and SEC Staff Accounting Bulletin Topic 4C, because the reverse stock split became effective on July 10, 2026, during the three months ended September 30, 2026, all share and per-share amounts in these consolidated financial statements and the accompanying notes have been retroactively adjusted to reflect the reverse stock split for all periods presented. The retroactive adjustment reduced the number of shares of Common Stock issued and outstanding at December 31, 2025, from 423,084,729 to 4,230,868, after rounding fractional shares up to the nearest whole share for each holder of record, reduced the par value of Common Stock from $42,308 to $423 with the difference of $41,885 reclassified to additional paid-in capital, and correspondingly adjusted weighted average shares outstanding and earnings per share for each period presented. The reverse stock split had no effect on total stockholders’ equity, total assets, total liabilities, net income (loss), or cash flows for any period presented.

 

Board of Directors

 

At present, the Company has four members of the Board of Directors. Mitchell M. Eaglstein is the acting Chairman of the Company. Mitchell M. Eaglstein and Imran Firoz are the Company’s executive directors and officers. Gope S. Kundnani is not an independent director because he beneficially owns more than 10% of the Company’s outstanding stock. Jonathan Baumgart is an independent director under NYSE and NASDAQ listing standards.

 

Mitchell M. Eaglstein and Imran Firoz have been Executive Directors of the Company since January 21, 2016.

 

On June 15, 2021, the Company appointed Jonathan Baumgart as the Director of the Company.

 

On September 30, 2022, the Company appointed Gope S. Kundnani as the Director of the Company.

 

F-8

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS (continued)

 

Recent Acquisitions and Developments

 

Acquisition of Alchemy International Ltd.

 

On November 11, 2025, the Company finalized the acquisition of Alchemy International Ltd., a Seychelles-licensed securities dealer regulated under license number SD136 by the Financial Services Authority (FSA). The change of control was approved on October 29, 2025, by the FSA.

 

Establishment of Xoala Asia

 

On November 6, 2025, Xoala Asia was granted a Payment Intermediary Services license by the Financial Services Commission of Mauritius (license no. GB25204956). Management is in the process of implementing the compliance, technology, and operating framework required by the FSC (including AML/CFT, safeguarding of client funds where applicable, operational resilience, data protection, and reporting). There has been no activity in Xoala Asia for the three and nine months ended September 30, 2026.

 

Establishment of Prime Intermarket Group Eurasia

 

Effective January 1, 2026, we commenced start-up work under Prime Intermarket Group Eurasia (FXPIG), a Mauritius-based private limited company under Section 24 of the Companies Act. The company was originally established in May 2025, with no operations.

 

Name Change of Alchemytech Ltd.

 

In June 2026, Alchemytech Ltd. changed its name to T.I.C.G. Integrated Solutions Ltd. (“ATECH” or “TICG”). The name change did not affect the Company’s ownership of, or the nature of the services provided by, that subsidiary.

 

Xoala AP Cyprus Ltd.

 

Xoala Asia holds 100% of Xoala AP Cyprus Ltd. (“XOA, Cyprus”), a Cyprus-incorporated subsidiary that provides intra-group treasury and payment-processing services. Under the intra-group exemption in Section 3(3)(n) of the Cyprus Payment Services Law, no Central Bank of Cyprus payment institution or electronic money institution license is required for XOA, Cyprus.

 

Acquisition of Alchemy Markets (Cayman) Ltd.

 

On May 1, 2026, the Company entered into a Share Purchase Agreement with Mr. Raymond Yip, who held the shares subject to the direction of Mr. Gope S. Kundnani, a Director and majority shareholder of the Company, to acquire all 100 issued and outstanding shares of Alchemy Markets (Cayman) Ltd. (“AML Cayman”), a Cayman Islands company incorporated on November 7, 2017, and licensed and regulated by the Cayman Islands Monetary Authority (“CIMA”) under License No. 1612590 to conduct securities investment business. AML Cayman holds a Broker/Dealer license, which authorizes it to buy, sell, subscribe for, or underwrite securities.

 

The aggregate purchase price is $250,000, payable in two installments: a closing payment of $70,000 due within thirty (30) days of execution of the Share Purchase Agreement, and a regulatory payment of $180,000 due within five (5) business days following receipt of CIMA approval of the change of control. In addition, the Company agreed to pay the seller $107,758 in respect of the regulatory own funds capital of AML Cayman.

 

On May 19, 2026, CIMA granted conditional approval under Section 8(1) of the Securities Investment Business Act (2020 Revision) for the change in the shareholding and control of AML Cayman, resulting in a change of the ultimate beneficial owner from Mr. Raymond Yip to Mr. Gope Shyamdas Kundnani. The conditional approval requires the licensee to deliver specified board resolutions, director due diligence documentation, an updated register of members, and an updated business plan including outsourcing arrangements, in each case within one (1) month of approval. The transfer of the 100 shares from Mr. Yip to the Company was entered in AML Cayman’s register of members on June 19, 2026, from which date the Company became the sole legal and beneficial owner of AML Cayman.

 

Because AML Cayman was under the control of Mr. Kundnani both before and after the transfer, the transaction is a transfer of an entity under common control and has been accounted for in accordance with ASC 805-50, Business Combinations — Related Issues. The assets and liabilities of AML Cayman have accordingly been recorded at the transferor’s historical carrying values, applied prospectively from the date of transfer, consistent with the Company’s treatment of its other transfers of entities under common control described in Note 2. No goodwill or intangible asset was recognized in connection with the transfer, and no fair value measurement of the assets acquired or liabilities assumed was performed. AML Cayman conducted no material operations during the period, and its results of operations for the nine months ended September 30, 2026, have been included in the consolidated statements of operations; the amounts attributable to the period prior to the transfer are not material to the Company’s consolidated results of operations for any period presented.

 

Consideration for the acquisition was $250,000. The consideration was paid directly to the seller by Mr. Gope S. Kundnani, a Director and majority shareholder of the Company, on the Company’s behalf, and was initially recorded as a capital contribution to additional paid-in capital. Under the Settlement Agreement described in Note 9, effective September 30, 2026, the $250,000 was redesignated as a payment applied against the stock subscription receivable due from Mr. Kundnani, with a corresponding reversal of the capital contribution. The Company made no cash payment in respect of the acquisition, and accordingly the acquisition is reflected as a non-cash transaction and is not presented within investing activities in the condensed consolidated statement of cash flows. The seller has been settled in full.

 

F-9

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS (continued)

 

AML Cayman is licensed to conduct securities investment business and, in the period from the acquisition date through September 30, 2026, did not conduct material brokerage operations. For the nine months ended September 30, 2026, AML Cayman contributed revenue of $149,769, general and administrative expenses of $107,846, and net income of $41,195, representing approximately 0.4% of consolidated total revenue, 0.9% of consolidated general and administrative expenses, and 0.5% of consolidated net income, respectively.

 

Name Changes of Alchemy Markets Ltd. and Xoala Asia

 

On June 1, 2026, the Malta Financial Services Authority (“MFSA”) confirmed its no objection to a change in the name of the Company’s wholly owned Maltese subsidiary, Alchemy Markets Ltd. (C 56519) (“AML”), to “Crestmark Trading Ltd.” On August 24, 2026, the Malta Business Registry issued an altered certificate of registration under Article 80 of the Companies Act, 1995 reflecting the new name, effective that date. The name change does not affect AML’s ownership, governance, capital position, or regulated activities, and has no effect on the Company’s consolidated financial statements. The subsidiary is referred to as “Crestmark” or “AML” in this Report. Separately, on August 26, 2026, the Registrar of Companies of Mauritius certified that Xoala Asia had changed its name to “XOALA”; the name change has no effect on its ownership, governance, capital position, or licensed activities.

 

Recent Corporate Actions

 

On September 4, 2025, our Board of Directors unanimously approved, and we obtained the written consent of holders of a majority of our voting power for, corporate actions to (i) amend our Certificate of Incorporation to increase the number of authorized shares of common stock from 500,000,000 to 750,000,000 and the number of authorized shares of preferred stock from 10,000,000 to 15,000,000; and (ii) authorize our Board of Directors, in its discretion, to amend our Certificate of Incorporation not later than June 30, 2026, to effect a reverse stock split of all outstanding shares of common stock in a ratio of not less than 1-for-10 and not more than 1-for-100, to be determined by the Board. The increase in authorized shares of common stock was effected by the Certificate of Amendment filed with the Secretary of State of the State of Delaware on June 29, 2026, which also effected the reverse stock split, and the increase in authorized shares of preferred stock from 10,000,000 to 15,000,000 was effected by a Certificate of Amendment filed on August 17, 2026. Following these amendments, the Company is authorized to issue 765,000,000 shares of capital stock, consisting of 750,000,000 shares of common stock and 15,000,000 shares of preferred stock.

 

Certificate of Designation of Series B Convertible Preferred Stock

 

On December 4, 2023, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series B Certificate of Designation designates 3,000,000 shares of the Company’s authorized preferred stock (par value $0.0001 per share) as “Series B Convertible Preferred Stock” and establishes the rights, preferences, privileges, and restrictions of such shares, including a conversion rate of one hundred (100) shares of Common Stock for each one share of Series B Convertible Preferred Stock. Section 4(f) of the Series B Certificate of Designation provides that the conversion rate is not adjusted for stock dividends, splits, combinations or reclassifications of the Common Stock. The principal terms of the Series B Convertible Preferred Stock are described further in Note 9.

 

Reorganization of Alchemy Markets Ltd. Shareholding

 

On June 16, 2026, the MFSA confirmed, in terms of Article 10 of the Investment Services Act (Malta), its no objection to the transfer of 1,629,999 ordinary A shares in Alchemy Markets Ltd. (“AML”) from Alchemy Markets Holdings Ltd. to FDCTech, Inc. Alchemy Markets Holdings Ltd. formed part of a prior ownership structure that the Company inherited on its acquisition of AML and no longer serves a functional purpose within the group; the transfer removes it from the ownership chain so that AML is held directly by FDCTech, Inc. The consideration for the transfer is €100, reflecting its character as an internal corporate reorganization. There is no change to the ultimate beneficial ownership of AML and no change or impact to AML’s governance, capital position, or regulated activities. Because both entities were under the common control of the Company both before and after the transfer, the reorganization has no effect on the Company’s consolidated financial position, results of operations, or cash flows for any period presented. The MFSA’s no objection was provided solely from a regulatory viewpoint. The relevant statutory forms have since been filed with the Malta Business Registry and the transfer has been completed.

 

Conversion of Series B Convertible Preferred Stock

 

On July 13, 2026, the Board of Directors, acting by unanimous written consent, approved and the Company effected the conversion of all 2,371,844 outstanding shares of Series B Convertible Preferred Stock into 118,592,200 shares of Common Stock at a conversion rate of fifty (50) shares of Common Stock for each one (1) share of Series B Convertible Preferred Stock. The reverse stock split constituted a Rate Determination Event under the Series B Certificate of Designation, as amended, pursuant to which the Board determined and fixed the conversion rate. Following the conversion, no shares of Series B Convertible Preferred Stock remain outstanding. The conversion was recorded as a non-cash reclassification of $3,344,300 from Series B Preferred stock and the related additional paid-in capital to common stock and additional paid-in capital, with no effect on total stockholders’ equity. See Note 9.

 

August 2026 Charter and Certificate of Designation Amendments

 

On August 17, 2026, the Company filed with the Secretary of State of the State of Delaware (i) a Certificate of Amendment of its Certificate of Incorporation increasing the number of authorized shares of preferred stock from 10,000,000 to 15,000,000, (ii) a Certificate of Amendment to the Certificate of Designation of the Series A Convertible Preferred Stock, which increased the number of shares designated as Series A Preferred Stock from 4,000,000 to 10,000,000, confirmed that each share is entitled to fifty (50) non-cumulative votes per share not adjusted for the reverse stock split, and eliminated all conversion and exchange rights, and (iii) a Certificate of Amendment to the Certificate of Designation of the Series B Convertible Preferred Stock, which, among other things, provides that upon a Rate Determination Event the Board may fix the conversion rate within a range of not more than 100 and not less than 10 shares of Common Stock per share and ratified the conversion rate of 50 shares fixed effective July 13, 2026. See Note 9.

 

Common Stock Issued for Consulting Services

 

On August 27, 2026, and August 28, 2026, the Company issued 1,500,000 and 1,000,000 restricted shares of Common Stock, respectively, to two consultants in consideration of consulting services. The 2,500,000 shares were valued at an aggregate of $915,000 based on the closing price of the Common Stock on the respective issuance dates, which was recognized in general and administrative expenses during the three months ended September 30, 2026. See Note 9.

 

Vanquish Funding Group Promissory Notes

 

On August 20, 2026, and September 15, 2026, the Company entered into Securities Purchase Agreements with Vanquish Funding Group Inc. (“Vanquish”) and issued promissory notes in the aggregate principal amounts of $329,940 and $242,190, respectively, which include original issue discount, for aggregate cash purchase prices of $475,000. The notes bear a one-time interest charge of 12% of principal, are payable in installments through June 30, 2027, and are convertible into Common Stock only following an event of default. The notes are described in Note 7.

 

F-10

 

 

Share Purchase Agreement for the Acquisition of The Millionaire’s Club Ltd

 

On August 7, 2026, the Company entered into a Share Purchase Agreement with TMC Holdings Ltd to acquire 100% of the issued and outstanding share capital of The Millionaire’s Club Ltd, a Malta company holding Type 1, Type 2 and Type 3 business-to-consumer gaming licenses issued by the Malta Gaming Authority (the “MGA”), for a purchase price of €150,000, consisting of a non-refundable deposit of €85,000 paid to an escrow agent in connection with the execution of the letter of intent and a non-refundable balance of €65,000 payable to the escrow agent at closing. As a condition precedent to closing, the Seller and its ultimate beneficial owner are required to deliver irrevocable waiver declarations extinguishing shareholder liabilities of the acquired company aggregating €821,098. Closing is deemed to occur upon submission of the executed share transfer documentation to the Malta Business Registry, and the Company is responsible for obtaining the MGA’s approval of the change of ownership following closing. As of September 30, 2026, closing had not occurred, and no assets or liabilities of The Millionaire’s Club Ltd have been recognized in the consolidated financial statements; the deposit paid, amounting to $173,610, is included in tax and other receivables on the consolidated balance sheet.

 

Term Sheet for the Acquisition of Larstal Limited

 

On August 3, 2026, the Company entered into a non-binding term sheet to acquire the entire issued share capital of Larstal Limited, a United Kingdom company authorized by the Financial Conduct Authority, and its Danish subsidiary, for aggregate consideration of $2,350,000. Amounts paid under the term sheet become non-refundable as paid, other than in limited circumstances. As of September 30, 2026, the Company had paid deposits of $234,976 under the term sheet, which are included in tax and other receivables on the consolidated balance sheet. On October 6, 2026, the Company entered into definitive share purchase agreements for the acquisition of Larstal Limited and Larstal Denmark ApS; see Note 16. Completion is subject to change-of-control approvals in the United Kingdom and Denmark, and there can be no assurance that the acquisition will be completed.

 

Conditional Appointment of Directors

 

On September 18, 2026, the Board of Directors approved an increase in the size of the Board from four to six directors and appointed Jeff M. Pies and Dena Lauren Decker to fill the resulting vacancies. The increase in Board size and each appointment are conditional and will become effective only on the date on which the Company’s common stock is approved for listing on The Nasdaq Stock Market LLC or the New York Stock Exchange and all conditions to such approval, other than the commencement of trading, have been satisfied. If that date does not occur on or before September 18, 2028, the appointments will lapse. On September 18, 2026, the Company entered into a Board of Directors Agreement with each director designee providing, from the effective date, for an annual cash fee of $35,000, an additional annual fee of $15,000 for each standing committee chaired, a one-time award of $7,500 upon obtaining a recognized directorship certification and $2,500 per year while maintained, and reimbursement of expenses, together with customary indemnification agreements. Under related side letters, the Company agreed to bind conforming directors’ and officers’ liability insurance by October 18, 2026, failing which a director designee may terminate his or her agreement (see Note 16). No compensation expense was recognized under these agreements during the three months ended September 30, 2026, as the appointments had not become effective.

 

Nasdaq Listing Application

 

In September 2026, the Company submitted an application to list its common stock on The Nasdaq Stock Market LLC (“Nasdaq”) and the related corporate governance certification. The application remains under review by Nasdaq. Approval of the application is subject to the Company satisfying all applicable initial listing requirements, including minimum stockholders’ equity, market value of unrestricted publicly held shares, minimum bid price, and corporate governance standards, and there can be no assurance that the Company’s common stock will be approved for listing or as to the timing of any such approval. Until any such listing becomes effective, the Company’s common stock will continue to be quoted on the OTC Markets under the symbol FDCT.

 

Relocation of Principal Executive Offices

 

Effective September 9, 2026, the Company relocated its principal executive offices from 200 Spectrum Center Drive, Suite 300, Irvine, California 92618 to Ground Floor, 10A Eleftheriou Venizelou Street, 3035 Limassol, Cyprus, in order to place senior management in closer geographic proximity to the Company’s principal operating subsidiaries and their regulators. The Company remains incorporated in Delaware and continues to maintain a registered office and registered agent in Delaware; the relocation does not change its state of incorporation, its status as a domestic issuer, or its reporting obligations, and is not expected to have a material effect on its results of operations or financial condition.

 

U.S.-Iran Military Conflict

 

On February 28, 2026, the United States and Israel launched coordinated joint military strikes against Iran, targeting military, governmental, and nuclear-related sites. Iran subsequently responded with missile and drone attacks targeting Israel, U.S. military bases in the region, and Gulf state infrastructure, and has sought to restrict commercial shipping traffic through the Strait of Hormuz. The Company maintains a sales office in Tel Aviv, Israel. As of the date of this report, the Tel Aviv office has not experienced any material disruption to its operations as a direct result of the conflict, and the safety of the Company’s personnel located there has not been compromised. The Company’s operating subsidiaries are located in the United Kingdom, Malta, Cyprus, Australia, Seychelles, and Mauritius, none of which are in the directly affected region. The conflict has contributed to significant volatility in global energy prices and financial markets, which may affect client trading volumes, foreign currency exchange rates, and the general business environment in which the Company operates. As of the date of this report, the Company has not experienced any material disruption to its business operations as a direct result of the conflict.

 

Ukraine-Russia Conflict

 

The geopolitical situation in Eastern Europe intensified on February 24, 2022, with Russia’s invasion of Ukraine. By the end of August 2022, the Company closed its technical support and development office in Russia and relocated its personnel to Turkey, currently considered a neutral zone. No individual associated with the Company is on the Specially Designated Nationals (SDN) and Blocked Persons list. As of the date of this report, there has been no disruption to our operations.

 

Description of Company’s Securities to be Registered

 

Effective September 3, 2021, the Company’s description of its common stock, par value $0.0001 per share, to be registered hereunder is contained under the heading “Description of Securities” in the Company’s Registration Statement on Form S-1 (File No. 333-221726), as initially filed with the Securities and Exchange Commission on November 22, 2017, as subsequently amended (the “Registration Statement”). Since the Registration Statement filing, the Company has made all required filings pursuant to Section 15(d) and has continued to file all reports voluntarily.

 

As of September 30, 2026, the Company had 125,323,068 shares of Common Stock and 4,500,000 shares of Series A Preferred Stock issued and outstanding, and no shares of Series B Preferred Stock outstanding following the conversion of all 2,371,844 outstanding shares of Series B Preferred Stock into 118,592,200 shares of Common Stock on July 13, 2026. Holders of Series A Preferred Stock are entitled to fifty (50) non-cumulative votes per share on all matters presented to stockholders for action and have no right to convert into the Company’s common stock. The Series B Preferred Stock is non-dilutive and is not subject to stock splits or any other adjustments to the Company’s common stock. Prior to its conversion, each share of Series B Preferred Stock was convertible into shares of the Company’s common stock at a conversion rate fixed by the Board of Directors, within a range of not more than 100 and not less than 10 shares, upon a Rate Determination Event; the Board fixed the rate at 50 shares of common stock per share of Series B Preferred Stock effective July 13, 2026. Series B Preferred Stock is entitled to one (1) vote per share on all matters presented to stockholders for action.

 

F-11

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of FDCTech, Inc. and its subsidiaries, including subsidiaries in which the Company holds a controlling but less-than-wholly-owned interest. We have eliminated all intercompany balances and transactions. The Company has prepared the consolidated financial statements consistent with the Company’s accounting policies in its financial statements. The Company has measured and presented the Company’s consolidated financial statements in US Dollars, which is the currency of the primary economic environment in which the Company operates (also known as its functional currency).

 

The Company provides trading technology, software development, and related support services to its subsidiary Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (“Crestmark”) under an intercompany services arrangement. Technology and service fees charged by the Company to Crestmark totaled $214,506 and $648,567 for the three and nine months ended September 30, 2026, respectively, and have been eliminated in consolidation against the corresponding trading technology expense recorded by Crestmark within brokerage cost of sales. These eliminations reduce consolidated revenue and cost of sales by equal amounts and have no effect on consolidated gross profit, net income (loss), earnings (loss) per share, cash flows, or stockholders’ equity. In total, intercompany revenue and the corresponding expense of $1,000,981 and $3,173,066 were eliminated for the three and nine months ended September 30, 2026, respectively, consisting of technology and service fees between the Company and Crestmark, and introducing-broker rebates and commissions and swaps on coverage accounts between Crestmark and Alchemy International Ltd.

 

Consolidated Financial Statement Preparation and Use of Estimates

 

The Company prepared the consolidated financial statements according to accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Estimates include revenue recognition, the allowance for doubtful accounts, website and internal-use software development costs, recoverability of intangible assets with finite lives, and other long-lived assets. Actual results could materially differ from these estimates.

 

Defined Terms

 

In these consolidated financial statements and the related notes, the terms “Restricted cash — client funds (segregated),” “client funds,” and “client money” are used interchangeably to refer to amounts held by the Company’s regulated brokerage subsidiaries on behalf of clients in segregated accounts pursuant to applicable regulatory requirements, presented on the consolidated balance sheets as a separately captioned restricted cash line item with an equal and offsetting client funds payable liability.

 

Restatement of Previously Issued Financial Statements

 

Subsequent to the issuance of its unaudited condensed consolidated financial statements for the three months ended March 31, 2026 (originally filed on Form 10-Q on May 15, 2026, and restated by Amendment No. 1 on Form 10-Q/A filed June 8, 2026), management of the Company identified errors in those financial statements. As previously disclosed in a Current Report on Form 8-K filed under Item 4.02 on June 8, 2026, the Board of Directors, after consultation with management and LAO Professionals (“LAO”), the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2026, should no longer be relied upon. The Company has restated the accompanying condensed consolidated financial statements in accordance with ASC Topic 250, “Accounting Changes and Error Corrections.” The restatement reflects the following adjustments:

 

(a) General and administrative expense — consolidated general and administrative expense was reduced from $4,324,900 as originally filed to $4,321,313 as restated, a decrease of $3,587, arising from an update to the parent company operating lease. The correction increases operating income, income before provision for income taxes, and net income by $3,587.

 

(b) Sign and footing error within total other income (expense) — the net interest and recharge line was reported as expense of $(132,492) as originally filed. This line is properly net income of $132,448, as it is dominated by income items, principally AML recharge income and bank and note interest income across APL, AML, and ADS, which exceed gross interest expense. As originally filed, the components of other income (expense) did not foot to the reported total; correcting the sign causes the restated components to foot to the total, which is unchanged at $14,611. There is no effect on net income.

 

(c) Net income attributable to noncontrolling interest (ASC 810-10) — net income attributable to the noncontrolling interest of $6,241, reflecting the noncontrolling holders’ share of subsidiary results (principally the 49% noncontrolling interest in AD Advisory Services Pty Ltd.), was $0 as originally filed. Combined with the $3,587 increase in consolidated net income described in (a), net income attributable to FDCTech, Inc. changes from $6,869,920 as originally filed to $6,867,266 as restated, a decrease of $2,654.

 

(d) Balance sheet corrections and reclassifications — the principal adjustments are: cash and cash equivalents $(4,429,781), reflecting the elimination of an intercompany cash position; related party receivable +$4,865,084, reflecting a one-sided intercompany residual reclassified to related party receivable; right of use (lease) +$98,124 and operating lease liabilities (current, $(42,356); non-current, $(143,803)), reflecting the parent operating lease update; trade receivable of $88,986 presented separately; and related adjustments to acquired intangible assets, related party advances, accrued expenses, accrued interest, additional paid-in capital, accumulated other comprehensive income (loss), and accumulated surplus (deficit), as set forth in the reconciliation below. Total assets and total liabilities and stockholders’ equity each increased by $611,895, and the balance sheet remains in balance.

 

(e) Intercompany rebate revenue (presentation) — rebate income of $804,664 (€687,311) earned by Alchemy Markets Ltd. from Alchemy International Ltd. continues to be presented as external revenue, consistent with prior filings. This presentation has no effect on total revenue, operating income, net income, or the balance sheet as restated.

 

F-12

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

The following tables reconcile the amounts as originally filed (Form 10-Q, filed May 15, 2026) to the amounts as restated. The share and per-share amounts in the reconciliation tables below are presented on a pre-reverse-stock-split basis, consistent with the amounts as previously reported, and have not been retroactively adjusted for the reverse stock split described in Note 1:

 

SCHEDULE OF RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

Consolidated Balance Sheet — March 31, 2026

 

             
   As Originally Filed   Adjustment   As Restated 
Cash and cash equivalents (including restricted cash)   36,891,541    (4,429,781)   32,461,760 
Accounts receivable, net   358,932    -    358,932 
Prepaid – current   345,612    -    345,612 
Related party receivable   30,154,645    4,865,084    35,019,729 
Prepaid – non-current   189,796    -    189,796 
Fixed assets, net   187,657    -    187,657 
Capitalized software, net   1,578,353    -    1,578,353 
Investment through subsidiary   34,510    -    34,510 
Accrued income   275,715    -    275,715 
Acquired intangible assets   1,250,397    (10,518)   1,239,879 
Tax receivable   187,508    -    187,508 
Other trade and tax receivable   -    88,986    88,986 
Fair value of trading positions for the firm, profit   72,386    -    72,386 
Right of use (lease)   668,214    98,124    766,338 
Total assets   72,195,266    611,895    72,807,161 
Accounts payable   502,087    -    502,087 
Line of credit   266,926    -    266,926 
Accrued expenses, related party   997,259    5,287    1,002,546 
Business acquisition loan   2,350,000    -    2,350,000 
Related party advances   3,296,890    524,289    3,821,179 
Client funds payable   28,339,255    -    28,339,255 
Operating lease liability, current   186,158    (42,356)   143,802 
Other current liabilities   1,642,601    -    1,642,601 
Deferred tax liabilities   372,339    -    372,339 
SBA loan – non-current   103,552    -    103,552 
Operating lease liability – non-current   482,056    (143,803)   338,253 
Accrued interest – non-current   43,650    (5,287)   38,363 
Total liabilities   38,582,773    338,130    38,920,903 
Series A Preferred stock   450    -    450 
Series B Preferred stock   237    -    237 
Common stock*   423    -    423 
Additional paid-in capital, Common and Series A Preferred   28,241,475    (195,777)   28,045,698 
Subscription receivable   (8,000,000)   -    (8,000,000)
Additional paid-in capital, Series B Preferred stock   3,344,063    -    3,344,063 
Accumulated other comprehensive income (loss)   (2,427)   188,472    186,045 
Accumulated surplus (deficit)   9,984,473    284,278    10,268,751 
Total FDCTech, Inc. stockholders’ equity (deficit)   33,568,694    276,973    33,845,667 
Noncontrolling interest   43,799    (3,208)   40,591 
Total liabilities and stockholders’ equity (deficit)   72,195,266    611,895    72,807,161 

 

F-13

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Consolidated Statement of Operations — Three Months Ended March 31, 2026

 

   As Originally Filed   Adjustment   As Restated 
Total revenue   15,214,492    -    15,214,492 
Total cost of sales   3,583,338    -    3,583,338 
Gross profit   11,631,154    -    11,631,154 
Total operating expenses   4,775,845    (3,587)   4,772,258 
Operating income (loss)   6,855,309    3,587    6,858,896 
Total other income (expense)   14,611    -    14,611 
Income (loss) before provision for income taxes   6,869,920    3,587    6,873,507 
Provision for income taxes   -    -    - 
Net income (loss)   6,869,920    3,587    6,873,507 
Net income (loss) attributable to noncontrolling interest   -    6,241    6,241 
Net income (loss) attributable to FDCTech, Inc.   6,869,920    (2,654)   6,867,266 

 

In the reconciliation above, cash and cash equivalents is presented inclusive of restricted cash; as restated at March 31, 2026, the $32,461,760 comprises cash and cash equivalents of $4,122,505 and restricted cash (client funds, segregated) of $28,339,255, presented as separate line items on the consolidated balance sheet, with a corresponding client funds payable of $28,339,255.

 

* $42,308 (before reverse split) to $423 (after reverse split).

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with three months or less of original maturities. The Company maintains its cash balances at multiple financial institutions, both domestic and foreign. For US financial institutions, the balances do not exceed Federal Deposit Insurance Corporation (FDIC) limits as of September 30, 2026. However, as of December 31, 2025, the majority of the cash balance was held with non-FDIC financial institutions in Malta, the UK, and other countries. As of September 30, 2026, and December 31, 2025, the Company had $33,144,429 and $17,669,749 in total cash, cash equivalents, and restricted cash (client funds segregated) held at financial institutions.

 

Restricted Cash — Client Funds Segregated

 

The Company’s regulated brokerage subsidiaries — Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (Malta, MFSA-licensed), Alchemy Prime Limited (United Kingdom, FCA-licensed), and Alchemy International Ltd. (Seychelles, FSA-licensed) — hold cash on behalf of clients in segregated bank accounts in accordance with the client-money rules of their respective regulators. These segregated client funds are not available for general corporate use and are matched by a corresponding liability presented as “Client funds payable” on the consolidated balance sheets. In accordance with ASC 230-10-50-8 and SEC Staff Accounting Bulletin Topic 11.M, these balances are classified as restricted cash and presented as a separate line item on the consolidated balance sheets under the caption “Restricted cash (client funds, segregated).”

 

Segregated client funds are held in designated client bank and payment-service-provider accounts and as margin in accounts at liquidity providers used to hedge client positions. Because client-money liabilities are measured at clients’ marked-to-market account equity and a portion of client money is placed with liquidity providers, the balance in segregated bank accounts at any date is not expected to equal the related liability; each subsidiary reconciles client-money resources to its client-money requirement in accordance with the rules of its regulator. Of total client-money resources of $13,050,103 at September 30, 2026, $6,561,247 was held in client-designated bank and PSP accounts and $6,488,856 as margin at third-party liquidity providers, against a client-money requirement of $11,729,042; the $1,321,061 excess represents the Company’s own buffer funds held alongside client money and is not client money. Client-money liabilities are measured at net client account equity, determined account by account; an account in debit is presented gross as a receivable under ASC 210-20-45-1 and is not offset against the balances of clients in credit.

 

The following table reconciles the components of cash, cash equivalents, and restricted cash reported on the consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows: 

SCHEDULE OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

   September 30, 2026   December 31, 2025 
Cash and cash equivalents  $21,415,387   $11,855,861 
Restricted cash (client funds, segregated)   11,729,042    5,813,888 
Total cash, cash equivalents, and restricted cash  $33,144,429   $17,669,749 

 

F-14

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Accounts Receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company’s accounts receivable arise principally from brokerage commissions, rebates, and technology service fees earned from counterparties and customers in the ordinary course of business. Receivables are generally short-term in nature and are typically settled within thirty days of the invoice date.

 

The Company evaluates the collectability of its accounts receivable on an ongoing basis and maintains an allowance for doubtful accounts at a level management believes to be sufficient to absorb estimated losses inherent in the receivable portfolio as of the balance sheet date. The allowance is determined based on a review of specific accounts considered to be at risk, taking into consideration the age of the receivable, the financial condition and payment history of the counterparty, current economic conditions, and other relevant factors. Account balances are charged against the allowance after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of receivables previously written off are recorded as a reduction to bad debt expense in the period the amounts are received.

 

As of September 30, 2026, and December 31, 2025, accounts receivable were $264,372 and $188,415, respectively, net of an allowance for doubtful accounts of $209,357 and $22,382, respectively. A provision for doubtful accounts of $186,975 was recorded during the three and nine months ended September 30, 2026, compared to $22,382 during the nine months ended September 30, 2025, and management believes the allowance is adequate to cover expected credit losses as of September 30, 2026.

 

Sales, Marketing, and Advertising

 

The Company recognizes sales, marketing, and advertising expenses when incurred.

 

The Company incurred $102,376 and $317,379 in sales, marketing, and advertising costs (“sales and marketing”) for the three months ended September 30, 2026, and 2025, respectively, and $720,763 and $887,520 for the nine months ended September 30, 2026, and 2025, respectively. Sales and marketing costs primarily consisted of travel costs for tradeshows and customer meetings, online marketing on industry websites, press releases, and public relations activities. Sales and marketing expense decreased for both the three and nine months ended September 30, 2026, reflecting a shift toward lower-cost digital channels and reduced tradeshow and travel activity supporting the Company’s broader brokerage and technology client base.

 

Sales, marketing, and advertising expenses represented approximately 2.79% and 5.40% of revenues for the three months ended September 30, 2026, and 2025, respectively, and approximately 2.01% and 5.14% of revenues for the nine months ended September 30, 2026, and 2025, respectively.

 

Revenue Recognition

 

On January 1, 2019, the Company adopted ASU 2014-09 Revenue from Contracts with Customers. The majority of the Company’s revenues come from two contracts – IT support and maintenance (‘IT Agreement’) and software development (‘Second Amendment’) that fall within the scope of ASC 606.

 

The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services as per the contract with the customer. As a result, the Company accounts for revenue contracts with customers by applying the requirements of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606), which includes the following steps:

 

  ● Identify the contract or contracts and subsequent amendments with the customer.
  ● Identify all the performance obligations in the contract and subsequent amendments.
  ● Determine the transaction price for completing performance obligations.
  ● Allocate the transaction price to the performance obligations in the contract.
  ● Recognize the revenue when, or as, the Company satisfies a performance obligation.

  

F-15

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

The Company adopted ASC 606 using the modified retrospective method applied to all contracts not completed as of January 1, 2019. The Company presents results for reporting periods beginning after January 1, 2019, under ASC 606, while prior period amounts are reported following legacy GAAP. In addition to the above guidelines, the Company also considers implementing guidance on warranties, customer options, licensing, and other topics. The Company considers revenue collectability, methods for measuring progress toward complete satisfaction of a performance obligation, warranties, customer options for additional goods or services, non-refundable upfront fees, licensing, customer acceptance, and other relevant categories.

 

The Company accounts for a contract when the Company and the customer (‘parties’) have approved of the contract and are committed to performing their respective obligations. Each party can identify its rights, obligations, and payment terms; the contract has commercial substance. The Company will collect all of the considerations. Revenue is recognized when performance obligations are satisfied by transferring control of the promised service to a customer. The Company fixes the transaction price for goods and services at contract inception. The Company’s standard payment terms are net 30 days and, in some cases, due upon receipt of the invoice.

 

The Company considers the change in scope, price, or both as contract modifications. The parties describe contract modification as a change order, a variation, or an amendment. A contract modification exists when the parties approve a modification that either creates new or changes existing enforceable rights and obligations. The Company assumes a contract modification by oral agreement or implied by the customer’s customary business practice when agreed in writing. If the parties to the contract have not approved a contract modification, the Company continues to apply the existing contract’s guidance until the contract modification is approved. The Company recognizes contract modification in various forms –partial termination, an extension of the contract term with a corresponding price increase, adding new goods or services to the contract, with or without a corresponding price change, and reducing the contract price without a change in goods/services promised.

 

At contract inception, the Company assesses the solutions or services, or bundles of solutions and services, obligated in the contract with a customer to identify each performance obligation within the contract and then evaluate whether the performance obligations are capable of being distinct and distinct within the context of the agreement. Solutions and services that are not capable of being distinct and distinct within the contract context are combined and treated as a single performance obligation in determining the allocation and recognition of revenue. For multi-element transactions, the Company allocates the transaction price to each performance obligation on a relative stand-alone selling price basis. The Company determines the stand-alone selling price for each item at the transaction’s inception, involving these multiple elements.

 

Since January 21, 2016 (‘Inception’), the Company has derived its revenues mainly from consulting services, technology solutions, and customized software development. The Company recognizes revenue when it has satisfied a performance obligation by transferring control over a product or delivering a service to a customer. We measure revenue based on the consideration outlined in an arrangement or contract with a customer.

 

F-16

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

The Company’s standard performance obligations include the following:

 

Performance Obligation   Types of Deliverables   When Performance Obligation is Typically Satisfied
Consulting Services   Consulting related to Start-Your-Own-Brokerage (“SYOB”), Start-Your-Own-Prime Brokerage (“SYOPB”), Start-Your-Own-Crypto Exchange (“SYOC”), FX/OTC liquidity solutions and lead generations.   The Company recognizes the consulting revenues when the customer receives services over the contract length. If the customer pays the Company in advance for these services, the Company records such payment as deferred revenue until the Company completes the services.
         
Technology Services   Licensing of Condor Risk Management Back Office (“Condor Risk Management”), Condor FX Pro Trading Terminal, Condor Pricing Engine, Crypto Trading Platform (“Crypto Web Trader Platform”), and other cryptocurrency-related solutions.   The Company recognizes ratably over the contractual period that the services are delivered, beginning on the date such service is made available to the customer. Licensing agreements are typically one year in length with an option to cancel by giving notice; customers have the right to terminate their agreements if the Company materially breaches its obligations under the agreement. Licensing agreements do not provide customers with the right to take possession of the software. The Company charges the customers a set-up fee for installing the platform, and implementation activities are insignificant and not subject to a separate fee.
         
Software Development   Design and build development software projects for customers, where the Company develops the project to meet the design criteria and performance requirements as specified in the contract.   The Company recognizes the software development revenues when the Customer obtains control of the deliverables as stated in the Statement-of-Work contract.

 

The Company assumes that the goods or services promised in the existing contract will be transferred to the customer to determine the transaction price. The Company believes that the contract will not be canceled, renewed, or modified; therefore, the transaction price includes only those amounts to which the Company has rights under the present contract. For example, suppose the Company enters a contract with a customer with an original term of one year and expects the customer to renew it for a second year. In that case, the Company will determine the transaction price based on the initial one-year period. When choosing the transaction price, the company first identifies the fixed consideration, including non-refundable upfront payment amounts.

 

To allocate the transaction price, the Company gives the amount that best represents the consideration that the entity expects to receive for transferring each promised good or service to the customer. The Company allocates the transaction price to each performance obligation identified in the contract on a relatively standalone selling price basis to meet the allocation objective. In determining the standalone selling price, the Company uses the best evidence of the stand-alone selling price that the Company charges to similar customers in similar circumstances. The Company sometimes uses the adjusted market assessment approach to determine the standalone selling price. It evaluates the market in which it sells the goods or services and estimates the price that customers in that market would pay for those goods or services when sold separately.

 

The Company recognizes revenue when or as it transfers the promised goods or services into the contract. The Company considers the “transfers” of the promised goods or services when the customer obtains control of the goods or services. The Company believes a customer “obtains control” of an asset when it can directly use and substantially obtain all the remaining benefits from an asset. The Company recognizes deferred revenue related to services it will deliver within one year as a current liability. The Company presents deferred revenue related to services that the Company will provide more than one year into the future as a non-current liability.

 

According to the contract’s terms and conditions, the Company invoices the customer at the beginning of the month for the month’s services. The invoice amount is due upon receipt. The Company recognizes the revenue at the end of each month, equal to the invoice amount.

 

F-17

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Wealth Management

 

AD Advisory Services Pty (ADS), the Company’s wealth management revenue, primarily consists of advisory revenue, commission revenue from insurance products, fees to prepare the statement of advice, rebalancing portfolio, and other financial planning activities. ADS is authorized and regulated by the Australian Securities & Investments Commission (ASIC) to conduct licensing activities in Australia.

 

ASC 606 establishes a five-step model for revenue recognition aimed at enhancing comparability and transparency across entities, industries, and capital markets. The Company only recognizes revenue that reflects the transfer of promised goods or services to customers in exchange for the consideration to which the entity expects to be entitled.

 

For ADS, a contract is an agreement between ADS and a client that creates enforceable rights and obligations, encompassing advisory services, insurance product commissions, and other financial planning activities. Contracts may be written, oral, or implied by customary business practices and are identified when both parties approve the agreement; each party can identify rights regarding the goods or services to be transferred, establish payment terms, the contract has commercial substance, and collection of payment is probable.

 

A performance obligation is a promise in a contract to transfer a distinct good or service to the Customer. For ADS, performance obligations may include:

 

  ● Providing ongoing financial advisory services,
  ● Preparing statements of advice,
  ● Executing portfolio rebalancing,
  ● Facilitating the purchase of insurance products, and
  ● Offering other specialized financial and estate planning services.

 

We evaluate these services to determine if they are distinct, considering whether the Customer can benefit from the service on its own or with other readily available resources, and if the promise to transfer the service is separately identifiable from other promises in the contract.

 

The transaction price is the amount of consideration ADS expects to receive in exchange for transferring the promised goods or services to the Customer. These services include fixed fees, commissions from insurance products, and variable consideration for performance-based fees. ADS estimates the amount of variable consideration to which it will be entitled in a manner that reflects the likelihood and magnitude of a revenue reversal.

 

If a contract includes more than one performance obligation, ADS allocates the transaction price to each performance obligation based on its standalone selling price. When standalone selling prices are not directly observable, ADS estimates them using methods that may include cost-plus margin, market assessment, or residual approach, considering the Customer’s perceived value of each service.

 

ADS recognizes revenue when (or as) a performance obligation is satisfied, i.e., when the control of the promised good or service is transferred to the Customer. For ongoing services, revenue is recognized over time, reflecting the continuous transfer of services. For services performed at a specific point in time, revenue is recognized upon completion of the service. The pattern of revenue recognition is determined based on when the Customer obtains control of the promised good or service, which, for advisory services, is typically throughout the contract, and for transaction-based services (like insurance commissions or fees for specific planning activities), is at the point in time when the transaction is executed, or the service is rendered. If we receive payments before services, we defer and recognize them as revenue when we are satisfied with our performance obligation. Advisory revenue includes fees charged to clients in advisory accounts for which we are the licensed investment advisor. We bill advisory fees weekly.

 

F-18

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Investment and Margin Brokerage Business

 

Alchemy Markets Ltd (Alchemy Malta) and Alchemy Prime Ltd (Alchemy UK) are providers of trading services and solutions specializing in over-the-counter (“OTC”) and exchange-traded markets for European markets. Malta Financial Services Authority (MFSA) regulates Alchemy Malta in authorized countries, including Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Liechtenstein, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden. The Financial Conduct Authority (FCA) regulates Alchemy UK in authorized countries, including England, Scotland, Wales, and Northern Ireland.

 

The Company serves two client channels within its brokerage business: retail and institutional (“clients” or “customers”). Through its retail and institutional segment, the Company provides its customers (individuals) around the world with access to a diverse range of global financial markets, including spot forex, precious metals, spread bets, and contracts for difference (“CFDs”) on currencies, commodities, indices, individual equities, cryptocurrencies, bonds, and interest rate products, as well as OTC options. The FCA defines a retail customer as a client who is not a professional or an eligible counterparty. A professional client is an entity that must be authorized or regulated to operate in the financial markets. According to the MFSA, a retail client is a client who is not a professional client or an eligible counterparty. A professional client possesses the knowledge, experience, and expertise to assess risks and make informed investment decisions.

 

We recognize Investment and Brokerage revenue through the principal model following the guidance outlined in ASC 606, Revenues from Contracts with Customers. The Company primarily generates revenue through market-making and trading execution services for its clients, known as Investment and Brokerage Revenues. The Investment and Brokerage revenue is the Company’s largest source of revenue. Investment and Brokerage revenue comprises revenue from the retail OTC business and the advisory business. OTC trading includes forex trading (“forex”), precious metals trading, CFDs, and spread betting (in markets that do not prohibit such transactions), as well as other financial products.

 

We realize gains or losses when we liquidate customer transactions. We revalue unrealized gains or losses on trading positions at prevailing market rates at the date of the balance sheet. We include them in Receivables from brokers, Payables to customers, and Payables to brokers on the Consolidated Balance Sheets. We record changes in net unrealized gains or losses in Investment and Brokerage revenue on the Consolidated Statements of Operations and Comprehensive (Loss)/Income. We record Investment and Brokerage revenue on a trade date basis.

 

We also generate business through an agency model by earning commissions and spreads for executing customer trades. We book these revenues on a trade-date basis. The Company acts as an agent concerning clearing trades, but is the principal on fees paid to introducing brokers. The Company does not assume any market-making risk related to customer trades in this business.

 

Net interest revenue consists primarily of the revenue generated by the Company’s cash and customer cash held at banks, as well as funds on deposit as collateral with the Company’s liquidity providers, less interest paid to the Company’s customers.

 

We record interest revenue and interest expense when earned and incurred, respectively.

 

F-19

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Concentrations of Credit Risk

 

Cash

 

Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with original maturities of three months or less at the date of acquisition. The Company maintains its cash balances at multiple financial institutions, both domestic and foreign. For balances held at U.S. financial institutions, such balances did not exceed Federal Deposit Insurance Corporation (“FDIC”) limits as of September 30, 2026. As of September 30, 2026, and December 31, 2025, the majority of the Company’s cash was held with non-FDIC financial institutions located in Malta, the United Kingdom, and other foreign jurisdictions. As of September 30, 2026, and December 31, 2025, the Company had $33,144,429 and $17,669,749 of total cash, cash equivalents, and restricted cash (client funds segregated) held at financial institutions.

 

Revenues

 

For the three months ended September 30, 2026, and 2025, the Company generated $3,671,775 and $5,872,372 in revenues, respectively, representing a decrease of approximately 37.5% from the prior-year period. For the nine months ended September 30, 2026, and 2025, the Company generated $35,924,742 and $17,269,111 in revenues, respectively, representing an increase of approximately 108.0% over the prior-year period. The Company’s revenues are derived from four operating segments: Margin Brokerage, Wealth Management, Technology and Software Development, and Payment Intermediary Services. The Payment Intermediary Services segment is in the start-up phase and did not generate revenues during the three and nine months ended September 30, 2026, or 2025. The increase in revenues during the nine months ended September 30, 2026, was primarily attributable to trading revenues generated by AIL during the first half of the year, while the decrease during the three months ended September 30, 2026, was primarily attributable to lower brokerage revenues.

 

Research and Development (R and D) Cost

 

The Company acknowledges that future benefits from research and development (R and D) are uncertain; therefore, we cannot capitalize on R and D expenditures. The GAAP accounting standards require us to expense all research and development expenditures as incurred. For the three and nine months ended September 30, 2026, and 2025, the Company incurred R and D costs of $0 and $0. The R and D costs in the previous period were based on an evaluation of the technological feasibility costs of the Condor Investing and Trading App.

 

Legal Proceedings

 

The Company discloses a loss contingency if there is at least a reasonable possibility that a material loss has been incurred. The Company records its best estimate of loss related to pending legal proceedings when the loss is probable, and the amount can be reasonably estimated. The Company can reasonably estimate a range of losses with no best estimate in the range; the Company records the minimum estimated liability. As additional information becomes available, the Company assesses the potential liability related to pending legal proceedings, revises its estimates, and updates its disclosures accordingly. The Company’s legal costs associated with defending itself are recorded as expenses when incurred.

 

For a description of the legal proceedings to which the Company and its subsidiaries are a party, see Note 8, Commitments and Contingencies — Pending Litigation.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment in accordance with FASB ASC 360, Property, Plant, and Equipment. Under the standard, long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. An impairment charge is recognized when the asset’s carrying value exceeds the fair value. There were no impairment charges as of September 30, 2026, and December 31, 2025.

 

Provision for Income Taxes

 

The provision for income taxes is determined using the asset and liability method. This method calculates deferred tax assets and liabilities based on the temporary differences between the consolidated financial statement and income tax bases of assets and liabilities using the enacted tax rates applicable each year.

 

F-20

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

The Company utilizes a two-step approach to recognizing and measuring uncertain tax positions (“tax contingencies”). The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount, exceeding 50%, that is likely to be realized upon ultimate settlement. The Company considers various factors when evaluating and estimating its tax positions and benefits, which necessitate periodic adjustments that may not accurately predict actual outcomes. The Company includes interest and penalties related to tax contingencies in the provision for income taxes in the consolidated statements of its operations. The Company’s management does not expect the total amount of unrecognized tax benefits to change significantly in the next twelve (12) months. See Note 14 for more details.

 

Software Development Costs

 

In accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, software development costs, including expenses incurred to develop software that is sold, leased, or otherwise marketed, are capitalized after the establishment of technological feasibility, to the extent such costs are significant. The Company amortizes capitalized software development costs using the straight-line method over the estimated useful life of the application software. Costs incurred prior to the establishment of technological feasibility are expensed as research and development costs in the period incurred.

 

The Company established the technological feasibility of the Condor FX Back Office, the Condor Pro Multi-Asset Trading Platform Version, and the Condor Pricing Engine by the end of February 2016. The Company established the technological feasibility of the Digital Assets Web Trader Platform in February 2018 and of the Condor Investing and Trading App in January 2021. The Company estimates the useful life of each application software to be three (3) years.

 

The Company is continuing to develop the Condor Investing and Trading App and is currently capitalizing the costs associated with such development in accordance with the Company’s software development cost policy. Research and development costs incurred during the period ended September 30, 2022, were incurred in connection with evaluating the technological feasibility of the Robo Advice Platform, and research and development costs incurred during the period ended December 31, 2022, were incurred in connection with evaluating the technological feasibility of the Condor Investing and Trading App. There were no research and development costs incurred during the three and nine months ended September 30, 2026, or 2025.

 

The Company also capitalizes major costs incurred during the application development stage for internal-use software in accordance with ASC 350-40, Internal-Use Software. Costs incurred during the preliminary project stage and post-implementation stage are expensed as incurred.

 

As of September 30, 2026, and December 31, 2025, capitalized software, net of accumulated amortization, was $1,760,022 and $1,480,246, respectively.

 

Property and Equipment, Net; Depreciation

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from three to five years for computer equipment, furniture, and office equipment. Leasehold improvements, if any, are amortized over the shorter of the estimated useful life of the asset or the remaining lease term. Expenditures for repairs and maintenance that do not extend the useful life of the related asset are charged to expense as incurred, while expenditures that materially extend the useful life or improve the functionality of an asset are capitalized. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in the consolidated statements of operations.

 

As of September 30, 2026, and December 31, 2025, property and equipment, net of accumulated depreciation, were $175,755 and $199,058, respectively. Depreciation expense was $19,920 and $44,992 for the three months ended September 30, 2026, and 2025, respectively, and $112,258 and $127,100 for the nine months ended September 30, 2026, and 2025, respectively, and is included in operating expenses in the consolidated statements of operations.

 

Convertible Debentures

 

The cash conversion guidance in ASC 470-20, Debt with Conversion and Other Options, is considered when evaluating the accounting for convertible debt instruments, including certain convertible preferred stock classified as a liability, to determine whether the conversion feature should be recognized as a separate component of equity. The cash conversion guidance applies to all convertible debt instruments that, upon conversion, may be settled entirely or partially in cash or other assets where the conversion option is not bifurcated and separately accounted for pursuant to ASC 815.

 

If the conversion features of conventional convertible debt provide a conversion rate below market value, this feature is characterized as a beneficial conversion feature (“BCF”). The Company records BCF as a debt discount in accordance with ASC Topic 470-20, Debt with Conversion and Other Options. In such circumstances, the convertible debt is recorded net of the discount related to the Black-Scholes formula. The Company amortizes the discount to interest expense over the life of the debt using the effective interest method.

 

F-21

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Foreign Currency Translation and Re-measurement

 

The Company translates its foreign operations into US dollars in accordance with ASC 830, “Foreign Currency Matters.” Gains or losses resulting from translating the foreign currency financial statements are accumulated as a separate component of accumulated other comprehensive income (“AOCI”) in the Company’s stockholders’ equity and noncontrolling interests. Transaction gains and losses resulting from exchange rate changes on transactions denominated in currencies other than the functional currency of the applicable subsidiary are included in the Consolidated Statements of Income, within “Other (income) expense, net”, in the year in which the change occurs.

 

The functional currency of ADS is the Australian Dollar (AUD), the functional currency of AML and ATECH is the Euro (EUR), and the functional currency of APL is the British Pound (GBP). The Company’s remaining subsidiaries are U.S. dollar functional and accordingly give rise to no translation adjustment. We have translated AUD, EUR, and GBP into US$1.00 at the following exchange rates for the respective dates:

 

The exchange rate at the reporting end date: 

 

   September 30, 2026   December 31, 2025 
USD: AUD  $1.4399    1.4888 
USD: EUR  $0.8818    0.8523 
USD: GBP  $0.7539    0.7436 

 

Average exchange rate for the period:

 

   Nine Months Ended
September 30, 2026
   Nine Months Ended
September 30, 2025
 
USD: AUD  $1.4217    1.5605 
USD: EUR  $0.8680    0.8814 
USD: GBP  $0.7437    0.7489 

 

ADS’ functional currency is AUD, and the reporting currency is the US dollar. AML’s functional currency is the EUR, and its reporting currency is the US dollar. APL’s functional currency is GBP, and its reporting currency is US dollars.

 

The Company translates its records into USD as follows:

 

  ● Assets and liabilities at the rate of exchange in effect at the balance sheet date
  ● Equities at the historical rate
  ● Revenue and expense items at the average rate of exchange prevailing during the period

 

F-22

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Fair Value

 

The Company uses current market values to recognize certain assets and liabilities at a fair value. The fair value is the estimated price at which the Company can sell the asset or settle a liability in an orderly transaction to a third party under current market conditions. The Company uses the following methods and valuation techniques for deriving fair values:

 

Market Approach – The market approach uses the prices associated with actual market transactions for similar or identical assets and liabilities to derive a fair value.

 

Income Approach – The income approach utilizes estimated future cash flows or earnings, adjusted by a discount rate that reflects the time value of money and the risk of not achieving the cash flows, to derive a discounted present value.

 

Cost Approach – The cost approach uses the estimated cost to replace an asset, adjusted for the obsolescence of the existing asset.

 

The Company ranks the fair value hierarchy of information sources from Level 1 (the best) to Level 3 (the worst). The Company uses these three levels to select inputs for valuation techniques:

 

Level 1   Level 2   Level 3
Level 1 is a quoted price for an identical item in an active market on the measurement date. Level 1 is the most reliable evidence of fair value and is used whenever this information is available.   Level 2 is directly or indirectly observable inputs other than quoted prices. An example of a Level 2 input is a valuation multiple for a business unit, based on the sales, EBITDA, or net income of comparable companies.   Level 3 is an unobservable input. It may include the company’s data, adjusted for other reasonably available information. Examples of a Level 3 input are an internally generated financial forecast.

 

Basic and Diluted Income (Loss) per Share

 

The Company computes earnings per share in accordance with ASC 260, Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing net income (loss) attributable to the Company’s common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) attributable to the Company’s common stockholders by the weighted average number of shares of common stock and dilutive common stock equivalents outstanding during the period. Common stock equivalents are excluded from the computation of diluted earnings per share when their effect would be antidilutive.

 

For the three and nine months ended September 30, 2026, and 2025, the weighted average number of shares of common stock outstanding, used to compute basic earnings per share, was 106,978,518 and 4,230,868, respectively, and 38,856,450 and 4,230,868, respectively, reflecting the conversion of the Series B Preferred Stock on July 13, 2026, and the issuance of 2,500,000 shares for consulting services in August 2026. See Note 13 — Earnings Per Share for the computation of, and the reconciliation of the numerators and denominators used in, basic and diluted earnings per share for the periods presented.

 

Reclassifications

 

We have reclassified certain amounts from the prior period to conform to the current year’s presentation. None of these classifications impacted reported operating or net loss for any presented period.

 

F-23

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Recent Accounting Pronouncements

 

The Company evaluates all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”) for applicability and impact on its consolidated financial statements. Because the Company ceased to qualify as an emerging growth company effective December 31, 2022, the Company applies the effective dates applicable to public business entities. The Company’s accounting policy for revenue recognition under ASC 606, Revenue from Contracts with Customers, which the Company adopted effective January 1, 2019, using the modified retrospective method, is described under Revenue from Major Contracts with Customers above.

 

Recently Adopted Accounting Pronouncements

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose significant segment expenses regularly provided to the chief operating decision maker, an amount and description of other segment items, and additional segment information. The Company adopted ASU 2023-07 effective January 1, 2024, on a retrospective basis. The adoption did not have a material impact on the Company’s consolidated financial statements but expanded the Company’s segment disclosures.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires enhanced disclosures about a reporting entity’s effective tax rate and its income taxes paid (refunded). ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. The Company adopted ASU 2023-09 effective January 1, 2025, on a prospective basis. The adoption expanded the Company’s annual income tax disclosures and did not affect the Company’s consolidated financial position, results of operations, or cash flows.

 

In December 2023, the FASB issued ASU 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets, which is effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company adopted ASU 2023-08 effective January 1, 2025. The adoption did not have a material impact on the Company’s consolidated financial statements because the Company does not hold crypto assets within the scope of the ASU.

 

In March 2024, the FASB issued ASU 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards, which provides guidance on determining the appropriate accounting treatment for the issuance of profits interest units and similar awards. The ASU is effective for public business entities for interim and annual periods for fiscal years beginning after December 15, 2024. The Company adopted ASU 2024-01 effective January 1, 2025. The adoption did not have a material impact on the Company’s consolidated financial statements because the Company has not issued profits interest or similar awards.

 

In March 2024, the FASB issued ASU 2024-02, Codification Improvements—Amendments to Remove References to the Concepts Statements, which removes various references to the FASB’s Concepts Statements from the Codification. The amendments are effective for public business entities for fiscal years beginning after December 15, 2024. The Company adopted ASU 2024-02 effective January 1, 2025, and the adoption did not have a material impact on the Company’s consolidated financial statements.

 

In March 2025, the FASB issued ASU 2025-02, Liabilities (Topic 405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122, which removed Codification references related to SAB 121 following its rescission by SAB 122. The amendments were effective upon issuance on a fully retrospective basis to annual periods beginning after December 15, 2024. The Company adopted ASU 2025-02 during 2025, and the adoption did not have a material impact on the Company’s consolidated financial statements because the Company does not safeguard crypto assets for platform users.

 

In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The ASU is effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company adopted ASU 2024-04 effective January 1, 2026. The adoption did not have a material impact on the Company’s consolidated financial statements because the Company had no induced conversions of convertible debt instruments during the periods presented.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to disclose, in tabular format, disaggregated information about specified categories of expenses, along with a qualitative reconciliation to the captions on the face of the financial statements. In January 2025, the FASB issued ASU 2025-01, which clarified that ASU 2024-03 is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is evaluating the effect that ASU 2024-03, as clarified by ASU 2025-01, will have on its disclosures and does not expect the ASU to affect its consolidated financial position, results of operations, or cash flows.

 

F-24

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity, which is effective for fiscal years beginning after December 15, 2026, including interim periods within those fiscal years. Early adoption is permitted. The Company is evaluating the impact of ASU 2025-03 on its consolidated financial statements.

 

In July 2025, the FASB issued ASU 2025-04, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer, which is effective for fiscal years beginning after December 15, 2026, including interim periods within those fiscal years. Early adoption is permitted. The Company does not currently have share-based consideration payable to customers within the scope of the ASU and does not expect adoption to have a material impact on its consolidated financial statements.

 

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the recognition guidance for internal-use software costs by removing references to project-stage concepts and providing updated capitalization guidance. The Company is evaluating the impact of ASU 2025-06 on its capitalization policies for internally developed software and related disclosures.

 

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which improves the navigability of ASC 270 and clarifies when it applies. Early adoption is permitted, and the ASU permits retrospective or prospective transition. The Company is evaluating the impact of ASU 2025-11 on its interim disclosures.

 

In December 2025, the FASB issued ASU 2025-12, Codification Improvements, which includes 33 targeted improvements to U.S. GAAP across multiple topics, including clarifications to diluted earnings per share calculations when a loss from continuing operations exists. The Company is evaluating the impact of ASU 2025-12 on its consolidated financial statements and disclosures.

 

NOTE 3. MANAGEMENT’S PLANS

 

The Company has prepared its consolidated financial statements on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. As of September 30, 2026, and December 31, 2025, the Company had an accumulated surplus of $11,658,387 and $3,401,487, respectively, and a working capital surplus of $21,949,185 and $17,831,410, respectively.

 

For the three months ended September 30, 2026, and 2025, the Company generated net income (loss) of $(6,299,675) and $735,252, respectively, and total revenues of $3,671,775 and $5,872,372, respectively, representing a decrease in revenues of approximately 37.5% from the prior-year period. For the nine months ended September 30, 2026, and 2025, the Company generated net income of $8,249,837 and $623,918, respectively, and total revenues of $35,924,742 and $17,269,111, respectively, representing an increase in revenues of approximately 108.0% over the prior-year period. The nine-month results reflect strong brokerage revenue generated by AIL during the first half of 2026, partially offset by a net loss in the third quarter attributable to lower brokerage revenues, higher brokerage cost of sales, and increased general and administrative expenses, including $915,000 of stock-based consulting expense and a $186,975 provision for doubtful accounts, while the Company continued to benefit from operating leverage on a largely fixed cost base. The accumulated surplus increased from $3,401,487 as of December 31, 2025, to $11,658,387 as of September 30, 2026, and the working capital surplus increased from $17,831,410 as of December 31, 2025, to $21,949,185 as of September 30, 2026.

 

Management has evaluated the Company’s ability to continue as a going concern in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 205-40, Presentation of Financial Statements—Going Concern. In performing this evaluation as of the date these consolidated financial statements are issued, management considered, among other factors, the Company’s results of operations during the nine months ended September 30, 2026, including the revenue growth, nine-month profitability, and strengthened liquidity position described above, as well as the net loss incurred during the third quarter, together with management’s continued execution of its strategic plan to streamline and integrate the Company’s recently acquired subsidiaries into a unified operating platform. Based on this evaluation, management has concluded that no conditions or events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern for at least twelve (12) months from the date these consolidated financial statements are issued. Accordingly, these consolidated financial statements have been prepared on a going concern basis, and no adjustments have been made to the carrying values of assets or liabilities that might result if the Company were unable to continue as a going concern.

 

As of September 30, 2026, the Company had a cash and restricted cash balance of $33,144,429 (inclusive of segregated client funds of $11,729,042), which management believes, together with cash expected to be generated from operations, is sufficient to support its ongoing operations and to meet its current obligations as they become due in the ordinary course of business for at least twelve (12) months from the date these consolidated financial statements are issued. While management believes the Company has adequate liquidity to sustain its existing business activities, the Company’s strategic growth initiatives, particularly the continued development of its financial technology platforms, may require additional capital investment. In order to accelerate expansion and enhance its technology offerings, the Company may seek external financing through private placements of equity, public offerings, or credit facilities. There can be no assurance, however, that such financing will be available on acceptable terms, if at all.

 

Management remains focused on strengthening the Company’s financial position by expanding its global customer base, increasing revenue from its diversified portfolio of technology solutions, realizing operating synergies from the continued integration of its acquired subsidiaries, and working toward sustainable positive cash flow from operations. To support long-term growth, the Company also intends to invest in long-lived assets that are expected to generate economic benefits beyond fiscal year 2026. In addition, the Company is pursuing a potential listing of its common stock on a national securities exchange in connection with a proposed public offering. If completed, the proceeds of such offering would meaningfully enhance the Company’s liquidity position and capital resources; however, the completion, timing, and terms of any such offering are subject to market conditions and other factors, and there can be no assurance that the offering will be consummated.

 

F-25

 

 

NOTE 4. CAPITALIZED SOFTWARE COSTS

 

The Company’s capitalized software consists of internally developed software and software development costs capitalized in accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, and ASC 350-40, Internal-Use Software. The estimated useful life of the Company’s capitalized software is three (3) years, and amortization is recognized on a straight-line basis over such estimated useful life commencing when the underlying software is placed in service.

 

As of September 30, 2026, and December 31, 2025, the unamortized balance of capitalized software, including capitalized software of the Company’s subsidiaries, was $1,760,022 and $1,480,246, respectively. During the nine months ended September 30, 2026, the Company capitalized $367,154 of software development costs. No software amortization expense was recognized during the three and nine months ended September 30, 2026, or 2025, as the underlying software assets had not yet been placed in service.

 

A substantial portion of the $1,760,022 capitalized software balance as of September 30, 2026, relates to (i) software assets added in connection with, or shortly after, the acquisition of Alchemy International Ltd. (the change of control of which was approved on October 29, 2025, and which closed on November 11, 2025), and (ii) the ongoing development of the Condor Investing and Trading App. As of September 30, 2026, the related software assets had not yet been placed in service, and accordingly, the Company has not commenced amortization. Amortization will be recognized on a straight-line basis over the estimated three (3) year useful life upon the date each underlying software asset is placed in service.

 

The Company has estimated aggregate amortization expense for each of the succeeding fiscal years based on the estimated three (3) year useful life of the underlying software assets, commencing in the fiscal period in which such assets are placed in service.

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

The Company has, from time to time, entered into transactions with related parties, including its founders, directors, principal shareholders, and entities controlled by them. The following describes related party balances and transactions as of and for the periods presented.

 

Nature of Relationships

 

The Company’s principal related parties are:

 

(i) Mr. Gope S. Kundnani, a Director of the Company and, as of September 30, 2026, the beneficial owner, directly and through APSI Holdings Limited (a United Kingdom entity), of 101,392,200 shares of common stock, including 99,592,200 shares issued upon the conversion of 1,991,844 shares of Series B Convertible Preferred Stock on July 13, 2026 (approximately 80.90% of the outstanding common stock), and 4,000,000 shares of Series A Preferred Stock (88.89%);

 

(ii) Mitchell M. Eaglstein and Imran Firoz, Co-Founders, Executive Officers, and Directors of the Company; and

 

(iii) certain non-consolidated affiliated entities controlled directly or indirectly by Mr. Kundnani, including Alchemy DMCC (United Arab Emirates), Alchemy Capital Markets (“ACM”) (United Kingdom), FXIFY Markets Ltd. (Labuan, Malaysia), and other Kundnani-affiliated sister entities, all of which are sister entities to the Company and not part of the consolidated group; and (iv) Sync Capital Limited (Seychelles), a shareholding company controlled and owned by Mr. Kundnani, which held the seller financing obligation described below and in Note 7 until its settlement during the three months ended September 30, 2026.

 

Related Party Receivables

 

Related party receivables totaled $6,492,563 as of September 30, 2026, compared to $40,090,051 as of December 31, 2025, a net decrease of $33,597,488 during the nine months ended September 30, 2026, principally reflecting the June 30, 2026, set-off and assignment arrangements described below and the collection of trading balances from related-party counterparties during the third quarter.

 

The largest counterparty is ACM, with a net receivable of approximately $4.0 million at September 30, 2026, compared with $15,294,937 at June 30, 2026, and $30,918,736 at March 31, 2026, the reduction reflecting the June 30, 2026, settlement of intercompany balances and collections during the third quarter. Other counterparties at September 30, 2026, are Alchemy Global at $2,081,735, FXPig Vanuatu at $1,847,777, Mr. Kundnani at $595,610 (representing the residual balance arising from the settlement of the stock subscription receivable under the Settlement Agreement described in Note 9, payable in cash on or before December 31, 2026, net of foreign currency remeasurement), Alchemy DMCC at $(863,030), Sync Capital at $265,170, Steven FS / BTFS at $111,633, FXIFY at $9,902, and Xoala Digital Poland at $(116,000). Other related-party balances, together with intercompany differences and amounts pending reclassification that are not yet allocated to a counterparty, comprise the remainder of the balance.

 

F-26

 

 

NOTE 5. RELATED PARTY TRANSACTIONS (continued)

 

As of December 31, 2025, the related party receivable balance was comprised primarily of approximately $35.8 million carried by AIL representing current account receivables from ACM and related affiliates, as further described in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025, supplemented by the loan receivable from FXIFY Markets Ltd. described above at FDCTech, Inc.

 

Related Party Advances Payable

 

Related party advances payable totaled $1,939,946 as of September 30, 2026, compared to $29,197,470 as of December 31, 2025, a net decrease of $27,257,524 during the nine months ended September 30, 2026. As of September 30, 2026, the $1,939,946 balance was comprised of approximately $1.1 million owed to Alchemy DMCC and approximately $0.5 million owed to Alchemy Capital Markets, in each case Kundnani-affiliated sister entities, approximately $0.2 million owed to Sync Capital, a shareholding company, and other smaller balances at the Company’s subsidiaries. The December 31, 2025, balance was comprised primarily of amounts owed by AIL to Alchemy DMCC, together with amounts owed at the FDCTech, Inc. parent level and across other subsidiaries, and other smaller balances.

 

During the nine months ended September 30, 2026, related party advances payable decreased by a net $27,257,524. That movement comprised non-cash extinguishments of $60,096,765, effected through the set-off and assignment arrangements completed on June 30, 2026, and described below, partially offset by $32,839,241 of net cash advances received from related-party counterparties, which is presented within financing activities in the condensed consolidated statements of cash flows. The non-cash arrangements included the transfer back to AIL of certain trading positions previously held with Alchemy DMCC and other liquidity arrangements designed to manage AIL’s counterparty risk exposures. As a result of these arrangements, AIL’s net advance payable to Alchemy DMCC was substantially reduced during the period, and the Company’s aggregate net payable to Alchemy DMCC decreased from approximately $29.1 million as of March 31, 2026, to approximately $1.1 million as of September 30, 2026. The Company held no net receivable from Alchemy DMCC as of September 30, 2026.

 

Supplemental Disclosure of Non-Cash Investing and Financing Activities

 

The settlement of the related party balances described above was effected on June 30, 2026, without any payment or receipt of cash. During the nine months ended September 30, 2026, the Company extinguished a net payable to Alchemy DMCC of $28,148,711, of which $5,257,670 was extinguished by assignment of the Company’s liquidity-provider balance with B2B Prime and $22,891,041 by offset against related party receivables. The Company also extinguished a non-trading payable to Alchemy Capital Markets Ltd. of $31,948,054 by offset, applied $54,839,095 against the client-trading receivable due from Alchemy Capital Markets Ltd., and applied rebates due to Alchemy Capital Markets Ltd. of $3,422,378 against the same balances. No cash was paid or received in connection with any of these arrangements, and accordingly they are excluded from the condensed consolidated statements of cash flows.

 

Accrued Expenses to Related Parties

 

Accrued expenses to related parties totaled $1,040,112 as of September 30, 2026, compared to $532,287 as of December 31, 2025. These amounts primarily represent accrued executive compensation owed to Mr. Eaglstein, the Company’s Chief Executive Officer, and Mr. Firoz, the Company’s Chief Financial Officer (through Thinkatalyst LLC, a Delaware limited liability company controlled by Mr. Firoz), each compensated at $15,000 per month under independent-contractor arrangements.

 

Other Related Party Transactions

 

Other than the settlements and accruals described above, the principal related party transactions during the three and nine months ended September 30, 2026, consisted of (i) the continued accrual of executive compensation to Messrs. Eaglstein and Firoz at $15,000 per month each on an independent-contractor basis; (ii) the settlement, during the three months ended September 30, 2026, of the $2,000,000 non-interest bearing seller financing obligation to Sync Capital Limited (a Seychelles entity controlled and owned by Mr. Gope S. Kundnani, a Director and majority shareholder of the Company), incurred in connection with the Company’s acquisition of Alchemy International Ltd., by set-off against the $8,000,000 stock subscription receivable due from Mr. Kundnani, together with the settlement of the remaining subscription receivable through capital contributions to the Company’s subsidiaries, cash collections, and a reclassification of $603,718 to a receivable from Mr. Kundnani (see Notes 7 and 9); and (iii) net activity in intercompany trading and rebate balances among the Company’s regulated subsidiaries (AML, APL, and AIL), all of which were eliminated in consolidation in accordance with ASC 810-10-45-1. Other than the settlement of the stock subscription receivable described above, there were no material new equity issuances, loans, or guarantees to or from related parties during the three and nine months ended September 30, 2026.

 

Intellectual Property Purchase Agreement – Iconic Advisors and Consulting Limited

 

On September 30, 2026, the Company entered into an Intellectual Property Purchase Agreement (the “IP Purchase Agreement”) with Iconic Advisors and Consulting Limited (“Iconic”), a Nevada company owned by Robert J. Winters, a director of the Company’s subsidiary Alchemy International Ltd. Iconic is a related party of the Company within the meaning of ASC 850; however, Iconic and the Company are not under common control, and the transaction is accounted for as an asset acquisition under ASC 805-50 rather than as a business combination or a transfer between entities under common control.

 

Under the IP Purchase Agreement, the Company acquired from Iconic certain customer data, risk management software, and machine-learning fraud detection assets, together with the related intellectual property rights, books and records, and related rights (the “Purchased Assets”). No liabilities were assumed. The purchase price is satisfied solely by the extinguishment of a receivable of $3,165,290 due from Iconic arising from cash advances previously made by the Company (the “Settled Receivable”); no cash consideration is payable. The settled amount may not exceed $3,165,290 and is limited to the fair value of the Purchased Assets as determined by an independent valuation commissioned by the Audit Committee in accordance with ASC 820; any excess of the Settled Receivable over the settled amount remains outstanding and due from Iconic on its original terms. Accrued and unpaid interest on the Settled Receivable, if any, is excluded from the settled amount.

 

As of September 30, 2026, the Company reclassified the $3,165,290 Settled Receivable from loans and advances receivable to acquired intangible assets, which is presented within acquired intangible assets on the consolidated balance sheet and as a non-cash investing activity in the consolidated statements of cash flows. Closing of the IP Purchase Agreement is subject to customary conditions, including delivery of the independent valuation, approval by the disinterested directors and the Audit Committee, completion of technical and privacy diligence, and consultation with the Company’s independent registered public accounting firm. The Purchased Assets are finite-lived intangible assets that the Company will amortize on a straight-line basis over an estimated useful life of five (5) years, commencing in the fourth quarter of 2026. Because the acquisition was effective on September 30, 2026, no amortization of the acquired intangible assets was recorded during the three and nine months ended September 30, 2026. Based on the $3,165,290 carrying amount and five-year useful life, estimated annual amortization expense is approximately $633,058, subject to finalization of the allocation of the settled amount among the Purchased Assets upon completion of the independent valuation.

 

Cross-Reference to Form 10-K/A

 

For additional historical background on related party transactions, including transactions prior to fiscal year 2025, refer to Item 13 (Certain Relationships and Related Transactions) of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (as most recently amended by Amendment No. 4 on Form 10-K/A filed July 1, 2026).

 

F-27
 

 

NOTE 6. LINE OF CREDIT

 

In June 2016, the Company obtained an unsecured revolving line of credit of $40,000 from Bank of America to fund various business purchases and travel expenses. The interest rates applicable to cash advances and other drawn amounts under this line of credit are 12% and 25%, respectively. In October 2024, the Company obtained an additional unsecured revolving line of credit with a flexible spending limit, under which no preset borrowing limit applies. The additional line of credit bears interest on purchases at an average rate of approximately 28% per annum.

 

As of September 30, 2026, the Company was in compliance with the terms and conditions of each of its lines of credit. As of September 30, 2026, and December 31, 2025, the aggregate outstanding balances under the lines of credit were $245,617 and $111,352, respectively.

 

NOTE 7. NOTES PAYABLE

 

CARES Act – Paycheck Protection Program (PPP Note)

 

On May 1, 2020, the Company received proceeds of $50,632 from a promissory note (the “PPP Note”) issued under the Paycheck Protection Program of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Note bears interest at a rate of 1.00% per annum. The PPP Note was not forgiven, and the Company commenced repayment of the PPP Note in August 2022. The PPP Note was repaid in full during the fiscal year ended December 31, 2025. As of September 30, 2026, and December 31, 2025, the outstanding balance of the PPP Note was $0 and $0, respectively.

 

SBA Loan

 

On May 22, 2020, the Company received proceeds of $144,900 under the U.S. Small Business Administration’s Economic Injury Disaster Loan (“EIDL”) program. The loan bears interest at a rate of 3.75% per annum on funds advanced. Installment payments of $707 per month, consisting of both principal and interest, are required, with the remaining principal and interest balance payable thirty (30) years from the date of the promissory note. As of September 30, 2026, and December 31, 2025, the non-current balance outstanding under the SBA loan was $99,299 and $105,678, respectively.

 

Business Acquisition Loan

 

As of September 30, 2026, and December 31, 2025, the Company had outstanding seller financing obligations incurred in connection with prior business acquisitions in the aggregate amount of $350,000 and $2,350,000, respectively, presented as Business acquisition loan on the consolidated balance sheets.

 

The December 31, 2025, balance of $2,350,000 was comprised of:

 

(i) $350,000 representing the unpaid portion of the purchase consideration owed to the former shareholders of Alchemy Markets Ltd. (“AML”) in connection with the Company’s June 2023 acquisition of AML, which amount is currently the subject of litigation as described below; and

 

(ii) $2,000,000 representing seller financing provided by Sync Capital Limited, a Seychelles entity controlled and owned by Mr. Gope S. Kundnani, a Director and majority shareholder of the Company, in connection with the Company’s acquisition of Alchemy International Ltd. (“AIL”), which was settled during the three months ended September 30, 2026, as described below. The September 30, 2026, balance of $350,000 consists solely of the AML amount described in (i).

 

The $2,000,000 obligation to Sync Capital Limited was non-interest-bearing and, as extended, matured on September 30, 2026. During the three months ended September 30, 2026, the obligation was released in full by Sync Capital Limited, without any payment of cash, and the $2,000,000 released was applied in payment of the stock subscription receivable due from Mr. Kundnani under the Settlement Agreement described in Note 9. The Company did not impute interest on this obligation, as the lender was a controlling shareholder of the Company, and any imputed interest, if material, would have been recognized as a deemed capital contribution from the controlling shareholder with no net effect on stockholders’ equity. No cash payments were made under this obligation during the three and nine months ended September 30, 2026, or 2025.

 

As of September 30, 2026, the Company has accrued the $350,000 withheld final payment within Business acquisition loan on the consolidated balance sheets. Management, after consultation with legal counsel, is unable to predict the ultimate outcome of the AML Litigation or to estimate the range of possible additional loss, if any, beyond the amount currently accrued. Accordingly, no additional accrual has been recorded as of September 30, 2026. An adverse outcome in the AML Litigation could result in the Company being required to pay additional amounts to the Claimants, which could have a material adverse effect on the Company’s results of operations and financial condition in the period of resolution.

 

The settlement of the $2,000,000 obligation to Sync Capital Limited is also disclosed as a related party transaction in Note 5.

 

Vanquish Funding Group Promissory Notes

 

On August 20, 2026, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group Inc. (“Vanquish”) and issued a promissory note in the aggregate principal amount of $329,940, which includes $47,940 of original issue discount, for a purchase price of $282,000 (“Vanquish Note #1”). On September 15, 2026, the Company entered into a second Securities Purchase Agreement with Vanquish and issued a promissory note in the aggregate principal amount of $242,190, which includes original issue discount and fees, for a purchase price of $193,000 (“Vanquish Note #2” and, together with Vanquish Note #1, the “Vanquish Notes”). The Company received aggregate net proceeds of $475,000 from the Vanquish Notes, which are being used for general working capital purposes.

 

A one-time interest charge of 12% of principal ($39,592 on Vanquish Note #1 and $29,063 on Vanquish Note #2) was applied at issuance and is included in accrued interest on the consolidated balance sheet. Principal and interest on Vanquish Note #1 are payable in five installments — $184,766 on February 28, 2027, and $46,191.50 on each of March 30, 2027, April 30, 2027, May 30, 2027, and June 30, 2027 — for a total payback of $369,532, and Vanquish Note #2 is payable on substantially similar installment terms. The Vanquish Notes mature on June 30, 2027, and may be prepaid in full at any time without penalty. Amounts not paid when due bear interest at 22% per annum, and a missed payment (subject to a five-day grace period) constitutes an event of default.

 

The Vanquish Notes are not convertible absent an event of default. Events of default include, among others, failure to pay, failure to comply with the Company’s reporting obligations under the Exchange Act, failure to maintain the quotation or listing of the Common Stock, failure to maintain the required share reserve with the Company’s transfer agent, and specified insolvency, liquidation and cross-default events. Upon an event of default, the outstanding balance becomes immediately due in an amount equal to 150% of the then-outstanding principal, accrued interest and default interest (increasing to 200% if the Company fails to honor a conversion), and, at any time beginning 180 days after the issue date, the holder may convert the outstanding balance into shares of Common Stock at a conversion price equal to 65% of the lowest trading price during the ten trading days preceding the conversion date, subject to a 4.99% beneficial ownership limitation. The Company is required to reserve four times the number of shares issuable upon full conversion of the notes and has instructed its transfer agent to reserve shares for this purpose. The Vanquish Notes are governed by the laws of the Commonwealth of Virginia.

 

The original issue discount and one-time interest charge, totaling $165,785, were recorded as a debt discount and are being amortized to interest expense using the effective interest method over the term of the Vanquish Notes. During the three and nine months ended September 30, 2026, the Company recognized $19,200 of debt discount amortization within other interest income (expense). As of September 30, 2026, the Vanquish Notes are presented on the consolidated balance sheet as promissory notes, net of unamortized discount of $146,585, in the amount of $425,545. Because the conversion feature is contingent upon an event of default that was not probable as of September 30, 2026, no separate accounting for the contingent conversion feature was required.

 

F-28
 

 

NOTE 8. COMMITMENTS AND CONTINGENCIES

 

The Company is subject to various commitments and contingencies arising in the ordinary course of business. The following discussion summarizes the Company’s significant commitments and contingencies as of September 30, 2026.

 

At September 30, 2026, the Company and its subsidiaries operate offices across multiple jurisdictions. Leases that qualify under ASC 842 are recognized on the consolidated balance sheet as Right-of-Use (“ROU”) assets and corresponding lease liabilities. At September 30, 2026, the ROU asset was $673,254, current operating lease liabilities were $106,969, and non-current operating lease liabilities were $283,437, compared to $811,038, $165,692, and $364,655, respectively, at December 31, 2025. The weighted-average discount rate for qualifying operating leases was approximately 5.5%. Service contracts and month-to-month arrangements that do not qualify as leases under ASC 842 are expensed as incurred and included in General and Administrative expenses.

 

Office Facility and Other Operating Leases

 

Limassol, Cyprus (Company’s Principal Executive Offices) and Irvine, California, USA (Former Headquarters)

 

Effective September 9, 2026, the Company relocated its principal executive offices to Ground Floor, 10A Eleftheriou Venizelou Street, 3035 Limassol, Cyprus, within the premises subleased by ATECH described below. From October 29, 2019, through the relocation, the Company’s principal executive offices were located at 200 Spectrum Center Drive, Suite 300, Irvine, CA 92618, under a coworking membership held on a month-to-month basis. The membership provides access to shared office and meeting facilities on an as-needed basis rather than a dedicated, exclusively controlled space. The Company may terminate the agreement by delivering an exit form at least one calendar month prior to the intended termination month. The monthly membership fee is $95. This agreement is classified as a service contract rather than a lease under ASC 842, and payments are recognized as operating expenses.

 

Brisbane, Australia (ADS Office)

 

Effective January 1, 2024, to the present, ADS holds a coworking membership for office space at Level 38/71 Eagle St, Brisbane City, QLD 4000, Australia, on a month-to-month basis. The membership provides access to shared office and meeting facilities on an as-needed basis rather than a dedicated, exclusively controlled space. The monthly membership fee is approximately $125. This agreement is classified as a service contract rather than a lease under ASC 842, and payments are recognized as operating expenses.

 

Limassol, Cyprus Lease (Company’s Executive Rental)

 

From July 2023 to the present, the Company has leased office and residential space in the Limassol District, Cyprus, from an unrelated party, at a monthly rent of approximately $3,500, included in General and Administrative expenses. This agreement is classified as a residential rental contract rather than a commercial lease and does not create an ROU asset under ASC 842. The leased premises comprise approximately 158 square meters (approximately 1,700 square feet), of which approximately 46 square meters (approximately 500 square feet) is designated for office use and the remaining approximately 112 square meters (approximately 1,200 square feet) serves as the residence of a Company executive.

 

Limassol, Cyprus Lease, Europe (ATECH Office)

 

Effective August 26, 2024, T.I.C.G. Integrated Solutions Ltd. (formerly Alchemytech Ltd.) (“ATECH”) entered into a Sublease Agreement for office premises located at 10A-10C Eleftheriou Venizelou Street, Limassol, Cyprus, with Aldeon Property Partners Ltd. as Sublessor, and FDCTech, Inc. acting as Guarantor. The leased premises are designated strictly for office use. The lease term is twenty-four (24) months, commencing November 1, 2024, and expiring October 31, 2026, with options to extend for up to two additional two-year terms. Effective September 9, 2026, these premises also serve as the Company’s principal executive offices. Monthly rent is €8,000 (approximately $8,600) plus VAT, for a total lease commitment of €192,000. Each option period is exercisable on three months’ written notice, and the sublease provides for the monthly rent to increase by up to five percent (5%), rounded up to the nearest €50, during each option period. The Company paid a deposit of €16,000, equal to two months’ rent. This agreement qualifies as a lease under ASC 842, and the Company has recognized an ROU asset and corresponding lease liability on its consolidated balance sheet. The leased premises comprise approximately 2,624 square feet. On July 30, 2026, the parties executed a First Addendum exercising the first renewal option, extending the sublease for a further two-year period commencing November 1, 2026, and expiring October 31, 2028, with monthly rent remaining at €8,000 plus VAT and aggregate rent for the renewal period of €192,000 plus VAT; the rent increase contemplated by the sublease for the option period was not applied. The exercise of the renewal option during the three months ended September 30, 2026, constitutes a reassessment event under ASC 842-10-35-1; the right-of-use asset and lease liability at September 30, 2026, have not yet been remeasured for the renewal term, and the Company expects to complete the remeasurement during the fourth quarter of 2026. The effect of the remeasurement is not expected to be material to the Company’s consolidated financial position.

 

F-29
 

 

NOTE 8. COMMITMENTS AND CONTINGENCIES (continued)

 

St. Julian, Malta (AML Office)

 

Effective July 11, 2024, to the present, AML leases office space with Regus Malta at Portomaso Business Centre, Portomaso, St. Julian, PTM01, Malta, on a month-to-month basis. The monthly membership fee is €1,659. This agreement is classified as a service contract rather than a lease under ASC 842, and payments are recognized as operating expenses. The allocated workspace comprises approximately 338 square feet.

 

London, United Kingdom (APL Office)

 

Effective December 20, 2024, Alchemy Prime Limited (“APL”) entered into a lease agreement for office space at the Fifth Floor, 142 Central Street, Clerkenwell, London, EC1V 8AR, with Agop Tanielian and Hourig Mercedes Tanielian as landlords. The lease has a fixed term of five years, expiring in 2029, with an annual rent of £112,500 (approximately $12,000 per month), payable in quarterly installments. The lease includes a Break Clause exercisable on or after 2026, subject to four months’ prior written notice. APL is liable for service charges, insurance rent, and reinstatement obligations upon termination. This agreement qualifies as a lease under ASC 842, and the Company has recognized an ROU asset and corresponding lease liability on its consolidated balance sheet. The leased premises comprise approximately 3,750 square feet.

 

Consolidated rent and lease expense for the three and nine months ended September 30, 2026, was $102,726 and $274,989, respectively (three and nine months ended September 30, 2025: $66,511 and $199,533, respectively), of which $13,669 and $57,804, respectively, related to the parent company’s corporate offices and the balance to the offices of its operating subsidiaries in Malta, the United Kingdom, Cyprus, Seychelles, the Cayman Islands, Vanuatu, and Australia. Rental expenses for all operating leases and service contracts are included in General and Administrative expenses.

 

Terminated Leases

 

Limassol, Cyprus (Ecastica). From October 2023 to August 2024, the Company leased office space in the Limassol District, Cyprus, for the intended establishment of ATECH. The monthly rent was approximately $1,000, and the down payment was approximately $6,300, included in General and Administrative expenses. The lease was terminated in August 2024.

 

Chelyabinsk, Russia. From April 2019 to August 2022, the Company leased office space in Chelyabinsk, Russia, at $500 per month for software development and technical support. The Company closed its Russian offices in August 2022 and relocated the team to Turkey, and subsequently to Kazakhstan in April 2023. This lease has been fully terminated.

 

Tel Aviv, Israel (AML Sales Office). From July 1, 2023, to June 30, 2026, AML held a service agreement with Mindspace Ltd. for office space and related services at Menachem Begin 11, Ramat Gan, Israel, on a monthly auto-renewing basis. The monthly fee was $4,500 (including VAT). Mindspace retained discretion over space allocation and could relocate AML within the premises upon prior notice, and AML did not have exclusive control over a specific unit. This agreement did not create a lease under ASC 842 and was accounted for as a service contract, with payments recognized as operating expenses. The Company terminated this agreement effective September 30, 2026, due to geopolitical conditions, and relocated all sales activities to the ATECH office in Limassol, Cyprus.

 

Employment Agreement

 

The Company compensates its key executives as independent contractors. Eaglstein and Firoz commit one hundred percent (100%) of their time to the Company. The Company has not formalized performance bonuses or other incentive plans. Each executive is paid at the beginning of each month. From September 2018 through September 30, 2020, the Company paid monthly compensation of $5,000 to its CEO and CFO, respectively. Effective October 1, 2020, the Company increased the monthly compensation to $12,000. Effective January 1, 2023, the Company pays $15,000 monthly to its CEO and CFO (see Note 5, Related Party Transactions – Accrued Expenses to Related Parties).

 

The Company is not currently a party to any formal employment agreement and has no compensation agreement with any officer or director. The Company plans to enter into employment agreements with its officers in connection with the planned uplisting to a senior national securities exchange. For additional information regarding executive compensation, refer to Item 11 (Executive Compensation) of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as most recently amended by Amendment No. 4 on Form 10-K/A filed with the SEC on July 1, 2026.

 

Accrued Interest

 

At September 30, 2026, and December 31, 2025, the cumulative accrued interest for the SBA loan, the Vanquish promissory notes, and other non-current loans was $109,502 and $42,396, respectively, including $68,655 of one-time interest charges on the Vanquish promissory notes described in Note 7.

 

F-30
 

 

NOTE 8. COMMITMENTS AND CONTINGENCIES (continued)

 

Pending Litigation

 

The Company and its subsidiaries are involved in the following legal proceedings:

 

Asher Alkoby, et al. v. FDCTech

 

This action is pending in the London Circuit Commercial Court under Claim Number LM-2024-000330, filed December 9, 2024. The claimants are Asher Alkoby and other former shareholders of Alchemy Markets Ltd. (“AML”), a Malta-incorporated broker that the Company purchased in June 2023. Following completion of the acquisition, the Company discovered that in 2019, the target company had anti-money laundering deficiencies and was fined by the Financial Intelligence Analysis Unit. An external audit also revealed that the previous shareholders had taken loans from the company that were never repaid, resulting in net capital being lower than disclosed during negotiations. Based on these findings, FDCTech withheld the final payment to the sellers.

 

The claimants are seeking approximately $1.02 million in amounts they allege are owing under the Share Sale Agreement, which they are seeking to rectify to make it legally enforceable. The Company has counterclaimed for a declaration that the Share Sale Agreement is ineffective and unenforceable and seeks repayment of $915,000 paid to the sellers. On October 17, 2025, the Court granted the claimants permission to amend their claim to include a third claimant. The Company has prepared an Amended Defense and Counterclaim through Counsel, which was served on May 9, 2025. A Costs and Case Management Conference took place on November 17, 2025. The trial is currently scheduled to take place in November 2026.

 

FDCTech, Inc. v. Intelligenceline.com, Fintelegram.com, et al.

 

This action is pending in the Superior Court of California, County of Orange. FDCTech alleges that the defendants, through their websites Intelligenceline.com, Fintelegram.com, and Criticalintel.com, published false and defamatory statements accusing the Company of fraud, illegal conduct, and regulatory violations. The Company claims these statements have caused significant reputational and financial harm, including lost business opportunities, and further alleges that the defendants engaged in an extortion scheme by demanding payment for the removal of defamatory content. The complaint asserts claims for defamation per se, defamation per quod, trade libel, and false light, seeking damages and injunctive relief. The complaint was filed in 2025 but had not yet been served as of December 31, 2025. A hearing took place on December 15, 2025, on the Company’s motion. Following the hearing, the court instructed FDCTech to conduct an adequate investigation as to the beneficial owner of Intelligenceline.com. FDCTech conducted the investigation and presented its findings during the management conference held on April 20, 2026. FDCTech is currently awaiting the court’s final judgment based on the outcome of the investigation.

 

Alchemy Markets Ltd. v. Il-Korp għall-Analizi ta’ Informazzjoni Finanzjarja (Ref: 104/2023)

 

This appeal is pending before the Court of Appeal (Inferior Jurisdiction) in Malta. On September 23, 2023, the Financial Intelligence Analysis Unit (“FIAU”) imposed an administrative penalty of €419,997 and a follow-up directive on Alchemy Markets Ltd. (formerly NSFX Limited), a subsidiary of the Company, based on a compliance examination conducted between November 25, 2019, and December 5, 2019. The examination occurred approximately four years prior to the decision and under different ownership and control of the subsidiary. The Company filed this appeal on October 19, 2023, challenging the decision-making process and the law on which it was based, asserting that the penalty is arbitrary and excessive. The Company seeks to overturn the administrative penalty and the follow-up directive imposed by FIAU. On October 24, 2025, a hearing was held for the Company to continue presenting evidence. The matter is in the evidentiary production stage pertaining to the Company as appellant. On July 17, 2026, a further hearing was held before Madam Justice Rachel Montebello for the FIAU to cross-examine the Company’s witnesses, following which the matter is to be adjourned for final legal submissions.

 

Alchemy Markets Ltd. v. L-Avukat tal-Istat u Il-Korp għall-Analizi ta’ Informazzjoni Finanzjarja (Ref: 159/2024)

 

This constitutional challenge is pending before the First Hall Civil Court (Constitutional Jurisdiction) in Malta and relates to the same September 23, 2023, FIAU decision described above. The Company filed this application on April 2, 2024, challenging: (i) the composition of the FIAU and its enabling law; (ii) the decision-making processes which allegedly breach the Company’s fundamental human right to a fair hearing; and (iii) that, given the penal nature of the penalty and in alleged breach of the Constitution of Malta, the Company was not adjudged by an independent court. The Company requests the Constitutional Court to set aside the FIAU decision in its entirety. A first procedural hearing took place on May 7, 2024, and the Company has brought its evidence in support of the claim. The First Hall Civil Court (Constitutional Jurisdiction) has, in various instances, pronounced that administrative penalties imposed by the FIAU are more akin to penal sanctions and that subject persons should be afforded the full rights of an accused under criminal law, consistently quashing FIAU decisions on this basis. On April 14, 2026, the Company submitted its final submissions before the Court. On July 12, 2026, the First Hall Civil Court (Constitutional Jurisdiction) delivered its judgment rejecting the Company’s constitutional claims and determining that the FIAU decision did not breach the Company’s right to a fair hearing. Under Maltese law, the Company had the right to appeal the judgment within twenty statutory running days from the date of judgment, and the Company filed its appeal in late July 2026. The related appeal before the Court of Appeal (Inferior Jurisdiction) described above remains pending. No amount has been accrued in respect of the administrative penalty, as the Company continues to contest the matter and a loss is not considered probable and reasonably estimable at this time.

 

The Company believes it has meritorious defenses and counterclaims in all of the above matters and intends to defend them vigorously. However, litigation is inherently uncertain, and the Company cannot predict the outcome of these proceedings with certainty. Management is unaware of any other actions, suits, investigations, or proceedings (public or private) pending or threatened against or affecting the Company, its subsidiaries, or any of their respective assets, other than those described above and other than ordinary routine litigation incidental to the business.

 

Tax Compliance Matters

 

From its inception to the present, the Company’s officers have been paid as independent contractors. As of September 30, 2026, the Company believes payroll tax liabilities are not material. The Company’s federal taxes are compliant with Internal Revenue Service regulations.

 

F-31
 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT)

 

Authorized Shares

 

On February 12, 2021, the Company filed a Certificate of Amendment with the Secretary of State of Delaware to change the authorized shares. As amended at that time, the Company had the authority to issue 260,000,000 shares, consisting of 250,000,000 shares of Common Stock having a par value of $0.0001 per share and 10,000,000 shares of Preferred Stock having a par value of $0.0001 per share.

 

On February 17, 2022, the Company filed an Information Statement pursuant to Section 14C of the Securities Exchange Act of 1934 to increase the authorized Common Stock from 250,000,000 to 500,000,000 shares and to approve the Company’s 2022 Equity Plan. The Approving Stockholders (common stock only) owned 96,778,105 shares, representing 64.62% of the total issued and outstanding voting power of the Company.

 

Recent Corporate Actions – September 2025

 

On September 4, 2025, the Board of Directors unanimously approved, and the Company obtained the written consent of holders of a majority of the Company’s voting power for, corporate actions to (i) amend the Certificate of Incorporation to increase the authorized shares of common stock from 500,000,000 to 750,000,000 and the authorized shares of preferred stock from 10,000,000 to 15,000,000 and (ii) authorize the Board of Directors, in its discretion, to amend the Certificate of Incorporation not later than June 30, 2026, to effect a reverse stock split of all outstanding shares of common stock in a ratio of not less than 1-for-10 and not more than 1-for-100, to be determined by the Board. On June 29, 2026, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware, increasing the authorized shares of common stock from 500,000,000 to 750,000,000 and effecting the 1-for-100 reverse stock split described in Note 1, which became effective on July 10, 2026. On August 17, 2026, the Company filed a further Certificate of Amendment increasing the authorized shares of preferred stock from 10,000,000 to 15,000,000. Following these amendments, the Company is authorized to issue 765,000,000 shares of capital stock, consisting of 750,000,000 shares of common stock and 15,000,000 shares of preferred stock, each with a par value of $0.0001 per share.

 

Certificate of Designation of Series B Convertible Preferred Stock

 

On December 4, 2023, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series B Certificate of Designation designates 3,000,000 shares of the Company’s authorized preferred stock (par value $0.0001 per share) as “Series B Convertible Preferred Stock” and establishes the rights, preferences, privileges, and restrictions of such shares.

 

Holders of Series B Convertible Preferred Stock have no dividend rights except as may be declared by the Board of Directors in its sole and absolute discretion, out of funds legally available for that purpose. Each share is entitled to one (1) vote per share on all matters presented to stockholders, and holders generally vote together with holders of Common Stock as a single class. The vote or consent of holders of a majority of the outstanding Series B Convertible Preferred Stock is required for: (i) matters that by law require the approval of the outstanding shares of the Series B Convertible Preferred Stock as a separate class; (ii) any amendment to the rights, preferences, privileges, or powers of the Series B Convertible Preferred Stock that would have a material adverse effect on the Series B Convertible Preferred Stock; (iii) any increase in the aggregate authorized number of shares of Series B Convertible Preferred Stock; (iv) any action that reclassifies any outstanding shares into shares having priority as to dividends or assets senior to the Series B Convertible Preferred Stock; or (v) any amendment to the Company’s Certificate of Incorporation that materially and adversely affects the rights of the Series B Convertible Preferred Stock.

 

Prior to its amendment, the Series B Certificate of Designation provided that each share of Series B Convertible Preferred Stock was convertible at the option of the holder, without payment of additional consideration, into one hundred (100) shares of Common Stock, and that the conversion rate was not subject to adjustment for stock splits or other changes to the Common Stock. In January 2026, and as further amended on August 17, 2026, the Series B Certificate of Designation was amended to provide that, upon a Rate Determination Event — consisting of either (i) the completion of a public offering of Common Stock resulting in gross proceeds of $10,000,000 or more that includes the listing of the Common Stock on The Nasdaq Stock Market or the New York Stock Exchange or (ii) any reverse stock split, combination, or similar reclassification of the outstanding Common Stock — the Board of Directors is authorized to determine and fix the conversion rate within a range of not more than one hundred (100) and not less than ten (10) shares of Common Stock for each share of Series B Convertible Preferred Stock. The reverse stock split effected on July 10, 2026, constituted a Rate Determination Event, and the Board of Directors determined and fixed the conversion rate at fifty (50) shares of Common Stock for each one share of Series B Convertible Preferred Stock, effective July 13, 2026. On July 13, 2026, all 2,371,844 outstanding shares of Series B Convertible Preferred Stock were converted into 118,592,200 shares of Common Stock at that rate. The conversion was recorded as a reclassification of $237 of Series B Preferred stock par value and $3,344,063 of related additional paid-in capital to common stock ($11,859) and additional paid-in capital, with no gain or loss and no effect on total stockholders’ equity. The Series B Certificate of Designation provides that no fractional shares of Common Stock will be issued upon conversion (any fractional share entitlement will be rounded up to the nearest whole share).

 

Shares of Series B Convertible Preferred Stock that are converted into Common Stock or are otherwise acquired by the Company are restored to the status of authorized but unissued shares of preferred stock, without designation as to class, and may thereafter be issued, but not as shares of Series B Convertible Preferred Stock. As of September 30, 2026, no shares of Series B Convertible Preferred Stock were issued and outstanding, compared to 2,371,844 shares as of December 31, 2025.

 

F-32
 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

 

Outstanding Capital Stock

 

As of September 30, 2026, and December 31, 2025, the Company had 125,323,068 and 4,230,868 common shares issued and outstanding, respectively. The increase of 121,092,200 shares during the three months ended September 30, 2026, consists of 118,592,200 shares issued upon the conversion of the Series B Convertible Preferred Stock on July 13, 2026, and 2,500,000 shares issued for consulting services in August 2026, each as described below. Subsequent to September 30, 2026, on November 3, 2026, the Company issued an additional 25,000 restricted shares of Common Stock, valued at $103,750, to a director of its subsidiary Alchemy International Ltd. as compensation for services, as described in Note 16, increasing the number of shares issued and outstanding to 125,348,068.

 

As of September 30, 2026, and December 31, 2025, the Company had 4,500,000 and 4,500,000 Series A Preferred Stock issued and outstanding, respectively.

 

As of September 30, 2026, and December 31, 2025, the Company had 0 and 2,371,844 Series B Preferred Stock issued and outstanding, respectively. Other than the conversion of the Series B Convertible Preferred Stock and the issuance of 2,500,000 shares of Common Stock for consulting services, there were no issuances or repurchases of common or preferred stock during the three and nine months ended September 30, 2026.

 

Series A Preferred Stock – Beneficial Ownership

 

The percentages below are calculated based on 4,500,000 shares of our Series A Preferred Stock issued and outstanding as of September 30, 2026, and as of the date of this Report. Series A Preferred Stock was not affected by the 1-for-100 reverse stock split effective July 10, 2026.

 

Name and Address(1) 

Title of

Class (4)

 

Number of Shares

Beneficially Owned

  

Percent of

Class

 
Mitchell M. Eaglstein, CEO, Director  Series A Preferred   500,000    11.11%
Gope S. Kundnani, Director (5)  Series A Preferred   4,000,000    88.89%
Officers and Directors as a group (2 persons)  Series A Preferred   4,500,000    100.00%

 

(4) Series A Preferred Stock is entitled to fifty (50) non-cumulative votes per share on all matters presented to stockholders for action and has no right to convert into the Company’s Common Stock. Series A Preferred Stock was not affected by the 1-for-100 reverse stock split effective July 10, 2026. As of September 30, 2026, and as of the date of this Report, the Company had 4,500,000 shares of Series A Preferred Stock issued and outstanding.
   
(5) The Company originally issued 2,600,000, 400,000, and 1,000,000 shares of Series A Preferred Stock to Mitchell M. Eaglstein, Imran Firoz, and Felix R. Hong, respectively, in December 2016 as founders, in consideration of services rendered. In January 2023, Eaglstein and Firoz transferred 1,100,000 and 400,000 shares, respectively, to Gope S. Kundnani, a Director of the Company. On November 30, 2023, the Company issued 2,500,000 shares of Series A Preferred Stock to Mr. Kundnani. On January 30, 2024, the Board of Directors approved the rescission and cancellation of 1,000,000 shares held by Mr. Eaglstein and 1,000,000 shares held by Mr. Hong. In connection with the Company’s contemplated listing on a national securities exchange, all 4,500,000 outstanding shares of Series A Preferred Stock are expected to be retired and cancelled immediately prior to the closing of the contemplated offering, without any cash consideration to the holders.

 

On November 30, 2023, the Company issued 2,500,000 Series A Preferred Stock to Kundnani, valued at $2,500,000. The Company will receive $2,500,000 in direct investment from Alchemy Prime Holdings Shareholder for Series A Preferred, valued at $1.00 per share.

 

On January 30, 2024, the Company’s board of directors adopted and approved the rescission and cancellation of (i) 1,000,000 shares of Series A Preferred Stock of the Company issued to Mitchell M. Eaglstein and (ii) 1,000,000 shares of Series A Preferred Stock of the Company issued to Felix R Hong.

 

F-33
 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

 

Common Stock – Beneficial Ownership

 

The percentages below are calculated based on 125,323,068 shares of our Common Stock issued and outstanding as of September 30, 2026 (125,348,068 shares as of the date of this Report, after giving effect to the issuance of 25,000 shares on November 3, 2026, described in Note 16), being the number of shares outstanding following the 1-for-100 reverse stock split effective July 10, 2026, the conversion of all outstanding shares of Series B Convertible Preferred Stock into Common Stock on July 13, 2026, and the issuance of 2,500,000 shares of Common Stock for consulting services in August 2026. Following the conversion, no shares of Series B Convertible Preferred Stock remain issued or outstanding.

 SCHEDULE OF COMMON STOCK

Name and Address(1) 

Title of

Class

 

Number of Shares

Beneficially Owned

  

Percent of

Class

 
Mitchell M. Eaglstein, CEO, Director (2)  Common   7,708,181    6.15%
Imran Firoz, CFO, Director (3)  Common   7,743,100    6.18%
Brian Platt, CTO (4)  Common   10,000    -* 
Jonathan Baumgart, Director (5)  Common   6,450    -* 
Gope S. Kundnani, Director (6)  Common   101,392,200    80.90%
Officers and Directors as a group (5 persons) (7)  Common   116,859,931    93.25%

 

(1) Unless otherwise indicated, the business address of each beneficial owner is c/o FDCTech, Inc., Ground Floor, 10A Eleftheriou Venizelou Street, 3035 Limassol, Cyprus. Beneficial ownership is determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. Share amounts and percentages give effect to the 1-for-100 reverse stock split effective July 10, 2026, to the conversion of all outstanding shares of Series B Convertible Preferred Stock into Common Stock on July 13, 2026, and to the issuance of 2,500,000 shares of Common Stock for consulting services in August 2026, and are calculated on 125,323,068 shares of Common Stock outstanding as of September 30, 2026. The issuance of 25,000 shares of Common Stock on November 3, 2026, described in Note 16, does not materially affect the percentages shown. An asterisk (*) denotes beneficial ownership of less than one percent.

 

(2) Consists of (a) 208,181 shares of common stock and (b) 7,500,000 shares of common stock issued upon the conversion of 150,000 shares of Series B Convertible Preferred Stock. Does not include 600,000 shares beneficially owned by Susan E. Eaglstein, mother of Mr. Eaglstein, as to which Mr. Eaglstein disclaims beneficial ownership.

 

(3) Consists of (a) 243,100 shares of common stock and (b) 7,500,000 shares of common stock issued upon the conversion of 150,000 shares of Series B Convertible Preferred Stock.

 

(4) Consists of 10,000 shares of common stock. Mr. Platt holds no shares of Series B Convertible Preferred Stock and no convertible promissory notes.

 

(5) Consists of 6,450 shares of common stock. Mr. Baumgart holds no shares of Series B Convertible Preferred Stock and no convertible promissory notes.

 

(6) Consists of (a) 1,500,000 shares of common stock held directly by Mr. Kundnani, (b) 9,592,200 shares of common stock issued upon the conversion of 191,844 shares of Series B Convertible Preferred Stock held directly by Mr. Kundnani, (c) 300,000 shares of common stock held by APSI Holdings Limited and (d) 90,000,000 shares of common stock issued upon the conversion of 1,800,000 shares of Series B Convertible Preferred Stock held by APSI Holdings Limited. Mr. Kundnani controls APSI Holdings Limited.

 

(7) Consists of (a) 2,267,731 shares of common stock and (b) 114,592,200 shares of common stock issued upon the conversion of 2,291,844 shares of Series B Convertible Preferred Stock, in each case held by our directors and executive officers as a group, and includes the securities held by APSI Holdings Limited described in footnote (6).

 

F-34
 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

 

On November 30, 2023, the Company issued 1,800,000 Series B Preferred Stock to Kundnani, valued at $2,538,000, for the purchase of 49.90% of AML and 100% of APL.

 

On January 4, 2024, the Company issued 150,000 Series B preferred stock to Mitchell M. Eaglstein, CEO and Director, for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 150,000 Series B preferred stock to Imran Firoz, CFO and Director, for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 50,000 Series B preferred stock to FRH Group for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 10,000 Series B preferred stock to William B. Barnett, Esq., for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 10,000 Series B preferred stock to Susan E. Eaglstein for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 50,000 Series B preferred stock to Gope S. Kundnani for services valued at $1.41 per share.

 

On January 30, 2024, the Company issued 141,844 Series B preferred stock to Gope S. Kundnani for cash valued at $1.41 per share.

 

On February 07, 2025, the Company issued 10,000 Series B preferred stock to Nicky G. Kundnani for services valued at $1.41 per share.

 

Common Stock Issued for Consulting Services

 

On August 27, 2026, the Company issued 1,500,000 restricted shares of Common Stock to Lux Limited, and on August 28, 2026, the Company issued 1,000,000 restricted shares of Common Stock to Global Alliance Consulting Group, in each case in consideration of consulting services rendered to the Company. The 2,500,000 shares were valued at an aggregate of $915,000, or approximately $0.366 per share, based on the closing price of the Common Stock on the respective dates of issuance, of which $250 was recorded as common stock at par value and $914,750 as additional paid-in capital. The fair value of the shares was recognized as stock-based consulting expense within general and administrative expenses during the three months ended September 30, 2026, and is presented as a non-cash adjustment to reconcile net income to net cash used in operating activities in the consolidated statements of cash flows. The shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Stock Subscription Receivable

 

As of December 31, 2025, the Company carried a stock subscription receivable of $8,000,000 due from Mr. Gope S. Kundnani, a Director and majority shareholder of the Company, which was presented as a reduction of stockholders’ equity in accordance with ASC 505-10-45-2. In August 2026, the Company and Mr. Kundnani agreed that amounts paid by Mr. Kundnani and members of his family on the Company’s behalf, together with the release of certain related-party obligations of the Company, would be applied in payment of the subscription receivable, with any balance to be paid in cash. That agreement was documented in a Payment Direction and Subscription Settlement Agreement effective September 30, 2026, among the Company, Mr. Kundnani, Nicky G. Kundnani, Sync Capital Limited, Alchemy Prime Limited, and The Millionaires’ Club Ltd (the “Settlement Agreement”), which was approved by the disinterested members of the Board of Directors. During the nine months ended September 30, 2026, the gross subscription receivable of $8,000,000 was reduced to nil as follows: (i) $2,339,524 was collected in cash and is presented within financing activities in the consolidated statements of cash flows; (ii) $5,660,476 was settled on a non-cash basis through the application of payments made by related parties on the Company’s behalf, principally capital contributed to the Company’s subsidiaries, and the release of related-party obligations of the Company, including the $2,000,000 seller financing obligation owed to Sync Capital Limited in connection with the acquisition of AIL (see Note 7). Of that $5,660,476, the sum of $603,718 was reclassified to a receivable from Mr. Kundnani, which is included in related party receivables on the consolidated balance sheet (see Note 5) and is payable in cash on or before December 31, 2026. The non-cash components of the settlement are presented as supplemental non-cash financing activities in the consolidated statements of cash flows. No shares were issued under the Settlement Agreement, and the number of shares held by Mr. Kundnani and his affiliates was unchanged. As of September 30, 2026, no stock subscription receivable remained outstanding.

 

Series B Convertible Preferred Stock – Holdings Before and After Conversion

 

The following table sets forth the shares of Series B Convertible Preferred Stock held by each holder immediately prior to conversion, and the shares of Common Stock issued to each holder upon the conversion of those shares on July 13, 2026, at a conversion rate of fifty (50) shares of Common Stock for each share of Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock was not subject to adjustment for the 1-for-100 reverse stock split effective July 10, 2026, and the shares of Common Stock issued on conversion are stated on a post-reverse-stock-split basis. Following the conversion, no shares of Series B Convertible Preferred Stock remain issued or outstanding.

 SCHEDULE OF CONVERTIBLE PREFERRED STOCK

Holder   Series B
Preferred Shares
Held Immediately
Prior to Conversion
   

Common Shares

Issued on
Conversion,

July 13, 2026

 
APSI Holdings Limited (formerly Alchemy Prime Holdings Limited)     1,800,000       90,000,000  
Gope S. Kundnani     191,844       9,592,200  
Mitchell M. Eaglstein     150,000       7,500,000  
Imran Firoz     150,000       7,500,000  
FRH Group Corporation     50,000       2,500,000  
William B. Barnett     10,000       500,000  
Susan E. Eaglstein     10,000       500,000  
Nicky G. Kundnani     10,000       500,000  
Total     2,371,844       118,592,200  

 

Cross-Reference to Form 10-K/A

 

For a complete history of the Company’s authorized share capital, common stock issuances, and preferred stock issuances, refer to Note 9 (Stockholders’ Equity (Deficit)) in the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as most recently amended by Amendment No. 4 on Form 10-K/A filed with the SEC on July 1, 2026.

 

F-35
 

 

NOTE 10. WARRANTS

 

As of September 30, 2026, and December 31, 2025, the Company had no outstanding warrants. There were no warrant issuances, exercises, or expirations during the three and nine months ended September 30, 2026.

 

NOTE 11. COMPREHENSIVE INCOME

 

The Company’s other comprehensive income (“OCI”) comprises foreign currency translation adjustments from subsidiaries that do not use the U.S. dollar as their functional currency.

 

The following tables show the changes in accumulated other comprehensive income (loss) (“AOCI”) by component for the nine months ended September 30, 2025, and the nine months ended September 30, 2026, respectively:

 

Accumulated Comprehensive Income: 

Cumulative Foreign

Currency Translation

 
Balance as of December 31, 2024  $(72,781)
Other comprehensive income (loss), attributed to ADS   14,518 
Other comprehensive income (loss), attributed to AML   375,066 
Other comprehensive income (loss), attributed to APL   (14,507)
Other comprehensive income (loss), attributed to ATECH   (278,493)
Total other comprehensive income (loss)   96,584 
Balance as of September 30, 2025  $23,803 

 

Accumulated Comprehensive Income: 

Cumulative Foreign

Currency Translation

 
Balance as of December 31, 2025  $296,257 
Other comprehensive income (loss), attributed to ADS   (2,211)
Other comprehensive income (loss), attributed to AML   (242,611)
Other comprehensive income (loss), attributed to APL   48,042 
Other comprehensive income (loss), attributed to ATECH   (25,605)
Other comprehensive income (loss), attributed to AIL   - 
Total other comprehensive income (loss)   (222,385)
Balance as of September 30, 2026  $73,872 

 

During the three months ended September 30, 2026, and 2025, the Company recognized total other comprehensive income (loss) of $(4,449) and $(240,851), respectively, comprising translation adjustments attributable to ADS of $20,152 and $3,522, AML of $2,851 and $22,185, APL of $5,319 and $(1,536), and ATECH of $(32,771) and $(265,022), respectively, changing AOCI from $78,321 at June 30, 2026, to $73,872 at September 30, 2026, and from $264,654 at June 30, 2025, to $23,803 at September 30, 2025. Of the total other comprehensive income (loss), $(11,321) and $(35,476) was attributable to noncontrolling interests for the three months ended September 30, 2026, and 2025, respectively, and $(18,753) and $(44,465) for the nine months then ended. No amounts were reclassified out of accumulated other comprehensive income (loss) to net income during the three and nine months ended September 30, 2026, or September 30, 2025. Total AOCI rolled forward above was $73,872 at September 30, 2026, which is presented in its entirety as accumulated other comprehensive income (loss) attributable to FDCTech, Inc. on the consolidated balance sheet. The December 31, 2025, balance of $296,257 is presented as accumulated other comprehensive income (loss) on the consolidated balance sheet. Because the undistributed earnings of the Company’s foreign subsidiaries are considered indefinitely reinvested, no deferred tax effect has been recorded on the OCI components presented (ASC 740-30-25-17).

 

NOTE 12. NONCONTROLLING INTEREST

 

Basis of presentation. Noncontrolling interest (“NCI”) represents the equity in consolidated subsidiaries that is not attributable, directly or indirectly, to the Company. The Company consolidates entities in which it holds a controlling financial interest and reports the portion of net income (loss), other comprehensive income (loss), and net assets attributable to the minority owners as noncontrolling interest in accordance with ASC 810, Consolidation. NCI is presented within total stockholders’ equity (deficit) on the consolidated balance sheets, separately from the equity attributable to the stockholders of FDCTech, Inc., and net income (loss) and comprehensive income (loss) attributable to NCI are presented separately on the face of the consolidated statements of operations and of comprehensive income (loss). Transactions with noncontrolling interest holders that do not result in a loss of control are accounted for as equity transactions, with no gain or loss recognized in net income; any difference between consideration and the carrying amount of the NCI acquired or relinquished is recognized directly in additional paid-in capital.

 

Subsidiaries with noncontrolling interests. The Company’s noncontrolling interests consist of the 49% minority interest in AD Advisory Services Pty Ltd. (“ADS”), held since the Company obtained control of ADS, and a 0.1% interest in Alchemy International Ltd. (“AIL”) arising from the Company’s consolidation of AIL effective October 29, 2025. The Company holds a controlling financial interest in each of these subsidiaries and consolidates their results, attributing the proportionate share of their earnings, other comprehensive income (loss), and net assets to the noncontrolling interest holders. No noncontrolling interest is recognized for wholly owned subsidiaries.

 

F-36
 

 

NOTE 12. NONCONTROLLING INTEREST (continued)

 

Changes in noncontrolling interest. The carrying amount of noncontrolling interest was $(2,794) at June 30, 2026. During the three months ended September 30, 2026, the Company attributed net income of $21,620 and foreign currency translation attributable to NCI of $(11,321), resulting in a noncontrolling interest balance of $7,505 at September 30, 2026. The carrying amount of noncontrolling interest was $33,323 at December 31, 2025; during the nine months ended September 30, 2026, the Company attributed net income (loss) of $(7,065) and foreign currency translation attributable to NCI of $(18,753), resulting in the same $7,505 balance at September 30, 2026. For the comparative periods, noncontrolling interest was $41,608 at June 30, 2025, and $16,820 at December 31, 2024, and the Company attributed net income of $79,765 and foreign currency translation of $(35,476) for the three months ended September 30, 2025, and net income of $113,542 and foreign currency translation of $(44,465) for the nine months ended September 30, 2025, resulting in a balance of $85,897 at September 30, 2025. The noncontrolling interest balances rolled forward above tie to the noncontrolling interest reported within stockholders’ equity (deficit) on the consolidated balance sheets and to the consolidated statements of stockholders’ equity (deficit).

 

The following table presents the activity in the noncontrolling interest balance for the three and nine months ended September 30, 2026, and 2025:

 

SCHEDULE OF NONCONTROLLING INTEREST

  

Three Months Ended

September 30, 2026

  

Three Months Ended

September 30, 2025

 
Balance, beginning of period  $(2,794)  $41,608 
Net income (loss) attributable to NCI   21,620    79,765 
Foreign currency translation — NCI   (11,321)   (35,476)
Balance, end of period  $7,505   $85,897 

 

  

Nine Months Ended

September 30, 2026

  

Nine Months Ended

September 30, 2025

 
Balance, beginning of period  $33,323   $16,820 
Net income (loss) attributable to NCI   (7,065)   113,542 
Foreign currency translation — NCI   (18,753)   (44,465)
Balance, end of period  $7,505   $85,897 

 

NOTE 13. EARNINGS PER SHARE

 

Basic earnings per share is computed by dividing net income (loss) attributable to the Company’s common stockholders by the weighted average number of shares of Common Stock outstanding during the period. Diluted earnings per share is computed by dividing the same amount by the weighted average number of shares of Common Stock outstanding plus the dilutive effect of potentially dilutive securities. The weighted average number of shares of Common Stock outstanding, used to compute basic earnings per share, was 106,978,518 and 4,230,868 for the three months ended September 30, 2026, and 2025, respectively, and 38,856,450 and 4,230,868 for the nine months ended September 30, 2026, and 2025, respectively, in each case as retroactively adjusted for the reverse stock split described in Note 1, including fractional shares rounded up to the nearest whole share for each holder of record.

 

The Company had no options, warrants, or restricted stock units outstanding during the three and nine months ended September 30, 2026, or 2025. The Company had 2,371,844 shares of Series B Convertible Preferred Stock outstanding from the beginning of each period until July 13, 2026, on which date all such shares were converted into 118,592,200 shares of Common Stock at a conversion rate of fifty (50) shares of Common Stock for each share (see Note 9). For the nine months ended September 30, 2026, the Series B Convertible Preferred Stock was included in the computation of diluted earnings per share using the if-converted method for the portion of the period prior to conversion (January 1 through July 12, 2026), and the shares of Common Stock issued on conversion are included in the basic weighted average shares from July 13, 2026; the resulting incremental dilutive shares were 83,839,907, giving diluted weighted average shares outstanding of 122,696,357. For the three months ended September 30, 2026, the Company reported a net loss attributable to common stockholders, and accordingly the 118,592,200 common-share equivalents of the Series B Convertible Preferred Stock for the period from July 1 through July 12, 2026, were antidilutive and excluded from the computation; diluted loss per share equals basic loss per share for that period. The Vanquish Notes described in Note 7 are convertible only upon an event of default and, because no event of default had occurred as of September 30, 2026, no shares were included in respect of those notes. The Series B Convertible Preferred Stock carried no cumulative dividend entitlement, and accordingly no adjustment to the numerator was required. The Series B Convertible Preferred Stock was antidilutive for the three and nine months ended September 30, 2025, and was therefore excluded from the computation of diluted loss per share for those periods.

 

The following table reconciles the numerators and denominators used in the computation of basic and diluted earnings per share for the periods presented:

 

   September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025 
   Three Months Ended   Nine Months Ended 
   September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025 
   (Unaudited)   (Restated, Unaudited)   (Unaudited)   (Restated, Unaudited) 
Net income (loss) attributable to FDCTech, Inc. shareholders — numerator   (6,321,295)   655,487    8,256,902    510,376 
Weighted average shares outstanding — basic denominator   106,978,518    4,230,868    38,856,450    4,230,868 
Effect of dilutive Series B Convertible Preferred Stock   -    -    83,839,907    - 
Weighted average shares outstanding — diluted denominator   106,978,518    4,230,868    122,696,357    4,230,868 
Earnings (loss) per share — basic   (0.06)   0.15    0.21    0.12 
Earnings (loss) per share — diluted   (0.06)   0.15    0.07    0.12 

 

The weighted average shares outstanding for the three and nine months ended September 30, 2026, reflect the issuance of 118,592,200 shares of Common Stock upon the conversion of the Series B Convertible Preferred Stock on July 13, 2026, and 2,500,000 shares of Common Stock issued for consulting services on August 27 and 28, 2026, each weighted for the portion of the period during which the shares were outstanding. All share and per-share amounts have been retroactively adjusted for the 1-for-100 reverse stock split effective July 10, 2026.

 

F-37
 

 

NOTE 14. INCOME TAXES

 

FDCTech, Inc. (the “U.S. Parent”) is a standalone U.S. domestic C-corporation and files its U.S. federal and California state income tax returns separately. The Company’s operating subsidiaries — Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (Malta), Alchemy Prime Limited (United Kingdom), AD Advisory Services Pty Ltd. (Australia), Alchemy International Ltd. (Seychelles) and T.I.C.G. Integrated Solutions Ltd. (Cyprus) — are separate legal entities that file and pay income tax in their own jurisdictions. The U.S. Parent does not include foreign subsidiary earnings in its U.S. returns, and the undistributed earnings of the foreign subsidiaries continue to be regarded as indefinitely reinvested outside the United States; accordingly, no deferred U.S. federal income tax liability has been recognized in respect of those earnings. The Company accounts for income taxes under ASC 740, Income Taxes, using the asset and liability method, and for interim periods applies the estimated annual effective tax rate to ordinary income in accordance with ASC 740-270.

 

No provision for income taxes was recorded for the three or nine months ended September 30, 2026, or 2025. The U.S. Parent has a history of standalone pre-tax losses and, as disclosed in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2025, carries a full valuation allowance against its net deferred tax assets, together with an accumulated U.S. federal net operating loss carryforward of approximately $1,842,001 at December 31, 2025. Federal net operating losses arising after December 31, 2017, carry forward indefinitely but may offset no more than 80% of taxable income in any year. Management has reassessed the valuation allowance at September 30, 2026, and concluded that a full allowance remains appropriate.

 

The Company’s operating subsidiaries are separate taxpayers in Malta, the United Kingdom, Australia, Seychelles, Cyprus and the Cayman Islands. As of the date of this Report, the Company had not received complete current and deferred income tax information, computed under local law, from all of its foreign subsidiaries, nor confirmatory advice from local tax advisers regarding the treatment of intercompany balances settled during the quarter and the availability of local loss relief. Based on information presently available, management estimates that the consolidated provision for income taxes for the nine months ended September 30, 2026, once determined, will be in the range of approximately $83,000 to $177,000, reflecting current income tax arising principally at the Company’s Maltese subsidiary and an estimated charge at its Cypriot subsidiary, partially offset by the reversal of deferred tax liabilities at the foreign subsidiaries. Management does not presently expect the amount to be material to the Company’s consolidated financial position. In addition, the Company is assessing, with the assistance of its U.S. tax advisers, whether the earnings of its non-U.S. subsidiaries give rise to a current inclusion in the taxable income of FDCTech, Inc. under the U.S. controlled foreign corporation rules. That assessment is not complete, and the Company is unable at this time to estimate the amount of any such inclusion or the related tax, if any. Any amount ultimately determined in respect of the matters described above could differ materially from the estimate above and will be recorded in the period in which it is determined.

 

The consolidated balance sheet includes tax and other receivables of $492,087 at September 30, 2026 (December 31, 2025: $190,346), which include amounts recoverable by Crestmark Trading Ltd. from the Maltese tax authorities and deposits of $408,586 paid in connection with the proposed acquisitions of Larstal Limited and The Millionaire’s Club Ltd described in Note 1. Malta levies corporate income tax at a standard rate of 35%, subject to a shareholder refund mechanism that generally reduces the effective rate on distributed trading income to approximately 5%; the receivable represents amounts recoverable under that mechanism. The Company also recognized current income tax payable of $128,031 at September 30, 2026 (December 31, 2025: $nil), arising at Crestmark Trading Ltd., and deferred tax liabilities of $156,525 (December 31, 2025: $377,975), which relate to temporary differences arising at the foreign subsidiaries, principally Crestmark Trading Ltd., and are measured using the enacted tax rates of the relevant jurisdictions.

 

The Company is subject to examination by the U.S. Internal Revenue Service, the California Franchise Tax Board, and the tax authorities of Malta, the United Kingdom, Australia, Seychelles and Cyprus. No income tax examinations were in progress at September 30, 2026, and no change in the Company’s assessment of uncertain tax positions arose during the nine months ended September 30, 2026.

 

NOTE 15. OFF-BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements affecting our liquidity, capital resources, market risk support, credit risk support, or other benefits.

 

NOTE 16. SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the date these consolidated financial statements were issued and, other than as described below, has identified no events requiring recognition or disclosure.

 

Effectiveness of Registration Statement on Form S-1

 

On October 1, 2026, the Securities and Exchange Commission declared effective the Company’s Registration Statement on Form S-1 (File No. 333-298944), as amended. The registration statement does not relate to any underwritten offering by the Company, and no proceeds were received by the Company upon effectiveness.

 

Definitive Agreements for the Acquisition of Larstal Limited and Larstal Denmark ApS

 

On October 6, 2026, the Company entered into two related share purchase agreements to acquire all of the issued share capital of Larstal Limited, a United Kingdom company authorized by the Financial Conduct Authority (“FCA”) as an electronic money institution, and Larstal Denmark ApS, a Danish company authorized by the Danish Financial Supervisory Authority (“DFSA”) as an electronic money institution (together, the “Larstal Companies”), from their respective sellers, with AstroPay Global Holdings as guarantor. The base purchase price under each agreement is $1,175,000, for an aggregate base price of $2,350,000, payable as follows under each agreement: (i) a deposit of $117,500 paid under the August 3, 2026, term sheet and released to the seller upon execution; (ii) $117,500 upon submission of the change-in-control application to the FCA or the DFSA, as applicable; (iii) interim payments of $60,000 on the 15th day of each month from execution until completion; and (iv) the balance at completion. At completion, the Company will also pay an amount equal to each target company’s regulatory own-funds requirement, and the purchase price is subject to a customary completion-accounts adjustment. Deposits, execution payments and interim payments are non-refundable once paid, including if the regulators refuse to approve the change in control, except in the case of fraud by the seller. Completion of each agreement is conditioned on, among other things, approval of the change in control by the FCA or the DFSA, as applicable, which the Company was required to apply for within 14 days after execution, and either party may terminate if completion has not occurred within 12 months after October 6, 2026, subject to automatic extension while the regulatory applications remain under consideration. The Company has not completed either acquisition and, upon completion, expects to account for the transactions in accordance with ASC 805.

 

In connection with the FCA’s assessment of the change-in-control application, the Company has disclosed that its subsidiary Alchemy Prime Limited (“APL”) has, at the FCA’s invitation, accepted a voluntary requirement on its Part 4A permission under the U.K. Financial Services and Markets Act 2000, and that a skilled person review of APL under section 166 of that Act, which began on October 24, 2025, remains ongoing. The Company cannot predict the outcome of the skilled person review or its effect, if any, on the outcome or timing of the FCA’s assessment.

 

Directors’ and Officers’ Liability Insurance

 

Under the side letters described in Note 1, the Company was required to bind conforming directors’ and officers’ liability insurance by October 18, 2026. The Company has engaged an insurance broker to procure the required coverage, which had not been bound as of October 18, 2026, or as of the date of this Report. Neither director designee has exercised his or her right to terminate his or her Board of Directors Agreement as a result, and both conditional appointments remain in effect. There can be no assurance that the Company will obtain the required coverage on acceptable terms, or that a director designee will not subsequently elect to terminate his or her agreement.

 

Issuance of Common Stock for Services

 

On November 3, 2026, the Board of Directors approved, and the Company subsequently issued, 25,000 restricted shares of Common Stock to a director of the Company’s subsidiary Alchemy International Ltd. (“AIL”) as compensation for services rendered to AIL in connection with the oversight of its dealing desk and brokerage operations. The shares were fully vested upon issuance and were not issued under any equity incentive plan of the Company. The Company valued the shares at $103,750, or $4.15 per share, based on the closing price of the Common Stock on the grant date, and will recognize the related stock-based compensation expense in full during the three months ending December 31, 2026. The shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and are restricted securities. Following the issuance, the Company had 125,348,068 shares of Common Stock issued and outstanding.

 

F-38
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This Quarterly Report Form 10-Q contains forward-looking statements. Our actual results could differ materially from those set forth as a result of general economic conditions and changes in the assumptions used in making such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “predict,” “potential,” “continue,” “expect,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” “forecast” and similar expressions (or the negative of such expressions). Forward-looking statements include, but are not limited to, financial and operational information, the volatility of our stock price, current competitive conditions, and the impact of U.S. tariffs, trade barriers, and restrictions. The following discussion and analysis of our financial condition and results of operations should be read together with the unaudited condensed financial statements and accompanying notes and the other financial information appearing elsewhere in this report. The analysis set forth below is provided pursuant to applicable Securities and Exchange Commission regulations and is not intended to serve as a basis for projections of future events.

 

FDCTech, Inc. (“FDCTech,” “Company,” “we,” “us,” or “our”) is a financial technology company specializing in developing and delivering innovative software solutions and business services to the over-the-counter (OTC) brokerage and financial services industries. The Company provides a range of proprietary and third-party technology solutions, including its flagship Condor Trading Technology, which supports multi-asset trading, risk management, and pricing for forex, equities, commodities, and digital assets. FDCTech is a U.S.-based, fully reporting public company and currently trades under the symbol OTC: FDCT.

 

FDCTech follows a strategic growth model centered on acquiring, integrating, and scaling legacy financial services firms. Through its acquisitions, the Company has expanded its global footprint in wealth management, brokerage, and financial advisory services.

 

Founded in January 2016 as a back-office technology solution provider, FDCTech has transformed into a comprehensive, end-to-end trading platform offering foreign exchange (FX), contracts for difference (CFDs), equities, bonds, and wealth management services. Our growth trajectory includes the acquisitions of AD Advisory Services Pty Ltd. (2021), Alchemy Markets Ltd. (2022–2023), Alchemy Prime Limited (2023), Alchemy International Ltd. (2025), and Alchemy Markets (Cayman) Ltd. (2026), together with the establishment of Alchemytech Ltd., now T.I.C.G. Integrated Solutions Ltd. (2024), and Xoala Asia (2025), expanding our global footprint across Australia, Malta, the United Kingdom, Cyprus, Seychelles, Mauritius, and the Cayman Islands.

 

 

FDCTech, Inc. is the parent holding company with the following wholly-owned and majority-owned subsidiaries:

 

Subsidiary  Ownership  Jurisdiction  Primary Business  Markets  Technology
AD Advisory Services Ltd. (ADS)  51.00%  Australia  Wealth Management  Australia  Third-party software
Alchemy Markets Ltd. (AML)  100.00%  Malta  FX, CFDs, Stocks, Bonds  Europe (excl the United Kingdom)  Condor Trading & Third-party
Alchemy Prime Ltd. (APL)  100.00%  United Kingdom  FX, CFDs  United Kingdom  Condor Trading & Third-party
T.I.C.G. Integrated Solutions Ltd. (ATECH)  100.00%  Cyprus  Technology Services  Europe  Condor Trading
Alchemy International Ltd. (AIL)  99.90%  Seychelles  FX, CFDs  Asia  Condor Trading & Third-party
Xoala Asia (XOA)  100.00%  Mauritius  Payment Intermediary Services  Asia  Third-party
Prime Intermarket Group Eurasia (PIG)  100.00%  Mauritius  FX, CFDs  Asia  Condor Trading & Third-party
Alchemy Markets (Cayman) Ltd. (AML Cayman)  100.00%  Cayman Islands  Securities Investment Business (Broker/Dealer)  International  Condor Trading & Third-party
Xoala AP Cyprus Ltd. (XOA, Cyprus)  100.00%  Cyprus  Intra-group Treasury and Payment Processing  Europe  Third-party

 

4
 

 

In June 2026, Alchemytech Ltd. changed its name to T.I.C.G. Integrated Solutions Ltd. (“ATECH”). Xoala Asia holds 100% of Xoala AP Cyprus Ltd. (“XOA, Cyprus”), a Cyprus-based subsidiary providing intra-group treasury and payment-processing services. In June 2026, the Company acquired 100% of Alchemy Markets (Cayman) Ltd. (“AML Cayman”), a Cayman Islands company licensed and regulated by the Cayman Islands Monetary Authority as a securities investment business licensee holding a Broker/Dealer license, which authorizes it to buy, sell, subscribe for, or underwrite securities. AML Cayman has been consolidated since June 19, 2026. Under the intra-group exemption in Section 3(3)(n) of the Cyprus Payment Services Law, no Central Bank of Cyprus payment institution or electronic money institution license is required for XOA, Cyprus.

 

The Company’s operating subsidiaries are described below:

 

AD Advisory Services Pty Ltd. (ADS) – An Australian-regulated wealth management firm regulated by the Australian Securities and Investments Commission (ASIC), managing and advising on approximately $770 million in client funds under advice with a network of 26 financial advisors.

 

Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (AML) – A Malta-based investment firm regulated by the Malta Financial Services Authority (MFSA), offering trading services across multiple asset classes in various European markets.

 

Alchemy Prime Limited (APL) – A UK-based investment firm regulated by the Financial Conduct Authority (FCA), providing investment advisory and brokerage services.

 

T.I.C.G. Integrated Solutions Ltd. (ATECH) – A Cyprus-based technology, sales, and marketing service provider supporting the Company’s subsidiaries and affiliated companies.

 

Alchemy International Ltd. (AIL) – A Seychelles-licensed securities dealer regulated under license number SD136 by the Financial Services Authority (FSA).

 

XOALA (formerly Xoala Asia) (XOA) – A Mauritian-based payment provider regulated by the Financial Services Commission of Mauritius (the “FSC”) to operate as a payment intermediary in Mauritius.

 

Prime Intermarket Group Eurasia (PIG) – A Mauritian-based company structured as a private company limited by shares and regulated by the Financial Services Commission.

 

Alchemy Markets (Cayman) Ltd. (AML Cayman) – A Cayman Islands company licensed and regulated by the Cayman Islands Monetary Authority (CIMA) as a securities investment business licensee. AML Cayman holds a Broker/Dealer license, which authorizes it to buy, sell, subscribe for, or underwrite securities.

 

Xoala AP Cyprus Ltd. (XOA, Cyprus) – A Cyprus-based subsidiary of Xoala Asia providing intra-group treasury and payment-processing services.

 

Corporate History and Transformation

 

In 2021, the Company’s revenues came solely from technology licensing. By fiscal year 2024 and during fiscal year 2025, the Company had transformed into a diversified global fintech with revenues from technology, financial planning, and brokerage trading operations. The Company has undergone a significant transformation since its inception to the present:

 

In December 2021, the Company acquired 51% of AD Advisory Services Pty Ltd. (ADS), an Australian wealth management firm. For fiscal year 2021, the Company reported revenue of $0.46 million and net assets of $1.41 million.

 

In June 2023, the Company acquired 51% of Alchemy Markets Ltd. (AML), a Malta-based financial services firm regulated by the Malta Financial Services Authority. For fiscal year 2022, the Company reported revenue of $6.4 million and net assets of $1.60 million.

 

In November 2023, the Company acquired 100% of AML and Alchemy Prime Ltd. (APL), a UK-based prime-of-prime brokerage regulated by the Financial Conduct Authority. For fiscal year 2023, the Company reported revenue of $12.8 million and net assets of $13.05 million.

 

In March 2024, the Company established Alchemytech Ltd. (ATECH) in Cyprus as a technology, sales, and marketing service provider supporting the Company’s subsidiaries and affiliated companies.

 

Fiscal year 2024 represented the first full year of integration of ADS, AML, and APL. For fiscal year 2024, the Company reported revenue of $26.9 million and net assets of $14.45 million.

 

In October 2025, the Company acquired AIL, a key operational subsidiary within the Company’s expanding global architecture, enabling the Company to serve a broader base of offshore brokerages, high-frequency traders, and institutional clients seeking regulated access to foreign exchange and multi-asset markets.

 

In November 2025, the Company established Xoala Asia, which was granted a Payment Intermediary Services (“PIS”) license by the Financial Services Commission of Mauritius (the “FSC”) to operate as a payment intermediary in Mauritius. Xoala Asia holds 100% of Xoala AP Cyprus Ltd., a Cyprus company providing intra-group treasury and payment-processing services.

 

In June 2026, Alchemytech Ltd. changed its name to T.I.C.G. Integrated Solutions Ltd., and the Company acquired 100% of Alchemy Markets (Cayman) Ltd. (AML Cayman), a Cayman Islands company licensed by the Cayman Islands Monetary Authority to conduct securities investment business under a Broker/Dealer license. The acquisition extends the Company’s regulated brokerage footprint to the Cayman Islands.

 

5
 

 

Our Business Segments

 

We operate through four complementary business segments:

 

Margin Brokerage: Through Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (Malta, MFSA-regulated), Alchemy Prime Limited (UK, FCA-regulated), and Alchemy International Ltd. (Seychelles, FSA-regulated), we provide multi-asset trading services in forex, CFDs, equities, commodities, and digital assets to retail and institutional clients globally.

 

Wealth Management: Through AD Advisory Services Pty Ltd. (Australia, ASIC-regulated), we operate a wealth management business with 26 financial advisors managing and advising over $770 million in funds under advice under the aegis of our license, where we provide licensing solutions and financial planning services to these financial advisors.

 

Technology and Software Development: Through FDCTech and T.I.C.G. Integrated Solutions Ltd. (formerly Alchemytech Ltd.) (Cyprus), we develop and license our proprietary Condor Trading Technology suite, including the Condor Pro Multi-Asset Trading Platform and Condor Risk Management back-office system.

 

Payment Intermediary Services: Through XOALA (formerly Xoala Asia) (Mauritius, FSC-licensed), we are developing a payment gateway, merchant acquiring, and cross-border payment capabilities to complement our brokerage and wealth management operations. This segment is in the early stages of development.

 

During the three months ended September 30, 2026, the Company generated total revenue of $3,671,775, a decrease of $2,200,597 (37.5%) from total revenue of $5,872,372 for the three months ended September 30, 2025. During the nine months ended September 30, 2026, the Company generated total revenue of $35,924,742, an increase of $18,655,631 (108.0%) over total revenue of $17,269,111 for the nine months ended September 30, 2025.

 

The substantial growth in nine-month revenue was driven primarily by the contribution of Alchemy International Ltd. (“AIL”) following the change of control approved by the Seychelles Financial Services Authority on October 29, 2025, and the closing of the acquisition on November 11, 2025, which generated significant brokerage revenue during the first half of 2026. Brokerage revenue declined sharply during the three months ended September 30, 2026, reflecting lower client trading volumes and market-making results at AIL and the Company’s other brokerage subsidiaries, and the Company recorded a gross loss for the quarter as brokerage cost of sales, including liquidity-provider, rebate, and trading-related costs, exceeded brokerage revenue.

 

AIL, a Seychelles-licensed securities dealer (license SD136) regulated by the Financial Services Authority, broadened the Company’s regulated multi-asset brokerage footprint to include Seychelles in addition to Malta (AML, MFSA-regulated) and the United Kingdom (APL, FCA-regulated), and added a base of offshore brokerages, high-frequency traders, and institutional clients seeking regulated access to foreign exchange and multi-asset markets.

 

The contribution from AIL during the nine months ended September 30, 2026 (compared with no contribution during the nine months ended September 30, 2025) accounted for the substantial majority of the year-over-year increase in the Margin Brokerage segment. The Technology and Software Development segment also contributed to the nine-month increase, while the Wealth Management segment was substantially flat compared with the prior-year periods. For the three months ended September 30, 2026, the Company reported a net loss, reflecting the decline in brokerage revenue, higher brokerage cost of sales, and an increase in general and administrative expenses, which included $915,000 of stock-based consulting expense and a $186,975 provision for doubtful accounts.

 

The Company is also pursuing a potential listing of its common stock on a national securities exchange (the New York Stock Exchange or the Nasdaq Stock Market) in connection with a proposed public offering of equity securities. In connection with these initiatives, the Company has engaged Lucosky Brookman LLP as legal counsel and is in discussions with E.F. Hutton and ThinkEquity LLC as financial advisors. The completion of any such offering or listing is subject to market conditions and customary regulatory and exchange approvals, and no assurance can be given that any such transaction will be completed.

 

6
 

 

Financial Condition as of September 30, 2026

 

As of September 30, 2026, the Company had total assets of $53,220,167, compared to $64,051,886 as of December 31, 2025, representing a decrease of $10,831,719, or approximately 16.9%. Total assets at September 30, 2026, were comprised primarily of cash and cash equivalents of $21,415,387 and restricted cash (client funds, segregated) of $11,729,042, related party receivables of $6,492,563, accrued income of $5,010,848, acquired intangible assets (net) of $4,457,595, capitalized software (net) of $1,760,022, right-of-use lease assets of $673,254, prepaid expenses (current and non-current) of $535,203, tax and other receivables of $581,073, accounts receivable (net of allowance for doubtful accounts) of $264,372, property and equipment (net) of $175,755, and other assets aggregating $125,053.

 

The $10,831,719 decrease in total assets during the nine months ended September 30, 2026, was primarily attributable to: (i) a decrease in related party receivables of $33,597,488, as further described in Note 5, principally reflecting the June 30, 2026, set-off and assignment arrangements with Alchemy DMCC and Alchemy Capital Markets and collections during the third quarter; and (ii) a decrease in the fair value of trading positions for the firm of $1,094,705, reflecting the closing-out and transfer of certain trading positions in the ordinary course; partially offset by (iii) an increase in cash, cash equivalents, and restricted cash of $15,474,680, including an increase in segregated client funds held by the Company’s regulated brokerage subsidiaries of $5,915,154; (iv) an increase in accrued income of $4,730,959, principally rebates receivable at AIL and Crestmark; (v) an increase in acquired intangible assets of $3,131,533, principally reflecting the reclassification of a $3,165,290 receivable from Iconic Advisors and Consulting Limited to acquired intangible assets under the IP Purchase Agreement described in Note 5; (vi) an increase in capitalized software (net) of $279,776; and (vii) an increase in tax and other receivables of $390,727, including deposits of $408,586 paid in connection with the proposed acquisitions of Larstal Limited and The Millionaire’s Club Ltd.

 

Total Liabilities

 

As of September 30, 2026, the Company had total liabilities of $18,935,187, compared to $41,360,598 as of December 31, 2025, representing a decrease of $22,425,411, or approximately 54.2%. Total liabilities at September 30, 2026, were comprised primarily of client funds payable of $11,729,042, related party advances payable of $1,939,946, other current liabilities of $1,697,778, accrued expenses to related parties of $1,040,112, accounts payable of $537,528, operating lease liabilities (current and non-current) of $390,406, promissory notes (net of unamortized discount) of $425,545, business acquisition loan of $350,000, line of credit of $245,617, deferred tax liabilities of $156,525, income tax payable of $128,031, financial liabilities at fair value through profit and loss of $85,856, and the SBA loan and accrued non-current interest aggregating $208,801.

 

The $22,425,411 net decrease in total liabilities during the nine months ended September 30, 2026, was primarily attributable to: (i) a decrease in related party advances payable of $27,257,524, principally reflecting the settlement of AIL’s net advances payable to Alchemy DMCC through non-cash set-off and assignment arrangements on June 30, 2026, as further described in Note 5; (ii) a decrease in the business acquisition loan of $2,000,000, reflecting the settlement of the seller financing obligation to Sync Capital Limited by set-off against the stock subscription receivable; (iii) a decrease in other current liabilities of $435,215; (iv) a decrease in deferred tax liabilities of $221,450; and (v) a decrease in operating lease liabilities (current and non-current) of $139,941; partially offset by (vi) an increase in client funds payable of $5,915,154, reflecting growth in customer deposits held by the Company’s regulated brokerage subsidiaries; (vii) an increase in accrued expenses to related parties of $507,825, primarily representing accrued executive compensation; (viii) the issuance of the Vanquish promissory notes with a net carrying amount of $425,545; (ix) an increase in accounts payable and line of credit of $505,581 in the aggregate; and (x) the recognition of income tax payable of $128,031, financial liabilities at fair value through profit and loss of $85,856, and additional accrued interest of $67,106.

 

Stockholders’ Equity and Working Capital

 

As of September 30, 2026, total stockholders’ equity attributable to FDCTech, Inc. stockholders was $34,277,475, compared to $22,657,965 as of December 31, 2025, representing an increase of $11,619,510, or approximately 51.3%. Total stockholders’ equity, including noncontrolling interests, was $34,284,980 as of September 30, 2026, compared to $22,691,288 as of December 31, 2025. The components of stockholders’ equity as of September 30, 2026, consisted of Series A preferred stock and common stock at par value of $450 and $12,532, respectively, additional paid-in capital of $22,532,234, accumulated other comprehensive income of $73,872, accumulated surplus of $11,658,387, and noncontrolling interest of $7,505. The subscription receivable of $(8,000,000) and the Series B preferred stock and related additional paid-in capital of $3,344,300 outstanding at December 31, 2025, were eliminated during the third quarter upon the settlement of the subscription receivable and the conversion of the Series B Convertible Preferred Stock, respectively.

 

7
 

 

The $11,619,510 increase in stockholders’ equity attributable to FDCTech, Inc. stockholders during the nine months ended September 30, 2026, was primarily attributable to: (i) net income attributable to FDCTech, Inc. shareholders of $8,256,902 for the period; (ii) the settlement of the $8,000,000 stock subscription receivable due from Mr. Gope S. Kundnani, as described in Note 9; and (iii) the issuance of 2,500,000 shares of common stock for consulting services valued at $915,000; partially offset by (iv) a net decrease in additional paid-in capital of $5,330,005 arising from transactions between entities under common control accounted for in accordance with ASC 805-50, Transactions Between Entities Under Common Control; and (v) a decrease in accumulated other comprehensive income of $222,385. The conversion of all 2,371,844 shares of Series B Convertible Preferred Stock into 118,592,200 shares of common stock on July 13, 2026, was a reclassification within stockholders’ equity and had no effect on total stockholders’ equity.

 

Working capital, defined as total current assets less total current liabilities, was $21,949,185 as of September 30, 2026, compared to $17,831,410 as of December 31, 2025, representing an increase of $4,117,775, or approximately 23.1%. The increase in working capital reflects the combined effect of the increase in cash and cash equivalents and the settlement of the December 31, 2025, related party advances payable and seller financing balances described above, partially offset by the decrease in related party receivables, the increase in client funds payable (which is matched by segregated client funds presented as restricted cash), and the issuance of the Vanquish promissory notes during the period. The Company’s working capital position, together with cash generated from operations, is expected to support the Company’s ongoing operations and growth initiatives for at least the next twelve months.

 

Note on Common Control Transactions Affecting Additional Paid-in Capital

 

The Company’s acquisitions of Alchemy Markets Ltd. (“AML”), Alchemy Prime Ltd. (“APL”), and Alchemy International Ltd. (“AIL”) were transactions between entities under common control, as each of AML, APL, and AIL was, at the date of the respective acquisition, controlled by Mr. Gope S. Kundnani, who is also a Director and the principal beneficial owner of the voting securities of the Company. Accordingly, the Company has accounted for these acquisitions in accordance with ASC 805-50, Transactions Between Entities Under Common Control. Under this guidance, the assets and liabilities of AML, APL, and AIL were recognized in the Company’s consolidated financial statements at the historical carrying values of the transferor on the respective dates of transfer, and no goodwill or intangible assets were recognized in connection with these common-control combinations. The difference between the consideration transferred by the Company and the historical carrying value of the net assets received was recorded as an adjustment to additional paid-in capital.

 

During the nine months ended September 30, 2026, the Company recorded a net decrease to additional paid-in capital of $5,330,005 in connection with transactions between entities under common control, comprising a net increase of $2,295,047 during the six months ended June 30, 2026 (principally relating to the finalization of the consolidation entries for the acquisition of AIL, completed on November 11, 2025, and the acquisition of AML Cayman) and a net decrease of $7,625,052 during the three months ended September 30, 2026. The third-quarter decrease principally reflects the attribution of capital contributed by the Company’s principal shareholder directly to the Company’s subsidiaries in settlement of the stock subscription receivable, the deemed distribution to the principal shareholder arising from the AML Cayman common-control combination, and the allocation of excess consideration on the consolidation of ADS to acquired intangible assets. These adjustments reflect differences between the consideration transferred and the historical carrying values of the net assets of the entities under common control. No new shares of the Company’s common stock or preferred stock were issued in connection with these adjustments, and the adjustments had no effect on the Company’s results of operations or cash flows.

 

The Company’s acquisition of AD Advisory Services Pty Ltd. (“ADS”), an Australia-incorporated subsidiary, in which the Company acquired a 51% controlling interest, was not a transaction between entities under common control. The ADS acquisition was effected at arm’s length with an unrelated counterparty and was accounted for as a business combination under ASC 805-10, Business Combinations, using the acquisition method. Accordingly, the assets and liabilities of ADS were recognized at their estimated fair values as of the acquisition date, and acquired intangible assets, including goodwill (carrying value of $1,280,522 at September 30, 2026), were recognized in connection with the ADS acquisition, representing the excess of the consideration transferred over the fair value of the identifiable net assets acquired. The noncontrolling interest in ADS was measured at the proportionate share of the fair value of the identifiable net assets at the acquisition date. No adjustment to additional paid-in capital was recognized in connection with the ADS acquisition.

 

Financial Condition at December 31, 2025

 

As of December 31, 2025, the Company had total assets of $64,051,886, comprised primarily of cash, cash equivalents, and restricted cash of $17,669,749, related party receivables of $40,090,051, accounts receivable, net of $188,415, capitalized software (net) of $1,480,246, and other balance-sheet items as further described in the Company’s Annual.

 

Report on Form 10-K/A for the fiscal year ended December 31, 2025.

 

Total liabilities at December 31, 2025, were $41,360,598, comprised primarily of related party advances payable of $29,197,470 (of which $27,257,524 was settled during the three and nine months ended September 30, 2026 — see Note 5 to the unaudited condensed consolidated financial statements); accounts payable, accrued expenses, and other current liabilities; the SBA loan; the business acquisition loan; and lease and other obligations.

 

Total stockholders’ equity at December 31, 2025, was $22,691,288, including an accumulated surplus of $3,401,487. Working capital at December 31, 2025, was $17,831,410.

 

8
 

 

RESULTS OF OPERATIONS

 

three and nine months ended September 30, 2026, compared with three and nine months ended September 30, 2025

 

The following table sets forth, for the periods indicated, the principal components of the Company’s consolidated results of operations and the change between the comparative periods (dollar amounts in U.S. dollars):

 

    Three Months Ended September 30,     Change  
    2026     2025     $     %  
Revenues:                                
Technology & software   $ 925,656       1,361,636       (435,980 )     (32.0 )%
Wealth management     1,759,384       1,788,079       (28,695 )     (1.6 )%
Brokerage     986,735       2,722,657       (1,735,922 )     (63.8 )%
Total revenue   $ 3,671,775       5,872,372       (2,200,597 )     (37.5 )%
Cost of sales:                                
Technology & software     -       -       -       -  
Wealth management     1,582,285       1,576,991       5,294       0.3 %
Brokerage     4,474,097       60,237       4,413,860       7327.5 %
Total cost of sales   $ 6,056,382       1,637,228       4,419,154       269.9 %
Gross profit   $ (2,384,607 )     4,235,144       (6,619,751 )     (156.3 )%
Operating expenses:                                
General and administrative     3,955,799       3,234,153       721,646       22.3 %
Sales and marketing     102,376       317,379       (215,003 )     (67.7 )%
Depreciation     19,920       44,992       (25,072 )     (55.7 )%
Total operating expenses   $ 4,078,095       3,596,524       481,571       13.4 %
Operating income   $ (6,462,702 )     638,620       (7,101,322 )     (1112.0 )%
Total other income (expense), net     163,027       96,632       66,395       68.7 %
Income before provision for income taxes     (6,299,675 )     735,252       (7,034,927 )     (956.8 )%
Provision for income taxes     -       -       -       -  
Net income   $ (6,299,675 )     735,252       (7,034,927 )     (956.8 )%
Less: Net income attributable to noncontrolling interest     21,620       79,765       (58,145 )     (72.9 )%
Net income attributable to FDCTech, Inc.   $ (6,321,295 )     655,487       (6,976,782 )     (1064.3 )%
Nine Months Ended September 30,                                
      2026       2025       $       %  
Revenues:                                
Technology & software     3,524,259       3,353,598       170,661       5.1 %
Wealth management     5,139,340       4,976,601       162,739       3.3 %
Brokerage     27,261,143       8,938,912       18,322,231       205.0 %
Total revenue     35,924,742       17,269,111       18,655,631       108.0 %
Cost of sales:                                
Technology & software     115,610       -       115,610       n/a  
Wealth management     4,672,338       4,410,589       261,749       5.9 %
Brokerage     10,016,018       3,458,121       6,557,897       189.6 %
Total cost of sales     14,803,966       7,868,710       6,935,256       88.1 %
Gross profit     21,120,776       9,400,401       11,720,375       124.7 %
Operating expenses:                                
General and administrative     12,507,681       7,505,861       5,001,820       66.6 %
Sales and marketing     720,763       887,520       (166,757 )     (18.8 )%
Depreciation     112,258       127,100       (14,842 )     (11.7 )%
Total operating expenses     13,340,702       8,520,481       4,820,221       56.6 %
Operating income     7,780,074       879,920       6,900,154       784.2 %
Total other income (expense), net     469,763       (256,002 )     725,765       283.5 %
Income before provision for income taxes     8,249,837       623,918       7,625,919       1222.3 %
Provision for income taxes     -       -       -       -  
Net income     8,249,837       623,918       7,625,919       1222.3 %
Less: Net income attributable to noncontrolling interest     (7,065 )     113,542       (120,607 )     (106.2 )%
Net income attributable to FDCTech, Inc.     8,256,902       510,376       7,746,526       1517.8 %

 

9
 

 

Revenue

 

Total revenue decreased to $3,671,775 for the three months ended September 30, 2026, compared to $5,872,372 for the three months ended September 30, 2025, a decrease of $2,200,597, or approximately 37.5%. For the nine months ended September 30, 2026, total revenue was $35,924,742, compared to $17,269,111 for the nine months ended September 30, 2025, an increase of $18,655,631, or approximately 108.0%. The nine-month growth was driven primarily by the Margin Brokerage segment, which contributed $27,261,143 of total revenue for the nine months ended September 30, 2026, compared to $8,938,912 for the comparable prior-year period, representing an increase of $18,322,231, or approximately 205.0%, reflecting the contribution of Alchemy International Ltd. (“AIL”) following the closing of the AIL acquisition on November 11, 2025 (with the change of control approved by the Seychelles Financial Services Authority on October 29, 2025), together with the continuing operations of the Company’s other regulated brokerage subsidiaries, Crestmark Trading Ltd. (formerly Alchemy Markets Ltd.) (“AML”) in Malta and Alchemy Prime Ltd. (“APL”) in the United Kingdom. For the three months ended September 30, 2026, however, Margin Brokerage revenue declined to $986,735, compared to $2,722,657 for the comparable prior-year period, a decrease of $1,735,922, or approximately 63.8%, reflecting substantially lower client trading volumes and adverse market-making results across the Company’s brokerage subsidiaries during the quarter.

 

Technology and software revenue was $925,656 for the three months ended September 30, 2026, compared to $1,361,636 for the comparable prior-year period, representing a decrease of $435,980, or approximately 32.0%, and $3,524,259 for the nine months ended September 30, 2026, compared to $3,353,598 for the comparable prior-year period, representing an increase of $170,661, or approximately 5.1%, with the nine-month increase reflecting the expansion of the Company’s technology and platform services to its expanded broker-dealer client base. Technology and software revenue excludes technology and service fees of $214,506 and $648,567 charged by the Company to its subsidiary Crestmark Trading Ltd. for the three and nine months ended September 30, 2026, respectively, which have been eliminated in consolidation against the corresponding brokerage cost of sales. Wealth Management revenue was $1,759,384 for the three months ended September 30, 2026, compared to $1,788,079 for the comparable prior-year period, representing a decrease of $28,695, or approximately 1.6%, and $5,139,340 for the nine months ended September 30, 2026, compared to $4,976,601 for the comparable prior-year period, representing an increase of $162,739, or approximately 3.3%.

 

Cost of Sales and Gross Profit

 

Cost of sales was $6,056,382 for the three months ended September 30, 2026, compared to $1,637,228 for the three months ended September 30, 2025, an increase of $4,419,154, or approximately 269.9%. For the nine months ended September 30, 2026, cost of sales was $14,803,966, compared to $7,868,710 for the nine months ended September 30, 2025, an increase of $6,935,256, or approximately 88.1%. The increase in cost of sales principally reflects higher brokerage cost of sales, including liquidity-provider, rebate, payment-processing, and clearing costs, which was $4,474,097 for the three months ended September 30, 2026 (compared to $60,237 for the comparable prior-year period) and $10,016,018 for the nine months ended September 30, 2026 (compared to $3,458,121). Brokerage cost of sales is presented net of intercompany technology and service fees charged by the Company to Crestmark Trading Ltd. of $214,506 and $648,567 for the three and nine months ended September 30, 2026, respectively, which have been eliminated in consolidation. Brokerage cost of sales for the three months ended September 30, 2026, exceeded brokerage revenue for the quarter, reflecting rebate and liquidity-provider costs incurred on client trading volumes that were not matched by corresponding trading revenue during the period. Wealth Management cost of sales was $1,582,285 and $4,672,338 for the three and nine months ended September 30, 2026, respectively, compared to $1,576,991 and $4,410,589 for the comparable prior-year periods, consistent with the segment’s revenue trend.

 

10
 

 

Gross profit (loss) was $(2,384,607) for the three months ended September 30, 2026, compared to gross profit of $4,235,144 for the three months ended September 30, 2025, a decrease of $6,619,751. For the nine months ended September 30, 2026, gross profit was $21,120,776, compared to $9,400,401 for the nine months ended September 30, 2025, an increase of $11,720,375, or approximately 124.7%. Consolidated gross margin was approximately (64.9)% and 72.1% for the three months ended September 30, 2026, and 2025, respectively, and approximately 58.8% and 54.4% for the nine months ended September 30, 2026, and 2025, respectively. The nine-month improvement principally reflects the change in revenue mix toward the Margin Brokerage segment during the first half of 2026, while the third-quarter gross loss reflects the decline in brokerage revenue relative to brokerage cost of sales described above.

 

Operating Expenses

 

Total operating expenses were $4,078,095 for the three months ended September 30, 2026, compared to $3,596,524 for the three months ended September 30, 2025, an increase of $481,571, or approximately 13.4%. For the nine months ended September 30, 2026, total operating expenses were $13,340,702, compared to $8,520,481 for the nine months ended September 30, 2025, an increase of $4,820,221, or approximately 56.6%. For the three months ended September 30, 2026, the increase reflects higher general and administrative expense of $3,955,799 (compared to $3,234,153, an increase of $721,646, or approximately 22.3%), partially offset by lower sales and marketing expense of $102,376 (compared to $317,379, a decrease of $215,003, or approximately 67.7%) and lower depreciation expense of $19,920 (compared to $44,992, a decrease of $25,072, or approximately 55.7%). For the nine months ended September 30, 2026, general and administrative expense was $12,507,681 (compared to $7,505,861, an increase of $5,001,820, or approximately 66.6%), sales and marketing expense was $720,763 (compared to $887,520, a decrease of $166,757, or approximately 18.8%), and depreciation expense was $112,258 (compared to $127,100, a decrease of $14,842, or approximately 11.7%).

 

The increase in general and administrative expense principally reflects additional compliance, audit, legal, and personnel-related expenses to support the Company’s expanded operating footprint following the AIL acquisition, professional fees and other costs incurred in connection with the Company’s contemplated listing of its common stock on a national securities exchange and the related proposed public offering, and, for the three months ended September 30, 2026, $915,000 of stock-based consulting expense relating to 2,500,000 shares of common stock issued to consultants in August 2026 and a $186,975 provision for doubtful accounts. The decrease in sales and marketing expense reflects a shift toward lower-cost digital channels and reduced tradeshow and travel activity, as further described in Note 2.

 

Operating Income

 

Operating loss was $(6,462,702) for the three months ended September 30, 2026, compared to operating income of $638,620 for the three months ended September 30, 2025, a decrease of $7,101,322. For the nine months ended September 30, 2026, operating income was $7,780,074, compared to operating income of $879,920 for the nine months ended September 30, 2025, representing an increase of $6,900,154. The nine-month increase in operating income reflects the increase in gross profit described above, partially offset by the increase in total operating expenses, while the third-quarter operating loss reflects the gross loss for the quarter together with higher general and administrative expenses.

 

Other Income (Expense), Net

 

Total other income (expense), net, was net other income of $163,027 for the three months ended September 30, 2026, compared to net other income of $96,632 for the three months ended September 30, 2025, an increase of $66,395. For the nine months ended September 30, 2026, total other income (expense), net, was net other income of $469,763, compared to net other expense of $(256,002) for the nine months ended September 30, 2025, an improvement of $725,765. For the three months ended September 30, 2026, total other income (expense), net, consisted of other interest income (expense) of $64,353 (compared to $(172,107) for the comparable prior-year period), which is net of $19,200 of debt discount amortization on the Vanquish promissory notes, and other income of $98,674 (compared to $268,739 for the comparable prior-year period). For the nine months ended September 30, 2026, it consisted of other interest income (expense) of $269,649 (compared to $(156,638)) and other income (expense) of $200,114 (compared to $(99,364)). The change principally reflects foreign exchange gains and losses on transactions denominated in currencies other than the functional currency of the applicable subsidiary, interest income on operating cash balances, and other miscellaneous items.

 

Net Income and Earnings per Share

 

Net loss was $(6,299,675) for the three months ended September 30, 2026, compared to net income of $735,252 for the three months ended September 30, 2025, a decrease of $7,034,927. For the nine months ended September 30, 2026, net income was $8,249,837, compared to net income of $623,918 for the nine months ended September 30, 2025, an increase of $7,625,919. No provision for income taxes was recorded for any period presented; as described in Note 14, the Company had not received complete income tax information from its foreign subsidiaries as of the date of this Report. Investors should not regard the absence of a recorded tax provision as an indication that the Company’s foreign operations bear no income tax. Net loss attributable to FDCTech, Inc. stockholders was $(6,321,295) for the three months ended September 30, 2026 ($(0.06) per share, basic and diluted), compared to net income attributable to FDCTech, Inc. stockholders of $655,487 for the three months ended September 30, 2025 ($0.15 per share, basic and diluted), and net income attributable to FDCTech, Inc. stockholders was $8,256,902 for the nine months ended September 30, 2026 ($0.21 per share basic and $0.07 per share diluted), compared to $510,376 for the nine months ended September 30, 2025 ($0.12 per share, basic and diluted).

 

Weighted average shares outstanding were 106,978,518 and 38,856,450 for the three and nine months ended September 30, 2026, respectively, compared to 4,230,868 for each of the comparable prior-year periods, reflecting the conversion of all 2,371,844 shares of Series B Convertible Preferred Stock into 118,592,200 shares of Common Stock on July 13, 2026, and the issuance of 2,500,000 shares for consulting services in August 2026. Diluted per-share amounts for the nine months ended September 30, 2026, reflect the assumed conversion of the Series B Convertible Preferred Stock for the portion of the period prior to its conversion; for the three months ended September 30, 2026, potentially dilutive shares were antidilutive because of the net loss. All share and per-share amounts give effect to the 1-for-100 reverse stock split effective July 10, 2026, as described in Note 1 and Note 13.

 

11
 

 

LIQUIDITY AND CAPITAL RESOURCES

 

Cash, Working Capital and Overview

 

As of September 30, 2026, the Company had cash, cash equivalents, and restricted cash of $33,144,429 (including segregated client funds of $11,729,042), compared to $17,669,749 as of December 31, 2025, representing an increase of $15,474,680, or approximately 87.6%. Working capital, defined as total current assets less total current liabilities, was $21,949,185 as of September 30, 2026, compared to $17,831,410 as of December 31, 2025, representing an increase of $4,117,775, or approximately 23.1%. The increase in working capital principally reflects the settlement of $27,257,524 of related party advances payable and the $2,000,000 seller financing obligation during the nine months ended September 30, 2026, together with the increase in cash and cash equivalents, partially offset by the decrease in related party receivables and the issuance of the Vanquish promissory notes.

 

Cash Flows from Operating Activities

 

Net cash used in operating activities was $(12,166,360) for the nine months ended September 30, 2026, compared to net cash used in operating activities of $(3,515,873) for the nine months ended September 30, 2025. Net cash used in operating activities for the nine months ended September 30, 2026, principally reflects (i) net income of $8,249,837 for the nine months ended September 30, 2026 (compared to $623,918 for the comparable prior-year period), adjusted for non-cash items including $915,000 of stock-based consulting expense, a $186,975 provision for doubtful accounts, depreciation of $112,258, and $19,200 of debt discount amortization; (ii) an increase in related party receivables of $(23,803,179), presented excluding the non-cash settlement arrangements described in Note 5; (iii) an increase in accrued income of $(4,730,959), principally rebates receivable at AIL and Crestmark; and (iv) a decrease in other current liabilities of $(435,215); partially offset by (v) an increase in client funds payable of $5,915,154, reflecting growth in customer deposits held by the Company’s regulated brokerage subsidiaries; (vi) a decrease in the fair value of trading positions for the firm, net of financial liabilities at fair value, of $1,180,561, reflecting the closing-out of certain trading positions in the ordinary course; (vii) an increase in accrued expenses to related parties of $507,825; and (viii) an increase in accounts payable of $371,316.

 

Cash Flows from Investing Activities

 

Net cash used in investing activities was $(368,554) for the nine months ended September 30, 2026, compared to net cash used in investing activities of $(359,968) for the nine months ended September 30, 2025. Net cash used in investing activities for the nine months ended September 30, 2026, principally consisted of (i) capitalized software development costs, net, of $367,154 and (ii) purchases of fixed assets of $1,577, partially offset by (iii) $177 of net investment activity in private entities. The non-cash reclassification of a $3,165,290 receivable from Iconic Advisors and Consulting Limited to acquired intangible assets under the IP Purchase Agreement described in Note 5, and the deposits paid in connection with the proposed acquisitions of Larstal Limited and The Millionaire’s Club Ltd did not involve investing cash flows in the period and are disclosed as non-cash activities or within changes in operating assets, as applicable. The comparable prior-year period reflects capitalized software development costs of $224,177 and purchases of fixed assets of $135,791.

 

Cash Flows from Financing Activities

 

Net cash provided by financing activities was $33,508,404 for the nine months ended September 30, 2026, compared to net cash used in financing activities of $(3,938,513) for the nine months ended September 30, 2025. Net cash provided by financing activities for the nine months ended September 30, 2026, principally consisted of (i) $32,839,241 of net related party advances received, presented excluding the non-cash settlement arrangements described in Note 5; (ii) $475,000 of net proceeds from the Vanquish promissory notes described in Note 7; (iii) $66,277 of stock subscription receivable collected in cash and capital contributions, net of common-control adjustments to additional paid-in capital, comprising $2,339,524 of cash collected in settlement of the stock subscription receivable less $2,273,247 of net common-control adjustments; and (iv) net draws of $134,265 on the Company’s lines of credit, partially offset by (v) net repayments of $6,379 on the Company’s SBA and PPP loans. The remaining $5,660,476 of the stock subscription receivable was settled by non-cash set-off, as described in Note 9.

 

Net Change in Cash

 

The Company’s cash, cash equivalents, and restricted cash increased by $15,474,680 during the nine months ended September 30, 2026, comprising net cash used in operating activities of $(12,166,360), net cash used in investing activities of $(368,554), net cash provided by financing activities of $33,508,404, the effect of exchange rate changes on cash of $(222,387), a $(18,753) change in the noncontrolling interest share of subsidiary net assets, and the $(5,257,670) non-cash assignment of the Company’s liquidity-provider balance previously included within cash and cash equivalents. Cash, cash equivalents, and restricted cash were $33,144,429 as of September 30, 2026, compared to $17,669,749 as of December 31, 2025.

 

Long-Term Obligations and Capital Adequacy

 

As of September 30, 2026, the Company’s principal long-term contractual obligations consisted of (i) the SBA loan in the non-current principal amount of $99,299, which bears interest at a rate of 3.75% per annum and is scheduled to mature thirty (30) years from the date of the underlying promissory note; (ii) the Business acquisition loan of $350,000, comprising the withheld portion of the purchase consideration owed to the former shareholders of Alchemy Markets Ltd. (which is currently the subject of litigation as further described in Note 7); (iii) the Vanquish promissory notes with an aggregate principal amount of $572,130 (carrying amount of $425,545, net of unamortized discount), which are payable in installments through June 30, 2027, as described in Note 7; (iv) operating lease liabilities (current and non-current) of $390,406 in the aggregate, principally relating to the Company’s office facilities, including the ATECH sublease renewed through October 31, 2028 (see Note 8); and (v) deferred tax liabilities of $156,525 and accrued non-current interest of $109,502. The $2,000,000 seller financing obligation to Sync Capital Limited outstanding at December 31, 2025, was settled during the three months ended September 30, 2026, by set-off against the stock subscription receivable, as described in Notes 7 and 9.

 

Management believes that the Company’s existing cash and cash equivalents, anticipated cash flows generated from operations, and available borrowings under its existing credit lines will be sufficient to fund the Company’s operations and meet its known contractual obligations and capital commitments for at least the twelve (12) months following the date of this Report. The Company may, from time to time, raise additional capital through private or public offerings of equity or debt securities, or through additional credit facilities, to support its strategic growth initiatives, including in connection with the Company’s application, submitted in September 2026, to list its common stock on The Nasdaq Stock Market and any related underwritten public offering. The listing application remains under review, and there can be no assurance that it will be approved, that any offering will be completed, or that additional capital, if needed, will be available on terms acceptable to the Company or at all.

 

12
 

 

GOING CONCERN CONSIDERATION

 

The Company has prepared its accompanying consolidated financial statements on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and other commitments in the ordinary course of business. In accordance with Accounting Standards Codification (“ASC”) 205-40, Presentation of Financial Statements — Going Concern, management has evaluated whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

 

As of September 30, 2026, the Company had cash, cash equivalents, and restricted cash of $33,144,429, working capital of $21,949,185, total stockholders’ equity of $34,284,980, and an accumulated surplus of $11,658,387, compared to cash, cash equivalents, and restricted cash of $17,669,749, working capital of $17,831,410, total stockholders’ equity of $22,691,288, and an accumulated surplus of $3,401,487 as of December 31, 2025. During the nine months ended September 30, 2026, the Company generated revenues of $35,924,742 (compared to $17,269,111 for the nine months ended September 30, 2025), net income of $8,249,837 (of which $8,256,902 was attributable to the stockholders of FDCTech, Inc. and $(7,065) was attributable to noncontrolling interests, compared to consolidated net income of $623,918 for the nine months ended September 30, 2025), and net cash used in operating activities of $(12,166,360) (compared to net cash used in operating activities of $(3,515,873) for the nine months ended September 30, 2025). The Company incurred a net loss of $(6,299,675) for the three months ended September 30, 2026.

 

Based on management’s evaluation of the Company’s historical and projected operating cash flows, existing cash and cash equivalents, working capital position, accumulated surplus, available borrowing capacity under existing credit facilities, and known contractual obligations and capital commitments, management has concluded that the Company’s existing cash and cash equivalents and anticipated cash flows from operations are sufficient to fund the Company’s operations and meet its known obligations as they become due for at least the twelve months following the date of issuance of these consolidated financial statements. Accordingly, management has concluded that there is no substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

We have based our management’s discussion and analysis of our financial condition and results of operations on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles. In preparing our financial statements, we must make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses for the reporting periods.

 

In more detail, we have described significant accounting policies in Note 2 of our annual financial statements included in our Form 10-K for the fiscal year ended December 31, 2025, as most recently amended by Amendment No. 4 on Form 10-K/A filed with the SEC on July 1, 2026. We continually evaluate our critical accounting estimates and judgments, as required by our policies, and update them as necessary based on changing conditions.

 

13
 

 

JOBS Act Accounting Election

 

Prior to December 31, 2022, the Company qualified as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as permitted under the JOBS Act, elected to delay the adoption of new or revised financial accounting standards until those standards would otherwise apply to private companies. The Company ceased to qualify as an emerging growth company effective December 31, 2022. Accordingly, the extended transition period for complying with new or revised financial accounting standards is no longer available to the Company, and the Company applies the effective dates applicable to public business entities for all periods presented in this Report.

 

Off-Balance Sheet Arrangements and Contractual Obligations

 

We have not engaged in any off-balance sheet arrangements as defined in Item 303 of the SEC’s Regulation S-K. We had no relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes.

 

Recent Accounting Pronouncements

 

The Company evaluates all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”) for applicability and impact on its consolidated financial statements.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose significant segment expenses regularly provided to the chief operating decision maker, an amount and description of other segment items, and additional segment information. The Company adopted ASU 2023-07 effective January 1, 2024, on a retrospective basis. The adoption did not have a material impact on the Company’s consolidated financial statements but expanded segment disclosures.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public business entities to disclose, on an annual basis, specific categories in the rate reconciliation and information about income taxes paid by jurisdiction. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. The Company adopted ASU 2023-09 effective January 1, 2025, on a prospective basis; the adoption expanded the Company’s annual income tax disclosures and did not affect its consolidated financial position, results of operations, or cash flows.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40),” which requires public business entities to disclose disaggregated information about specific income statement expense categories. ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statement disclosures.

 

Other recently issued ASUs not yet adopted by the Company are not expected to have a material impact on the Company’s consolidated financial statements when adopted.

 

For a complete description of accounting pronouncements recently adopted and issued but not yet adopted, see Note 2, Summary of Significant Accounting Policies — Recent Accounting Pronouncements, to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report.

 

For a more detailed description of our significant and critical accounting policies, please refer to Note 2 in the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025, as most recently amended by Amendment No. 4 on Form 10-K/A filed with the SEC on July 1, 2026.

 

14
 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS.

 

Not Applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer (together, the “Certifying Officers”), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Report, as further described below in connection with the restatement of our previously issued financial statements.

 

In light of the material weaknesses described below, management performed additional procedures to ensure that the unaudited condensed consolidated financial statements included in this Report have been prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management has concluded that, notwithstanding the material weaknesses identified, the unaudited condensed consolidated financial statements included in this Report present fairly, in all material respects, the Company’s financial position, results of operations, and cash flows for the periods presented.

 

Material Weaknesses in Internal Control over Financial Reporting

 

In connection with the preparation of this Report and the restatement described in Note 2 (Summary of Significant Accounting Policies — Restatement of Previously Issued Financial Statements) to the unaudited condensed consolidated financial statements, the Company identified the following material weaknesses in its internal control over financial reporting: (i) Consolidation and Intercompany Elimination — the Company did not have effective controls to ensure that intercompany cash positions and one-sided intercompany residual balances were identified and eliminated or appropriately classified in consolidation, resulting in the overstatement of cash and cash equivalents and the misclassification of related party receivable and related party advance balances; (ii) Noncontrolling Interest Attribution — the Company did not have effective controls to ensure that net income (loss) attributable to the noncontrolling interest was attributed and presented on the face of the consolidated statements of operations in accordance with ASC 810-10; (iii) Account Classification and Footing Review — the Company did not have effective controls to ensure that the components of other income (expense) were presented with the correct sign and footed to the reported total; and (iv) Lease Accounting Updates — the Company did not have effective controls to ensure that modifications to the parent company operating lease were timely reflected in rent expense, the right-of-use asset, and the related operating lease liabilities in accordance with ASC 842.

 

Remediation Plan

 

Management, under the oversight of the Board of Directors, has begun implementing the following remediation measures: (a) implementation of a standardized intercompany reconciliation and elimination checklist, including specific procedures to identify one-sided intercompany balances, performed as part of each quarterly close; (b) use of standardized templates and review procedures for the attribution of net income (loss) and other comprehensive income (loss) to the noncontrolling interest; (c) enhanced footing, cross-referencing, and sign-convention review procedures over the statement of operations and supporting schedules; and (d) a quarterly review of lease agreements and lease modifications to ensure timely recognition under ASC 842. These measures supplement the remediation actions previously described in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025. Management believes the steps outlined above, when fully implemented and operating effectively, will remediate the material weaknesses described herein; however, the material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period and management has concluded, through testing, that the controls are designed and operating effectively.

 

15
 

 

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

Management’s Report on Internal Controls over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act, as amended. Management, with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the Company’s internal control over financial reporting as of September 30, 2026. In making this assessment, management utilized the criteria established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in its 2013 Framework for Internal Control. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our consolidated financial statements for external reporting purposes in accordance with Generally Accepted Accounting Principles (GAAP). Our internal control over financial reporting includes those policies and procedures that:

 

(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,

 

(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

 

(3) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the consolidated financial statements.

 

Due to its inherent limitations, internal control over financial reporting may not be effective in preventing or detecting errors or misstatements in our consolidated financial statements. Additionally, projections of any evaluation of effectiveness in future periods are subject to the risk that controls may become inadequate due to changes in conditions or that the degree of compliance with policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting as of September 30, 2026. Based on our assessments, management determined that we did not maintain effective internal control over financial reporting as of September 30, 2026, due to the material weakness in our internal controls, including inadequate segregation of duties within account processes due to limited personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.

 

Management intends to implement remediation steps to enhance our internal controls, addressing inadequate segregation of duties within account processes, limited personnel resources, and insufficient written policies and procedures for accounting, IT, financial reporting, and record-keeping. We plan to further improve this process by enhancing the size and composition of our board upon the closing of the business, identifying third-party professionals with whom to consult regarding complex accounting applications, and considering additional staff with the requisite experience and training to supplement existing accounting professionals, and implementing additional layers of reviews in the internal controls and financial reporting process.

 

This Report does not include an attestation report from our independent registered public accounting firm on the effectiveness of our internal control over financial reporting, as the Company is a non-accelerated filer and is therefore not subject to the auditor attestation requirement of Section 404(b) of the Sarbanes-Oxley Act of 2002.

 

Changes in Internal Control over Financial Reporting

 

During the three and nine months ended September 30, 2026, in connection with the remediation efforts described above, the Company implemented changes in its internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting. These changes were directed principally at the Company’s operating subsidiaries and consisted of: (i) the designation of finance personnel at each of Alchemy Markets Ltd. (“AML”), Alchemy Prime Limited (“APL”) and Alchemy International Ltd. (“AIL”) with defined responsibility for the completeness and accuracy of the reporting package submitted to the parent for consolidation; (ii) implementation of a standardized monthly intercompany reconciliation and confirmation process under which each subsidiary agrees its intercompany and related party balances to the corresponding counterparty balance and identifies one-sided or unmatched items for resolution before the consolidation is prepared; (iii) introduction of a standardized subsidiary reporting template incorporating footing, cross-referencing and sign-convention checks over the statement of operations and supporting schedules; (iv) establishment of a preparer-and-reviewer approval hierarchy requiring sign-off at the subsidiary level and a second-level review at the parent level prior to submission for consolidation; and (v) enhanced segregation of duties over the recording and approval of intercompany transfers, related party advances and client money movements at the regulated subsidiaries. Management believes these changes strengthen the checks and balances applied at the subsidiary level; however, as described above, the material weaknesses will not be considered remediated until the applicable controls have operated for a sufficient period and management has concluded, through testing, that they are designed and operating effectively.

 

16
 

 

PART II.

 

ITEM 1. LEGAL PROCEEDINGS.

 

The Company and its subsidiaries are, from time to time, involved in legal proceedings arising in the ordinary course of business. The Company is currently a party to (or defending) the legal proceedings described in Note 8 (Commitments and Contingencies — Pending Litigation) to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report, which discussion is incorporated herein by reference.

 

Pursuant to Item 103 of Regulation S-K, the Company is required to disclose in this Item only those material pending legal proceedings, other than ordinary routine litigation incidental to the business, to which the Company or any of its subsidiaries is a party or of which any of their property is the subject, and any such proceeding involving a governmental authority where the monetary sanctions, exclusive of interest and costs, are reasonably expected to exceed $1,000,000, a threshold the Company has elected to apply in lieu of the $300,000 default threshold specified in Item 103(c)(3)(iii) of Regulation S-K. Based on the Company’s assessment, the amounts at issue in the proceedings described in Note 8 do not exceed 10% of the Company’s consolidated current assets, and the Company has determined that the proceedings described therein, individually or in the aggregate, do not currently rise to the level of “material” for purposes of Item 103. Notwithstanding this determination, the Company has elected to provide the more comprehensive descriptions in Note 8 to assist readers in understanding the Company’s litigation posture.

 

As of September 30, 2026, other than the $350,000 withheld purchase consideration accrued within Business acquisition loan in respect of the AML Litigation as described in Note 7, the Company has not recorded a loss accrual with respect to the matters described in Note 8, as Management has determined that any additional loss is not both probable and reasonably estimable as of that date. Management is unaware of any other material actions, suits, investigations, or proceedings (public or private) pending or threatened against or affecting the Company, its subsidiaries, or any of their respective assets, other than the matters described in Note 8 and other than ordinary routine litigation incidental to the business.

 

Item 1A. Risk Factors. 

 

In accordance with the requirements of Form 10-Q, the Company, as a smaller reporting company, is not required to disclose this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the three months ended September 30, 2026, the Company issued the following unregistered equity securities: (i) on July 13, 2026, 118,592,200 shares of Common Stock to eight holders upon the conversion of all 2,371,844 outstanding shares of Series B Convertible Preferred Stock, as described in Item 5 below and in Note 9; and (ii) on August 27, 2026, and August 28, 2026, 1,500,000 and 1,000,000 restricted shares of Common Stock, respectively, to two consultants in consideration of consulting services valued at an aggregate of $915,000. In addition, on August 20, 2026, and September 15, 2026, the Company issued promissory notes to Vanquish Funding Group Inc. in the aggregate principal amounts of $329,940 and $242,190, respectively, which are convertible into Common Stock only upon an event of default, as described in Note 7. Subsequent to the end of the quarter, on November 3, 2026, the Company issued 25,000 restricted shares of Common Stock, valued at $103,750, or $4.15 per share, to a director of the Company’s subsidiary Alchemy International Ltd. as compensation for services rendered to that subsidiary, as described in Note 16. Each of these issuances was made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D thereunder, and the securities are restricted securities. No underwriters were involved, and no commissions were paid. Other than as set forth above or previously reported in a Current Report on Form 8-K, there were no unregistered sales of the Company’s equity securities during the three months ended September 30, 2026, or through the date of this Report. For information regarding the Company’s prior unregistered issuances, refer to Item 5 (Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities) and Item 13 (Certain Relationships and Related Transactions) of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as most recently amended by Amendment No. 4 on Form 10-K/A filed with the SEC on July 1, 2026.

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

None

 

17
 

 

Item 5. Other Information.

 

Reverse Stock Split and Conversion of Series B Convertible Preferred Stock

 

On June 29, 2026, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware, effecting a one-for-one hundred (1-for-100) reverse stock split of its issued and outstanding shares of Common Stock, with any resulting fractional share rounded up to the nearest whole share for each holder of record. Following announcement by the Financial Industry Regulatory Authority on its Daily List on July 9, 2026, the reverse stock split became effective, and the Company’s Common Stock began trading on a post-split basis at the open of business on July 10, 2026. All share and per-share amounts in the consolidated financial statements and the accompanying notes have been retroactively adjusted to reflect the reverse stock split for all periods presented, in accordance with ASC 260-10-55-12 and SEC Staff Accounting Bulletin Topic 4C. See Note 1.

 

On July 13, 2026, the Board of Directors, acting by unanimous written consent, approved the conversion of all 2,371,844 outstanding shares of Series B Convertible Preferred Stock into 118,592,200 shares of Common Stock at a rate of fifty (50) shares of Common Stock for each share of Series B Convertible Preferred Stock. Following the conversion, no shares of Series B Convertible Preferred Stock remain issued or outstanding.

 

The shares of Common Stock issued upon conversion were issued to eight holders in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and are restricted securities. The conversion is described in Note 9 (Stockholders’ Equity) to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report. These matters were also reported in the Company’s Current Report on Form 8-K filed with the SEC on August 17, 2026. On August 17, 2026, the Company also filed Certificates of Amendment to its Certificate of Incorporation and to the Certificates of Designation of its Series A Convertible Preferred Stock and Series B Convertible Preferred Stock, as described in Notes 1 and 9, and, effective September 9, 2026, relocated its principal executive offices to Limassol, Cyprus, as described in Note 1.

 

Rule 10b5-1 Trading Arrangements

 

During the three months ended September 30, 2026, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408(a) of Regulation S-K.

 

Item 6. Exhibits.

 

(a) Exhibits.

 

Exhibit   Item
     
31.1   Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

18
 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  FDCTECH, INC.
   
Date: November 13, 2026 /s/ Mitchell M. Eaglstein
 

Mitchell M. Eaglstein, President and CEO

(Principal Executive Officer)

 

Date: November 13, 2026 /s/ Imran Firoz
 

Imran Firoz, CFO

(Principal Financial and Accounting Officer)

 

19
 

 

EXHIBIT INDEX

 

Exhibit   Item
     
31.1   Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

20

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-31.1

EX-31.2

EX-32.1

EX-32.2

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: R49.htm

IDEA: R50.htm

IDEA: R51.htm

IDEA: R52.htm

IDEA: R53.htm

IDEA: R54.htm

IDEA: R55.htm

IDEA: R56.htm

IDEA: R57.htm

IDEA: R58.htm

IDEA: R59.htm

IDEA: R60.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: form10-q_htm.xml